MicroRNAs regulate "de novo" DNA methylation and histone mRNA 3' end formation in mammalian cells by Sinkkonen, Lasse
 
 
 
 
MicroRNAs regulate de novo DNA methylation and 
histone mRNA 3’ end formation in mammalian cells 
 
 
 
 
 
Inauguraldissertation 
 
zur 
Erlangung der Würde eines Doktors der Philosophie 
vorgelegt der 
Philosophisch-Naturwissenschaftlichen Fakultät 
der Universität Basel 
 
von 
 
 
 
Lasse Sinkkonen 
aus Imatra, Finnland 
 
 
Basel, 2008 
 
 
  
Genehmigt von der Philosophisch-Naturwissenschaftlichen Fakultät auf Antrag von 
Professor Dr. Witold Filipowicz und Professor Dr. Mihaela Zavolan. 
 
 
 
Professor Dr. Witold Filipowicz   Professor Dr. Mihaela Zavolan 
(Referent)     (Koreferent) 
 
 
 
 
 
 
 
 
 
Basel, 16.9.2008 
 
 
 
         Professor Dr. Eberhard Parlow 
            (Dekan) 
 
 
 
 
 
 
Acknowledgements 
 
First of all, I would like to thank Witold Filipowicz for giving me the opportunity to do my PhD studies 
under his supervision in a new and exciting field. Witek is a supportive, inspiring mentor and a great 
scientist with passion for his work. 
 
I also wish to thank the members of my thesis committee, Helge Grosshans and Dirk Schübeler, for their 
critique and encouragement during our meetings as well as outside them.  
 
Thank you to Mihaela Zavolan for her ideas and support, and for being the co-referee of this thesis. 
Together with her students, Philipp Berninger and Dimos Gaidatzis, Mihaela helped me to understand how 
much bioinformatics can do for us. 
 
I wish to thank all the former and present members of the Filipowicz group. During the past 4 years, I have 
had the opportunity to work with more than 30 different group members with equally many backgrounds. 
You have all contributed to my studies and made it a unique experience. 
 
Special thanks to Petr Svoboda, supervisor of my PhD studies. Petr showed amazing patience by tolerating 
my endless questions and correcting my rough drafts into the early morning. His mind can create more 
projects than one can ever undertake and he has constantly new ideas, especially after a visit to the PB. 
 
Special thanks go also to Caroline Artus-Revel and Tabea Hugenschmidt. They have greatly helped me in 
all aspects in the lab and many aspects outside the lab. They have taught me several techniques and 
contributed to plenty of important experiments. 
 
I would like to thank Fabio Mohn for sharing his reagents and expertise on studying epigenetics of 
embryonic stem cells. 
 
I am thankful for the great facilities at the FMI. Especially I will remember the discussions with Ed 
Oakeley and the FACS expertise and tea offered by Hubertus Kohler. 
 
I am grateful for my family for their continuous support and belief in me. Their encouragement has always 
been important for me. 
 
Finally, I wish to thank Anne-Maria, for her support and understanding that have allowed me to pursue my 
ambitions, and most of all, for her love. 
Abbreviations 
 
ARE AU-rich element 
BS bisulphite sequencing 
CBC Cap-binding complex 
cDNA complementary DNA 
CDS coding sequence 
ChIP chromatin immunoprecipiation 
cpm counts per minute 
DNMT DNA methyltransferase 
dsRNA double-stranded RNA 
ESC embryonic stem cell 
FCS fetal calf serum 
GO gene ontology 
GSC germ-line stem cell 
H3K27me3 trimethylated lysine 27 of histone H3 
H3K4me2 dimethylated lysine 4 of histone H3 
H3K9me3 trimethylated lysine 9 of histone H3 
HDE histone downstream element 
HIST histone gene cluster 
HMT histone methyltransferase 
ICM inner cell mass 
kb kilobase 
KD knock-down 
LIF leukemia inhibitor factor 
miRNA microRNA 
miRNP micro-ribonucleoprotein  
mRNA messenger RNA 
natsiRNA natural-antisense transcript-derived siRNA 
NELF nuclear elongation factor 
NP neuronal precursor 
nt nucleotide 
P-body processing body 
piRNA Piwi-associated RNA 
PRC Polycomb group repressive complex 
PRE Polycomb response element 
pre-miRNA miRNA precursor 
pri-miRNA primary miRNA transcript 
PTGS post-transcriptional gene silencing 
RA retinoic acid 
rasiRNA repeat-associated siRNA 
RISC RNA-induced silencing complex  
RNAi RNA interference 
RPA RNase protection assay 
RT-qPCR real-time quantitative reverse transcription-PCR 
shRNA short haipin RNA 
siRNA short interfering RNA 
snRNA small nuclear RNA 
ta-siRNA trans-acting siRNA 
TE Tris-EDTA 
TN terminal neuron 
tRNA transfer RNA 
TSS transcription start site 
UTP uridine triphosphate 
UTR untranslated region 
 
 
 
 
 
 
 
 
 
 
 
Table of Contents 
 
1. SUMMARY ..............................................................................................1 
2. INTRODUCTION....................................................................................3 
2.1 GENE REGULATION BY SMALL RNAS......................................................................... 3 
2.2 MECHANISM OF RNA SILENCING ............................................................................... 4 
2.2.1 miRNA and siRNA biogenesis – Dicer as a key enzyme ............................................................ 5 
2.2.2 The effector phase of RNAi and miRNA pathways..................................................................... 7 
2.2.3 miRNAs and recognition of their target mRNAs........................................................................11 
2.3 BIOLOGICAL ROLE OF MIRNAS IN ANIMALS............................................................. 14 
2.3.1 miRNAs in proliferation and cell cycle control ..........................................................................14 
2.3.2 miRNAs in development and differentiation ..............................................................................19 
2.4 EPIGENETICS OF EMBRYONIC STEM CELLS AND THEIR DIFFERENTIATION ................. 24 
2.4.1 Transcriptional core circuitry of ESCs........................................................................................24 
2.4.2 Histone modifications in ESCs ...................................................................................................27 
2.4.3 DNA methylation in ESCs..........................................................................................................31 
2.4.4 miRNAs in ESCs ........................................................................................................................33 
2.5 REPLICATION-DEPENDENT HISTONE GENES .............................................................. 36 
2.6 REFERENCES ............................................................................................................ 40 
3. RESULTS AND DISCUSSION ............................................................54 
3.1 MIRNAS CONTROL DE NOVO DNA METHYLATION THROUGH REGULATION OF    
TRANSCRIPTIONAL REPRESSORS IN MOUSE EMBRYONIC STEM CELLS.............................. 54 
3.1.1 Published manuscript ..................................................................................................................55 
3.1.2 Supplementary material ..............................................................................................................64 
3.1.3 The silencing of pri-miR-290 locus by de novo DNA methylation during neuronal 
differentiation enables upregulation of neuronal genes .....................................................................100 
3.1.3.1 Aim of the project ............................................................................................................................. 100 
3.1.3.2 Results and discussion....................................................................................................................... 100 
3.1.3.3 Conclusions....................................................................................................................................... 106 
3.1.3.4 Methods............................................................................................................................................. 108 
3.1.3.5 References......................................................................................................................................... 111 
3.2. INTACT RNA SILENCING MACHINERY IS NECESSARY FOR PROPER 3’ END PROCESSING 
OF REPLICATION-DEPENDENT HISTONE MRNAS........................................................... 112 
3.2.1 Aim of the project .....................................................................................................................113 
3.2.2 Results and discussion ..............................................................................................................113 
3.2.3 Conclusions...............................................................................................................................125 
3.2.4 Methods ....................................................................................................................................127 
3.2.5 References.................................................................................................................................130 
4. CURRICULUM VITAE......................................................................131 
 
1 
1. Summary 
 
MicroRNAs (miRNAs) are known to have many important functions in mammalian cells. 
They can influence the expression of their target genes and in this way regulate the 
function of not only their primary targets, but also of the pathways and mechanisms 
acting downstream of the primary targets. There are several key proteins that are required 
for the biogenesis of miRNAs and for mediating the repressive functions of miRNAs in 
mammals, the most critical being the ribonuclease (RNase) III enzyme Dicer. Since Dicer 
is required for generation of all known mammalian miRNAs, depletion of Dicer is an 
appealing strategy to identify and study the pathways under miRNA-mediated control.  
  Deletion of Dicer in mouse embryonic stem cells (ESCs) is rendering the cells to 
slow growth rate and inability to differentiate, and thus, to loose their most important 
feature i.e. pluripotency. We aimed to understand in further detail the causes behind these 
critical defects. We have performed transcriptional profiling of Dicer-deficient ESCs and 
through bioinformatic analysis we identified miRNAs of the ESC-specific miR-290 
cluster to be functionally most important for mouse ESCs. These miRNAs were found to 
directly control the expression of several hundred primary targets and through their 
regulation influence many features of the ESCs. We found the miR-290 miRNAs to 
contribute to the growth rate of the ESCs and to influence also expression of many 
secondary target genes. Among their secondary targets we identified de novo DNA 
methyltrasferases (DNMT3s) that were significantly downregulated in Dicer-deficient 
mouse ESCs. The downregulation was due to an increased expression of Retinoblastoma-
like2 (RBL2), a transcriptional repressor and primary target miR-290 miRNAs. As a 
consequence of lowered DNMT3 expression the cells were unable to methylate DNA at 
the promoter of pluripotency genes such as Oct-4 (Octamer-binding transcription factor-4, 
also known as Pou5f1 for POU-domain, class 5, transcription factor 1), and thus, 
incapable of fully silencing these genes during differentiation. Hence, regulation of 
DNMT3s by miR-290 miRNAs is contributing to the maintenance of mouse ESC 
pluripotency. 
 Further analysis of the promoter of primary miR-290 transcript (pri-miR-290) 
showed that the ESC specific expression and subsequent silencing of the transcript during 
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neuronal differentiation is regulated by the chromatin status of the promoter. During 
neuronal differentiation the pri-miR-290 promoter looses histone modifications 
characteristic of active genes and gains typical marks of silenced chromatin. This is 
followed by de novo DNA methylation of the pri-miR-290 promoter. It is likely that the 
silencing of pri-miR-290 depends on DNA methylation of its promoter, thus allowing an 
auto-regulatory loop between the miRNAs and DNMT3 enzymes. 
 In addition to Dicer-deficient mouse ESCs, we have studied the importance of 
Dicer as well as Argonaute proteins for the function of human cell lines by inducibly 
depleting these proteins in human HEK293T-REx cells. We observed that an intact RNA 
silencing pathway is needed for normal expression of many of the replication-dependent 
histone genes. We found up to 25% of all histone mRNAs to be upregulated upon loss of 
RNAi machinery and more detailed analysis of one of the histone genes, HIST1H3H, 
demonstrated that the upregulation was due to enhanced polyadenylation of the histone 
mRNA. This is in contrast to the normal 3’ end processing of replication-dependent 
histone mRNAs that takes place at the 3’ end-proximal stem-loop and is not followed by 
polyadenylation. The analysis of RNA from Dicer- or Dgcr8-deficient ESCs showed that 
this type of regulation of 3’ end formation by RNA silencing pathway is conserved in 
mice and depends on the generation of miRNAs. Thus, miRNAs seem to regulate the 3’ 
end processing of replication-dependent histone mRNAs. Future work will be needed to 
identify specific miRNAs and processing factors involved. 
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2. Introduction 
 
2.1 Gene regulation by small RNAs 
It has become evident that non-coding RNA molecules play pivotal regulatory roles in 
eukaryotic cells, indicating that these cells are more complex than would be expected 
simply based on the number of their protein coding genes. Our understanding of these 
regulatory phenomena has substantially increased during the past decade with the 
discovery and characterization of various classes of small regulatory RNAs (21- to 30-nt 
in length). The early work in plants had described post-transcriptional gene silencing 
(PTGS) where expression of a transgene was capable of suppressing other homologous 
sequences, suggesting a regulatory role for RNA (Napoli et al. 1990; Hobbs et al. 1993; 
Lindbo et al. 1993; English et al. 1996). But it was the experiments of Andrew Fire and 
Craig Mello showing double stranded RNA (dsRNA) as a potent inducer of gene 
silencing or RNA interference (RNAi) in nematode Caenorhabditis elegans, that 
provoked great interest into the regulatory function of RNA (Fire et al. 1998). Subsequent 
research in many different species has revealed that dsRNA is processed into short 
interfering RNAs (siRNAs, 21- to 25-nt in length) that guide the cleavage of their 
cognate target RNAs (Hamilton and Baulcombe 1999; Hammond et al. 2000; Zamore et 
al. 2000). 
 The discovery of siRNAs has been followed by identification of many other small 
regulatory RNAs. miRNAs were originally identified as non-coding developmental 
regulators in C. elegans and were later found to be evolutionary ancient, endogenously 
encoded, small RNAs (21- to 25-nt in length) capable of regulating the translation of their 
target mRNAs (Lee et al. 1993; Lagos-Quintana et al. 2001; Lau et al. 2001; Lee and 
Ambros 2001). miRNAs are now known to play important roles in many cellular 
processes (see chapter 2.3). In addition to siRNAs produced from exogenous dsRNA, 
endogenously encoded siRNAs have been described in many different species. Plants 
have the biggest variety of endogenous siRNAs ranging from trans-acting siRNAs (ta-
siRNAs) and natural-antisense transcript-derived siRNAs (natsiRNAs) to repeat-
associated siRNAs (rasiRNAs), which differ from each other in both their biogenesis as 
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well as function (Vazquez 2006). Improved high-throughput sequencing technologies 
have allowed detection of endogenous siRNAs also in fission yeast Schizosaccaromyces 
pombe, nematode C. elegans and more recently also in fruit fly Drosophila melanogaster 
as well as mouse oocytes (Cam et al. 2005; Ruby et al. 2006; Czech et al. 2008; Tam et al. 
2008; Watanabe et al. 2008). The main function of these siRNAs appears to be the 
repression of retrotransposons and other repetitive sequences. At least in plants and 
fission yeast the endogenous siRNAs can direct transcriptional silencing and chromatin 
condensation at the homologous sites of the genome (Wassenegger et al. 1994; Mette et 
al. 2000; Volpe et al. 2002; Verdel et al. 2004).  
 The most recently identified class of small regulatory RNAs is that of Piwi-
associated RNAs (piRNAs). The biogenesis of piRNAs differs from siRNAs and 
miRNAs, which is reflected by their slightly longer length (24- to 30-nt), and piRNAs are 
produced from single-stranded precursors (Aravin et al. 2006; Grivna et al. 2006; Lau et 
al. 2006; Brennecke et al. 2007). piRNAs are specifically expressed in germ cells and 
seem to mediate their function through association with the Argonaute-related effector 
proteins called Piwi-proteins. The exact mechanisms of piRNA function through Piwi-
proteins remains elusive but genetic studies in D. melanogaster, zebrafish and mice 
suggests that they are necessary for germline development and, similarly to endogenous 
siRNAs, needed for retrotransposon silencing (Cox et al. 1998; Deng and Lin 2002; 
Aravin et al. 2004; Kuramochi-Miyagawa et al. 2004; Carmell et al. 2007; Houwing et al. 
2007). According to recent data, this silencing appears to be medaited by DNA 
methylation of the repeat sequences (Kuramochi-Miyagawa et al. 2004). 
 In the following chapters of the introduction I will be focusing on the biogenesis 
of siRNAs and miRNAs, mechanism of their function in RNA silencing - including the 
target recognition by miRNAs - and on the biological function of miRNAs in animals. 
Especially I will focus on the different cellular roles of miRNAs in mammals. 
2.2 Mechanism of RNA silencing 
Both siRNAs and miRNAs are processed from dsRNA precursors into mature 21- to 25-
nt RNA duplexes by RNase III type enzyme called Dicer. Following this processing, they 
are loaded into a multiprotein-complex called RNA-induced silencing complex (RISC) 
(or micro-ribonucleoprotein (miRNP) complex in the case of miRNAs, see Figure 1). 
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This is considered the initiation phase of RNA silencing. It is followed by the effector 
phase where the mature siRNA or miRNA guides the RISC/miRNP to the correct target 
mRNA to induce its silencing. 
NUCLEUS
CYTOPLASM
pri-miRNA
Drosha
(+DGCR8)
pre-miRNA
Pol II
DICER
short mature miRNAs
(21-22 nt)
Exportin 5
pre-miRNA
AGO
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storage of mRNA 
in P-body
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Figure 1. Biogenesis and function of miRNAs. 
Primary miRNA transcripts are transcribed by RNA Pol II in the nucleus where they are processed by 
RNase III type enzyme Drosha and its dsRNA-binding partner DGCR8 into miRNA precursors. Precursor 
of the miRNA is exported to the cytoplasm where it is further processed by another RNase III type enzyme 
Dicer into a mature miRNA duplex. The strand with lower stability at its 5’ end (in red) is selected to be 
loaded on to the miRNP complex. The miRNA guides the Argonaute protein and rest of the complex to the 
correct target mRNA that becomes translationally repressed and destabilized. This is accompanied by 
relocalization of the mRNA to a P-body. 
 
2.2.1 miRNA and siRNA biogenesis – Dicer as a key enzyme 
The main difference between siRNAs and miRNAs is the source of their double-stranded 
precursor-RNA. The long dsRNA precursors of siRNAs can derive from antisense 
transcription, viral replication or for example transfection. miRNAs on the other hand are 
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RNA-polymerase II (RNA Pol II) transcripts of variable length that are 5’ capped and 
polyadenylated (Cai et al. 2004). Still, the majority of miRNAs seem to arise from introns 
of protein coding genes (Kim and Kim 2007). These primary miRNA transcripts (pri-
miRNAs) usually give rise to several different mature miRNAs. Such a group of co-
transcribed miRNAs is called a miRNA cluster. They are processed in the nucleus by the 
Microprocessor complex containing RNase III enzyme Drosha and a double-stranded 
RNA binding protein DGCR8 (DiGeorge syndrome critical region gene-8 in vertebrates, 
Pasha in invertabrates) into around 70-nt imperfect hairpin structures called miRNA 
precursors (pre-miRNAs) (Denli et al. 2004; Gregory et al. 2004). Recent data has also 
indicated existence of so called mirtrons, miRNAs derived from introns through splicing, 
independently of Drosha and DGCR8 (Berezikov et al. 2007; Okamura et al. 2007; Ruby 
et al. 2007). 
 After the pre-miRNAs are exported into the cytoplasm by Exportin 5, like 
siRNAs, they are further cleaved by the RNase III enzyme Dicer (Hutvagner et al. 2001; 
Yi et al. 2003; Lund et al. 2004). Mammals and C. elegans have only one Dicer gene 
while D. melanogaster has two Dicers, Dcr-1 for miRNA production and Dcr-2 for 
siRNA production (Lee et al. 2004). Thus, in D. melanogaster miRNA and siRNA 
pathways are genetically diverged. Dicer measures approximately two helical turns from 
the Drosha cleavage site to produce 21- to 25-nt RNA duplex that has 2-nt 3’-overhangs, 
hallmarks of RNase III enzyme cleavage. Together with its interacting partner TRBP 
(TAR RNA binding protein), Dicer recruits one of the Argonaute proteins (AGO1 to 
AGO4 in mammals) to form a trimeric complex (Chendrimada et al. 2005; Haase et al. 
2005). This initiates the formation of the RISC/miRNP (Gregory et al. 2005). Only one 
strand of the small RNA duplex, the guide strand, is loaded on to the RISC/miRNP and 
into the RNA binding pocket of the Argonaute protein, while the other strand, called the 
passenger strand, is degraded. The guide strand is selected based on the stability of the 
base-pairing at the 5’ end of the RNA duplex so that the strand with lower stability is 
loaded on to the RISC/miRNP (Schwarz et al. 2003). Argonautes are considered to be the 
effector proteins of the RISC/miRNP. This is reflected for example by their ability to 
repress protein synthesis, when they are artificially tethered to the 3’ untranslated region 
(3’ UTR) of a reporter mRNA, independently of miRNAs (Pillai et al. 2004). 
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 It has been shown that, in addition to transcriptional regulation, the biogenesis of 
miRNAs can be regulated both at the level of Drosha cleavage as well as at the level of 
Dicer cleavage (Obernosterer et al. 2006; Thomson et al. 2006; Davis et al. 2008; 
Newman et al. 2008; Rybak et al. 2008; Viswanathan et al. 2008). But the fact that all 
siRNAs and miRNAs require Dicer for their maturation makes Dicer the key enzyme 
necessary for RNA silencing.  
2.2.2 The effector phase of RNAi and miRNA pathways 
Once bound by the Argonaute protein of the RISC/miRNP, the siRNA or the miRNA can 
direct the complex to the correct target mRNA. This happens by basepairing between the 
guide RNA and the target mRNA, typically at the 3’ UTR of the mRNA. When this 
interaction happens through perfect complementarity, a characteristic of siRNAs, it leads 
to endonucleolytic cleavage of the target mRNA in the middle of the interaction between 
positions 10 and 11 of the siRNA. This cleavage, referred to as slicing, can be mediated 
only by one of the mammalian Argonaute proteins, AGO2, and is catalyzed by the RNase 
H fold in the PIWI-domain of the protein (Liu et al. 2004; Meister et al. 2004). Only one 
miRNA has been shown to induce AGO2 mediated slicing (Yekta et al. 2004). However, 
animal miRNAs usually bind to their target mRNAs with partial complementarity and 
induce repression of protein synthesis. 
  The exact mechanism of repression of protein synthesis is still under debate and 
several different mechanisms have been proposed. Initial experiments aiming to address 
the mechanism of miRNA-mediated silencing showed that the cognate mRNAs of the 
original C. elegans miRNA lin-4 were associated with polyribosomes, arguing that 
repression by the miRNA takes place after the initiation of translation (Olsen and Ambros 
1999; Seggerson et al. 2002). Degradation of the nascent polypeptide was suggested as 
one of the possible mechanisms. Later studies were able to confirm the association of the 
target mRNAs as well as of the miRNAs with polyribosomes in human cells but excluded 
peptide degradation as a possible mechanism of function (Maroney et al. 2006; Petersen 
et al. 2006). Instead, miRNAs were suggested to cause the ribosomes to drop off and 
prematurely terminate the translation of the repressed target mRNAs. This model is in 
conflict with the accumulating evidence for miRNA-mediated repression at the 
translational initiation. Experiments using reporter genes carrying let-7 binding sites in 
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their 3’ UTRs have shown that m7G-cap of the mRNA is necessary for translational 
repression (Humphreys et al. 2005; Pillai et al. 2005). This observation has been 
supported by several different in vitro assays using cell-free extracts from different 
species (Wang et al. 2006; Mathonnet et al. 2007; Thermann and Hentze 2007; 
Wakiyama et al. 2007). In addition to m7G-cap, these studies also suggest a role for poly-
A tail in miRNA-mediated repression. This is consistent with the model for inhibition of 
translational initiation, since poly-A-tail and the poly-A binding protein (PABP) are 
known to work in synergy with the m7G-cap to regulate translational initiation 
(Kahvejian et al. 2005). Recently, a compromise to resolve the conflicting data 
supporting repression on initiation and repression on elongation was suggested. Kong et 
al. propose that the method of repression would be dependent on the promoter driving the 
expression of the target mRNA i.e. the nuclear history of the mRNA might determine its 
destiny in regard to miRNA-mediated repression (Kong et al. 2008). 
 Also additional proteins called GW182 proteins (GW182A to GW182C in 
mammals, GW182 in D. melanogaster) and their C. elegans homolog AIN-1 have been 
shown to be essential for miRNA-mediated repression (Ding et al. 2005; Liu et al. 2005; 
Eulalio et al. 2008). A direct interaction between GW182 and the Argonaute protein was 
found to be necessary for miRNA-induced repression, signifying that GW182 is 
mediating the repressive activity of the miRNA-bound Argonaute. This fits with the fact 
that the repressed mRNAs, miRNAs, as well as many components of the RNA silencing 
pathway, including Argonautes and GW182 proteins, accumulate in discrete cytoplasmic 
foci called GW-bodies or processing bodies (P-bodies) (Jakymiw et al. 2005; Liu et al. 
2005; Pillai et al. 2005; Sen and Blau 2005; Bhattacharyya et al. 2006). Since the 
Argonaute proteins can be found distributed throughout the cytoplasm, in addition to 
their P-body localization, it is likely that they initiate the repression of the target mRNA 
in the cytoplasm outside of P-bodies, which is then later followed by accumulation into 
the P-bodies. The exact order of these events is still unknown. But interestingly, intact 
miRNA biogenesis and RNA silencing machinery are required for formation of P-bodies, 
supporting the idea that P-body accumulation of RISC/miRNP is a secondary effect of 
RNA silencing (Pauley et al. 2006; Eulalio et al. 2007). Because siRNA-loaded AGO2 
can slice its target mRNA itself immediately after recognition, it would be reasonable to 
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suggest that P-body formation depends only on miRNA function. But curiously, also 
depletion of DCR-2 or AGO2, proteins specific for the RNAi pathway in D. 
melanogaster, is sufficient to disrupt P-bodies (Eulalio et al. 2007). 
  The P-bodies were originally identified as conserved sites of mRNA storage and 
degradation that contain a plethora of proteins required for different aspects of mRNA 
turnover such as decapping, deadenylation and exonucleolytic activity (reviewed in 
(Parker and Sheth 2007). Such colocalization of RNA silencing pathway and miRNAs 
with the mRNA decay machinery would argue for degradation of miRNAs targets, in 
addition to their translational inhibition. This indeed seems to be the case. Schmitter et al. 
showed that repression of reporter gene construct by endogenous let-7 is accompanied by 
mRNA degradation in human cells, more so in HEK293 than HeLa cells (Schmitter et al. 
2006). In C. elegans the endogenous target mRNAs of miRNAs let-7 and lin-4, as well as 
transgene reporter mRNAs carrying response elements for these miRNAs, were shown to 
be downregulated in their translational efficiency as well as at the mRNA level, when the 
miRNAs were expressed (Bagga et al. 2005). Similarly, miR-125b was shown to target 
LIN28 during differentiation of mouse embryonal carcinoma cells and, in addition to 
downregulation of the protein, also the lin28 mRNA was reduced (Wu and Belasco 2005). 
This regulation too could be recapitulated using reporter gene constructs. Further analysis 
of miR-125b mediated silencing in human cell lines revealed that the mRNAs targeted by 
miR-125b were not cleaved at the miRNA binding site but were targeted for removal of 
their poly-A tail (Wu et al. 2006). Interestingly, replacement of the poly-A tail by histone 
3’ end stem-loop stabilized the mRNA but did not fully rescue the translation, indicating 
that the translational inhibition and mRNA decay are working in an additive manner. 
Observations supporting the role of miRNAs in target mRNA deadenylation have been 
also made in zebrafish where miR-430 has been shown to be responsible for 
deadenylation and removal of hundreds of maternal transcripts during early 
embryogenesis (Giraldez et al. 2006). The most detailed analysis of miRNA induced 
mRNA degradation was done with S2 cells of D. melanogaster (Behm-Ansmant et al. 
2006). These experiments further strengthened the importance of GW182 in miRNA 
function by showing that tethered GW182 alone was sufficient to silence a reporter gene 
mRNA independently of the Argonaute protein or the miRNA. Notably, the GW182 
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induced mRNA decay was accompanied by deadenylation of the mRNA. And depletion 
of CCR4:NOT deadenylation complex or DCP1:DCP2 decapping complex, all of which 
are components of P-bodies, was sufficient to alleviate the mRNA degradation. Thus, 
miRNA-mediated RNA silencing seems to induce translational repression as well as 
mRNA degradation. Importantly, the fact that miRNAs affect their targets also at the 
mRNA level allows a genome-wide analysis of their impact on the transcriptome by the 
use of mRNA microarrays. Indeed, additional support for miRNA induced mRNA decay 
comes from microarray experiments (Lim et al. 2005; Behm-Ansmant et al. 2006; 
Rehwinkel et al. 2006; Schmitter et al. 2006; Wu et al. 2006). Overexpression or 
depletion of specific miRNAs is causing misregulation of transcripts enriched for 
respective miRNA binding sites in their 3’ UTRs. And depletion of different components 
of the RNA silencing pathway seems to lead to similar misregulation at the transcriptome 
level, irrespective of which RNA silencing protein is depleted.  
 Yet several examples exist where miRNAs or tethering of RISC/miRNP 
components leads only to translational inhibition. In fact, in some special cellular 
conditions the repression by the miRNAs can be relieved (Bhattacharyya et al. 2006; 
Schratt et al. 2006; Kedde et al. 2007). This is consistent with the other function of P-
bodies, the storage of repressed mRNAs. Some miRNA targets can become 
translationally silenced and stored in P-bodies until a specific cellular signal such as 
neuronal stimulation or cellular stress induces their rapid return to the translated pool. 
This relief of repression is mediated by additional translational regulators that bind to the 
3’ UTRs of the mRNAs targeted by the miRNA. The details of how certain miRNA 
targets are selected only for translational repression while others exhibit also mRNA 
decay remain to be solved. However, a very recent, large scale analysis for both 
proteomic and transcriptomic status of cells overexpressing or depleted of different 
miRNAs indicated that in most cases both protein as well as the mRNA level of the 
miRNA target are affected (Selbach et al. 2008). 
 Generally miRNAs and siRNAs are inducing repression and/or degradation of 
their target mRNAs. But some reports suggest that also the opposite i.e. RNA activation 
could be taking place under specific conditions. Vasudevan et al. were able to show that 
miR-369-3p can activate translation of TNFα (Tumor necrosis factor-α) mRNA through 
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binding to an AU-rich element (ARE) in its 3’ UTR in cell cycle arrested, G0-stage 
human cells (Vasudevan and Steitz 2007; Vasudevan et al. 2007). This activation 
depended on the presence of AGO2 and an AGO2-interacting protein FXR1 (fragile-X-
mental-retardation-related protein 1). The observation could be further extended also for 
regulation by other miRNAs like let-7 and a synthetic miRNA miRcxc4. For each of 
these miRNAs the selection between repression and activation of the target mRNA 
depended on the cell cycle conditions. Taken together, these and other reports imply that 
we have still a lot to learn about the exact mechanism of miRNA function. 
2.2.3 miRNAs and recognition of their target mRNAs 
The miRNA Registry (http://microrna.sanger.ac.uk) currently (release 11.0) enlists 678 
human and 472 mouse miRNAs. The same number for both C. elegans and D. 
melanogaster is around 150 miRNAs each. These numbers of identified miRNAs have 
been steadily increasing over the past years and with the development of more 
sophisticated high-throughput sequencing methods, are expected to further increase. 
Considering that many of the miRNAs might be expressed in tissues and conditions that 
have not yet been analyzed, the total number of the mature miRNAs in mammals could 
rise to thousands. The largest analysis of miRNA expression profiles in mammals so far 
was conducted by Landgraf et al. (Landgraf et al. 2007). They cloned and sequenced 
small RNA sequences from 26 different organs and cell types from humans, mice and 
rats. This effort was able to confirm expression of 300-400 different miRNAs in each 
species with at least 70 different mature miRNAs expressed in each given cell type. 
Deep-sequencing of HeLa cells was able to identify more than 200 expressed miRNAs in 
this single cell type (Friedlander et al. 2008). However, approximately half of these 
miRNAs were expressed at fairly low levels that might not have a physiological 
significance. Landgraf et al. found several miRNAs to be expressed ubiquitously across 
the tested cell types while other miRNAs showed more specific expression patterns. A 
third of the miRNAs were expressed with high tissue specificity while only a few were 
restricted for certain cell type. The most ubiquitous and abundant miRNA turned out to 
be miR-16 while the highest exclusivity was conferred by the miRNAs expressed solely 
in embryo (Landgraf et al. 2007). 
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  The number of miRNA targets varies depending on the miRNA and the more 
conserved miRNAs seem to have the highest number of targets (Lewis et al. 2003). 
Computational predictions based on miRNA binding sites in the 3’ UTRs of mRNAs 
imply that an average vertebrate miRNA has more than 200 putative targets and, at least 
in humans, more than 20% of the transcriptome could be regulated by miRNAs (Lewis et 
al. 2003; Krek et al. 2005; Xie et al. 2005). Yet these predictions may be underestimates 
as they do not take into consideration the evolutionary new, non-conserved binding sites. 
On the other hand, many mRNAs and miRNAs might never interact with each other in 
physiological conditions since they can be expressed in different tissues or developmental 
stages. The predicted numbers of targets have received some validation from microarray 
experiments monitoring the transcriptomes of cells overexpressing or depleted of 
individual miRNAs (Krutzfeldt et al. 2005; Lim et al. 2005; Linsley et al. 2007). 
Depletion of endogenous miR-122 from mouse liver by use of antagomirs induced 
upregulation of 363 transcripts (Krutzfeldt et al. 2005). Consistent with direct miRNA-
mediated regulation, these transcripts were enriched for binding sites for miR-122 in their 
3’ UTRs. Similarly, transfection of miR-1 or miR-124 to HeLa cells led to 
downregulation of 96 and 174 mRNAs, respectively (Lim et al. 2005). Consistently with 
their specific endogenous expression in skeletal muscle (for miR-1) and in brain (for 
miR-124), their transfection shifted the transcriptome of HeLa cells towards that of the 
aforementioned tissues. That is to say that genes downregulated by miR-1 or mir-124 are 
ones that are expressed at low levels in skeletal muscle or brain, respectively. This is in 
keeping with the analyses of expression profiles of predicted miRNA targets  (Farh et al. 
2005; Stark et al. 2005; Sood et al. 2006). These analyses show that a miRNA and its 
putative targets are often expressed in the same tissues but the levels of the target 
mRNAs are very low compared to other tissues not expressing the miRNA. In addition, 
the mRNAs that are expressed at high levels in a tissue with a given miRNA, especially 
the ubiquitously expressed mRNAs of housekeeping genes, have evolved to avoid 
miRNA binding sites in their 3’ UTRs (Farh et al. 2005). 
 miRNAs recognize their target mRNAs by basepairing to the complementary 
binding sites in the target mRNA. Several reports have described universal and conserved 
rules for miRNA target recognition in animals (Doench and Sharp 2004; Kloosterman et 
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al. 2004; Brennecke et al. 2005; Gaidatzis et al. 2007; Grimson et al. 2007). The binding 
sites for miRNAs are usually located in the 3’ UTRs of the target mRNAs but an 
insertion of a binding site to the 5’ UTR or even the coding sequence (CDS) is also 
capable of inducing silencing. In the long 3’ UTRs (> 1300-nt) the binding sites seem to 
localize to the 5’ and 3’ends of the 3’ UTR rather than the center. Still, the binding site 
should be further than 15 nt from a stop codon. Number of miRNA binding sites appears 
to be attributable to the extent of silencing observed and a close proximity of binding 
sites in the 3’ UTR seems to enhance the silencing. This is true for two binding sites for 
the same miRNA as well as binding sites for two different miRNAs. In addition, miRNA 
binding sites reside preferentially near AU-rich sequences supporting the idea of 
interplay between miRNA regulation and regulatory proteins binding to AREs. While 
siRNAs bind their targets with perfect complementarity, miRNAs show imperfect 
basepairing. The computational analysis of microarray data as well as reporter gene 
assays utilizing point mutations have demonstrated that the 5’ end of the miRNA is most 
important for the miRNA:mRNA interaction. Especially the positions 2-8 of the miRNA 
appear to be critical for efficient target repression. This region has been termed the seed 
region of the miRNA. Yet, there are cases where imperfect base-pairing or weaker G-U 
base-pairing at the seed can still stimulate effective silencing. This is usually due to an 
increased base-pairing in the 3’ half of the miRNA, especially at the positions 13 to 16. 
 Defining rules for miRNA:mRNA interaction has been vital for generation of 
different tools for predicting miRNA targets. Currently most prediction programs rely on 
the presence and conservation of an intact complement for the seed sequence in the target 
mRNA. In their proteome and transcriptome wide analysis of miRNA-mediated 
regulation, Selbach et al. compared the accuracy of different prediction programs 
(Selbach et al. 2008). This comparison, together with other aforementioned genome-wide 
analyses, suggests that in general the seed sequence is the most critical determinant of 
miRNA target recognition. But it is likely that many special cases exist where the seed 
does not play a crucial role. 
 Many of the mature miRNAs are conserved across animal species, particularly at 
their seed regions. In addition to their homologs in other species, the miRNAs can also 
have multiple paralogous miRNAs expressed from within the same genome. These 
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related miRNAs can derive from the same primary transcript or from separate transcripts 
and have probably been generated through gene duplications during the evolution. The 
miRNAs with similar sequences at their seed region as well as beyond it form miRNA 
families. Members of miRNA families are often functionally redundant, meaning that 
they can regulate the same target mRNAs and the removal of a single member of a family 
is often not sufficient to cause major regulatory defects. This type of additive regulation 
has been demonstrated for example by genetic studies of miRNA families in C. elegans 
and mouse (Abbott et al. 2005; Miska et al. 2007; Ventura et al. 2008). The redundancy 
between miRNAs allows multicellular organisms an additional level of regulation by 
altering the number of miRNA family members expressed in a given tissue but further 
complicates our effort to understand the miRNA-mediated regulation. 
2.3 Biological role of miRNAs in animals 
Gene ontology (GO) analysis of predicted miRNA targets revealed gene categories 
related to developmental processes as the most significant categories under miRNA 
control in the tissues of Drosophila (Stark et al. 2005). This prediction is now supported 
across the animal kingdom by vast body of literature that relies on different approaches 
from complete depletion of miRNAs to analysis of effects of single miRNAs. miRNAs 
appear to fine-tune and support the transition from one transcriptional program to another 
during development. Still, miRNAs have biological functions beyond just development 
and they have been implicated in processes as variable as immune defense and 
metabolism (Esau et al. 2006; Vigorito et al. 2007). In the following chapters (2.3.1 and 
2.3.2) I will focus on few main biological roles of miRNAs that are also interconnected, 
their function in cell cycle and in development. 
2.3.1 miRNAs in proliferation and cell cycle control 
Proliferation is a critical part of successful development and defects in differentiation can 
often be attributed to malfunctioning cell cycle control. During differentiation from a 
stem cell or a progenitor to a terminally differentiated cell type, the cells usually have to 
orchestrate an exit from the cell cycle, and occasionally, re-enter it. miRNAs are known 
to be necessary for proliferation and proper cell cycle control in many species. Grishok 
and Sharp studied the nuclear divisions in C. elegans intestine and discovered that knock-
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down (KD) of Argonaute proteins of C. elegans (ALG-1 and ALG-2) or Dicer (DCR-1) 
resulted in slight increase in the number of divisions (Grishok and Sharp 2005). And 
when these KDs were carried out in the absence of LIN-35 (C. elegans homolog of 
retinoblastoma (RB) protein), the increase was even greater than that in Lin35 knock-out 
alone. One of the reasons for increased divisions was found to be upregulation of cyclin E 
expression. These data suggest a synergistic function of RNAi pathway and RB pathway 
in the control of cell cycle, although miRNAs were not directly implicated. Similarly, the 
analysis of germ-line stem cells (GSCs) in D. melanogaster showed that loss of DCR-1, 
the Drosophila Dicer required for miRNA processing, triggered a delay in G1- to S-phase 
transition (Hatfield et al. 2005). This delay was found to be specific for stem cells. Also 
here the phenotype was accompanied by increased cyclin E expression that interestingly 
depended on upregulation of cyclin-dependent kinase inhibitor Dacapo (Dap, homolog of 
mammalian cyclin-dependent kinase inhibitors CDKN1A/CDKN1B or p21/p27). The 
role of miRNAs in cell cycle control is not a specialty of invertebrates. Loss of Dicer and 
miRNAs in both mouse ESCs as well as mouse chondrocytes leads to drastically 
decreased growth rate (Kanellopoulou et al. 2005; Murchison et al. 2005; Kobayashi et al. 
2008). Very similar proliferation defect was observed also in mouse ESCs lacking 
DGCR8, arguing that this defect is due to loss of Drosha and Dicer generated miRNAs 
(Wang et al. 2007). Consistent with these observations, inducible human HEK293 Dicer- 
and AGO2-KD cells lines show significantly decreased growth rate upon loss of Dicer or 
AGO2 (Schmitter et al., unpublished results). Reduced cell division is also true for 
chicken-human DT40 hybrid cells that have been depleted for Dicer (Fukagawa et al. 
2004). These cells accumulate in the G2/M-phase of the cell cycle but in this case the 
growth defect was suggested to be due to premature sister chromatid separation in mitosis, 
possibly caused by improper heterochromatin formation. 
 Since loss of miRNAs seems to cause decreased proliferation in so many different 
cell types and species, it is tempting to speculate that there are miRNAs that can inhibit 
some conserved pathways responsible for stalling the cell cycle progression. Indeed, such 
miRNAs have been described. One of the first miRNAs to have a function described to 
was bantam miRNA of D. melanogaster. bantam null mutants are lethal and Brennecke 
et al. showed that bantam was necessary for growth of imaginal discs through regulation 
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of cell proliferation (Brennecke et al. 2003). Consistently, cells overexpressing bantam 
show a strong increase in growth rate (Thompson and Cohen 2006). In addition, bantam 
has also some anti-apoptotic activity. The above discussed growth defect involving Dap 
(CDKN1A/CDKN1B homolog) overexpression upon loss of miRNAs in D. melanogaster 
has been further dissected in human cells. Several groups have shown that two miRNAs 
with the same seed sequence, miR-221 and miR-222, are able to induce proliferation of 
human cancer cells by repressing the translation of human CDKN1B (Galardi et al. 2007; 
Gillies and Lorimer 2007; le Sage et al. 2007). The repression happens through two miR-
221/222 binding sites in the 3’ UTR of the Cdkn1b mRNA and removal of miR-221 and 
miR-222 or points mutations in their binding sites were sufficient to reduce the growth 
rate of the cells. Another similar case of miRNA-mediated proliferation control comes 
from investigation of role of miR-21 in cancer cells in vivo and in vitro (Si et al. 2007). 
miR-21 was found to be necessary for fast proliferation and inhibition of miR-21 using 
antagomirs led to slower growth rate. The observation was reproduced by many groups 
and several targets mediating the activity of miR-21 have been identified (Frankel et al. 
2008). One of the best studied miRNA clusters with a role in cell cycle control in 
mammals is that of miR-17-92. miR-17-92 is overexpressed in many rapidly dividing 
cancers and its overexpression has been shown to induce faster proliferation also in other 
cells (Hayashita et al. 2005; He et al. 2005; Lu et al. 2007). In fact, miR-17-92 is also 
called Oncomir-1. Expression of miR-17-92 is regulated by c-Myc, a transcription factor 
equally upregulated in many human cancers (O'Donnell et al. 2005). It gives rise to 6 
mature miRNAs and has two paralogs, miR-106a-363 cluster and miR-106b-25 cluster, 
which transcribe additional 9 mature miRNAs. miR-17-92 and miR-106b-25 are 
expressed fairly ubiquitously with highest expression in embryos and ESCs while tissues 
expressing miR-106a-363 are unknown (Ventura et al. 2008). Experiments with mice 
lacking these miRNAs suggest that they play important roles in many biological 
processes in a redundant manner (Ventura et al. 2008). The mature miRNAs from these 
clusters can be divided into four miRNA families based on their seed sequence. Most 
functional data on these miRNAs deals with the six miRNAs forming the miRNA family 
that shares a common seed sequence AAAGUGC, namely miR-17, miR-20a, miR-20b, 
miR-106a, miR-106b, and miR-93. Recent reports have identified some targets for these 
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miRNAs and elucidated the mechanisms that allow them to accelerate the cell cycle. 
miR-17 and miR-20a can silence mRNAs encoding transcription factors E2F1, E2F2 and 
E2F3 (O'Donnell et al. 2005; Sylvestre et al. 2007). All of these transcription factors were 
found to regulate the expression of miR-17-92, creating a self-regulatory loop. In addition, 
the members of this miRNA family were discovered to control the translation of mRNAs 
encoding for RBL2 (or p130) in different tissues (Lu et al. 2007; Wang et al. 2008). This 
is interesting since RBL2 is a transcriptional repressor that represses expression of E2F 
target genes by binding to some E2F proteins at the target gene promoters during G1-
phase of the cell cycle and, in this way, regulates the decision between cell cycling and 
cell cycle exit (Litovchick et al. 2007). Finally, miR-106b was lately found to inhibit 
translation of CDKN1A, a cyclin-dependent kinase inhibitor related to CDKN1B and D. 
melanogaster Dap and an upstream regulator of RB pathway (Ivanovska et al. 2008). In 
addition to proliferation control, the AAAGUGC-seeded miRNAs are known to have 
anti-apoptotic activity and this activity is at least in part mediated through inhibition of 
proapoptotic factor BIM (Matsubara et al. 2007; Ventura et al. 2008). Some human 
miRNAs have also been implicated as oncogenes in testicular germ cell tumors 
(Voorhoeve et al. 2006). Both human miR-372 and miR-373 can induce proliferation and 
tumorigenesis of primary human cells. Remarkably, these miRNAs have the same core 
hexamer (AAGUGC) in their seed sequence as miR-17 and the related miRNAs 
discussed above, suggesting further redundancy. 
 As we have seen, many miRNAs can increase cell proliferation and act as 
oncogenes, and the net outcome of total loss of miRNAs appears to be slower growth rate. 
But there are also some miRNAs that can do the opposite i.e. inhibit cell cycle 
progression and in this way function as tumor suppressors rather than oncogenes. One of 
the first miRNAs to be identified as a potential growth repressor was also one of the first 
known miRNAs: let-7 and miR-84, a member of let-7 miRNA family, were shown to 
regulate protein levels of RAS, a kinase signaling protein and a known oncogene, both in 
C. elegans and in humans (Johnson et al. 2005). RAS and let-7 showed inverse 
expression patterns in lung cancer cells, and consistently, increased expression of let-7 
was sufficient to decrease proliferation of these cells. Lee et al. were able to reproduce 
the effect on lung cancer proliferation and proposed HMGA2 as another oncogene that is 
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a primary target of let-7 and could contribute to the phenotype (Lee and Dutta 2007). 
Further follow-up of the original discovery of RAS regulation in lung cancer showed that 
also proliferation of human liver cancer cells could be reduced by let-7 expression and 
that any of the let-7 family members could trigger this reduction (Johnson et al. 2007). 
The growth defect was suggested to be mediated by delaying G1- to S-phase transtition. 
This work was accompanied by microarray analysis to identify transcripts targeted by let-
7 in both types of cancer cells and found a number of cell cycle regulators to be inhibited 
by let-7.  These included for example cyclin-dependent kinase 6 and cyclin D. Although 
well studied, let-7 is not the only miRNA to restrain cell cycle progression. Linsley et al. 
screened 24 miRNAs for transcriptomic changes induced by their overexpression 
(Linsley et al. 2007). They found that miRNAs sharing similar seed sequences were 
causing similar transcriptomic changes. For one miRNA family (formed by miR-15, 
miR-16 and miR-103) a significant enrichment for cell cycle regulating genes was found 
among the downregulated transcripts. miR-16 was confirmed to be able to cause 
accumulation of cells to G0/G1-phase of the cell cycle and this phenotype could be 
reversed by using anti-miR-16 oligonucleotides. Several primary miR-16 targets were 
tested by siRNA induced KDs and were found to be able to partially phenocopy miR-16 
overexpression. But it is likely that the strong effect of miR-16 on cell cycle comes, as 
often with miRNAs, from synergistic effect of inhibiting several different targets.  
 In some cases miRNAs have been described as an important part of signaling 
cascades. TP53 (Tumor protein p53) is a DNA-binding transcription factor that responds 
to various cellular stress conditions such as DNA damage by activation of numerous 
target genes that can, for example, induce apoptosis and stall cell cycle progression. 
Several laboratories have reported miRNAs of the miRNA family of miR-34 to be 
conserved target genes of TP53 (Bommer et al. 2007; Chang et al. 2007; He et al. 2007; 
Raver-Shapira et al. 2007). There are two primary transcripts giving rise to miR-34 
miRNAs, one for miR-34a and one for miR-34b and miR-34c. TP53 was shown to bind 
to conserved binding sites in the promoters of both of these miRNA genes and upregulate 
their transcription. Increased expression of miR-34 miRNAs was leading to altered 
expression of various genes functionally related to TP53 target genes (cell cycle, 
apoptosis, DNA repair etc.). Importantly, blocking of miR-34a function by anti-miR-34a 
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was sufficient to significantly reduce apoptotic response to TP53 activation, arguing that 
miR-34a mediates a major fraction of TP53 signaling and, together with miR-34b-c, is an 
important tumor suppressor. 
 As apparent from aforementioned instances, many of the examples for miRNA 
controlled proliferation come from study of cancer cells. This is reasonable since it is 
cancer where the miRNAs are often misregulated, making pinpointing of their role in cell 
cycle much easier. In fact, miRNA expression analysis has become increasingly useful 
diagnostic tool for classification of tumours (Rosenfeld et al. 2008). And the 
misexpression of miRNAs is often a major contributer to the abnormal behaviour of a 
cancerous cell: miRNA genes are repeatedly located at fragile genomic sites that undergo 
amplifications or deletions in different cancers (Calin et al. 2004). For example, miR-21 
and miR-17-92 cluster are amplified in neuroblastoma and follicular lymphoma, 
respectively, while many let-7 family members, miR-34a and miR15a/miR-16 cluster 
have been deleted in diverse cancers. The significance of miRNA-mediated regulation for 
cancer simply highlights the importance of miRNAs in control of endogenous processes, 
coordinating the balance between proliferation and differentiation, and allowing normal 
development of an organism. 
2.3.2 miRNAs in development and differentiation 
The development from one totipotent cell to a functioning, multicellular organism 
requires numerous coordinated cell divisions that are followed by differentiation from 
one cell type to another. At molecular level the difference between the various cell types 
is determined by the transcriptome and the proteome expressed by the cells. And any 
failure in accomplishing this specific expression profile can challenge the normal 
development. It has now become clear that miRNAs are needed to adjust these expression 
profiles and to support the transcriptional regulation in a range of developmental 
processes in all studied animal species. Below I will discuss a few examples where 
miRNAs are known to contribute to regulation of development  
 Clear evidence for the importance of miRNAs for development comes from 
animals lacking the protein components indispensable for miRNA biogenesis. Screens for 
RNAi-resistant mutants in C. elegans demonstrated that deletion of dcr-1 or the 
Argonaute genes alg-1 and alg-2 leads to several defects in larval development including 
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a classical loss of let-7 phenotype, burst vulva. (Grishok et al. 2001; Ketting et al. 2001; 
Knight and Bass 2001). In D. melanogaster, AGO1 and AGO2 are known to have 
overlapping functions and double, but not single, mutations of ago1 and ago2 as well as 
of ago1 and dcr-1 lead to segmentation defects in the embryo (Meyer et al. 2006). For 
zebrafish the loss of Dicer is leading to a growth arrest one week after fertilization and by 
two weeks most fish die (Wienholds et al. 2003). The relatively long survival time was 
shown to be due to presence of maternal Dicer in the embryos and later Giraldez et al. 
created zebrafish depleted of both maternal and zygotic Dicer (Giraldez et al. 2005). Also 
in these fully Dicer-deficient fish many parts of the early development were unaffected 
but processes like gastrulation and heart and brain development were strongly perturbed. 
Interestingly, another family of miRNAs with an AAGUGC-sequence in their seed region, 
the miR-430 family of zebrafish, was found to be able to rescue large part of the brain 
development defect. In mouse the loss of Dicer or loss of Ago2 are embryonic lethal but 
the details of the phenotype vary between reports (Bernstein et al. 2003; Liu et al. 2004; 
Yang et al. 2005; Morita et al. 2007). Bernstein et al. reported that Dicer knock-out mice 
show morphological abnormalities by embryonic day 7.5, die already before embryonic 
day 8.5 and the embryos do not have stem cells. Yang et al. created Dicer knock-out mice 
that survived somewhat longer until embryonic day 12.5 and the death was accompanied 
by impaired blood vessel formation. Similarly to Dicer-depleted mice of Bernstein et al., 
Ago2-deficient mice produced by Morita et al. are dying by embryonic day 7.5 but many 
developmental markers absent in Dicer knock-outs were present after the loss of Ago2. 
Again the phenotype of another Ago2 knock-out was less severe and embryos survived 3 
days longer (Liu et al. 2004). It is curious that depletion of AGO2 is embryonic lethal 
although at least AGO1 and AGO3 are expressed in embryos and should be able to 
compensate for AGO2. It is possible that AGO2 is normally expressed at very high levels 
and other AGOs can not match this expression level. Another possibility is that, since 
AGO2 is the only mammalian Argonaute able to cleave its target mRNA, some 
developmental processes require this cleavage activity for example to degrade targets of 
endo-siRNAs (Liu et al. 2004). 
  miRNAs are also important for proper germ cell development and meiosis. As 
mentioned above, dcr-1 null C. elegans are sterile, and their oocytes are abnormal and 
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divide (Ketting et al. 2001). The fertility of these worms can be restored by expression of 
transgenic dcr-1. In D. melanogaster, Loquacious, a dsRNA-binding partner of Dicer 
required for pre-miRNA processing, was shown to be necessary for oogenesis and 
fertility (Forstemann et al. 2005). The mutant flies had small ovaries and appeared to be 
unable to maintain GSCs. This is reminiscent of the results of Hatfield et al. that were 
discussed above and suggested a role for miRNAs in proliferation control of GSCs 
(Hatfield et al. 2005). Indeed, analysis GSCs in ago1 mutant flies further confirmed that 
miRNAs are needed for division and self-renewal, rather than survival of GSCs in D. 
melanogaster (Yang et al. 2007). In mice the miRNAs with AAGUGC-seed sequence are 
highly expressed in primordial germ cells and conditional deletion of Dicer from these 
cells, similarly to D. melanogaster, causes defective proliferation and leads to an early 
arrest in spermatogenesis (Hayashi et al. 2008). Interestingly, conditional knock-out of 
Ago2 does not show a similar defect. Furthermore, conditional Dicer knock-out oocytes 
have been described (Murchison et al. 2007; Tang et al. 2007). They arrest in meiosis due 
to spindle formation defects that prevent normal chromosome segregation. It is unclear 
whether this defect is a result of loss of miRNAs or some other function of Dicer. Tang et 
al. observed similar fault in Dicer knock-out oocytes’ spindle formation and additionally 
reported that maternal miRNAs of the oocyte are present in the zygote still after 
fertilization, suggesting that they have a role in the first moments of the embryonic 
development (Tang et al. 2007). Indeed, mice lacking maternal miRNAs are infertile and 
unable to proceed through the first cell divisions. 
 Another conserved function for miRNAs in early embryonic development has 
been described in D. melanogaster and zebrafish. When zygotic transcription takes place 
soon after fertilization, many of the maternally contributed mRNAs get degraded fairly 
rapidly in order to make way for establishment of a new transcriptional profile. Giraldez 
et al. demonstrated that miR-430, a miRNA family expressed at high levels in zebrafish 
development after the onset of zygotic transcription, is needed for degradation of many of 
the maternal mRNAs (Giraldez et al. 2006). Similarly, miRNAs of miR-309 cluster, also 
expressed after the onset of zygotic transcription, are necessary for maternal mRNA 
degradation in D. melanogaster (Bushati et al. 2008). Interestingly, miRNAs of the miR-
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309 cluster of D. melanogaster are not related to the miR-430 family of zebrafish in their 
sequence. 
 One of the extensively studied processes of cell differentiation and lineage 
commitment in mammals is that of hematopoiesis where hematopoietic stem cells give 
rise to a variety of progenitor cells that further differentiate to mature blood cells. 
Hematopoiesis also serves as a valuable model system for studying miRNAs in 
differentiation. Hematopoietic cells express more than one hundred different miRNAs, 
five of which are fairly specific for the hematopoietic cells (Chen et al. 2004; Landgraf et 
al. 2007; Neilson et al. 2007). These are miR-142, -144, -150, -155 and -223. In addition, 
miR-181 is expressed at very high levels in these cells. Detailed analysis of miRNA 
expression during T-lymphocyte development shows that expression of most of these as 
well as many other miRNAs, such as members of miR-17-92 cluster, varies between 
differentiation stages (Neilson et al. 2007). A change in expression of certain miRNAs 
like miR-181 was accompanied by altered levels of mRNAs that have their 3’ UTRs 
enriched for sequences complementary to the seed sequence of the respective miRNA. 
Targets of miR-181 included for example the mRNA for T-cell receptor-α. miR-181 has 
a role in lineage selection as overexpression of miR-181 in hematopoietic progenitors can 
increase the number of cells differentiating to B-lymphocyte lineage (Chen et al. 2004). 
In contrast, overexpression of miR-142 or miR-223 can lead to an increase in cells that 
differentiate to T-lymphocytes. Similarly, overexpression of miR-150 in hematopoietic 
stem cells can block the differentiation of B-lymphocytes without affecting development 
of other lineages (Zhou et al. 2007). The importance of miRNAs for T-cell differentiation 
has been substantiated by conditional deletion of Dicer at different stages of T-
lymphocyte development (Cobb et al. 2005; Muljo et al. 2005; Neilson et al. 2007). The 
loss of Dicer and the subsequent loss of miRNAs affect different aspects of T-cell 
biology and cause a decrease in the number of differentiated T-cells, at least in part, 
through an increase in apoptosis.  
 Several miRNAs might contribute to the apoptosis control in lymphocytes. miR-
181 was shown to inhibit pro-apoptotic protein B-cell CLL/lymphoma 2 (BCL2). 
Another pro-apoptotic protein, BCL2-like 11 or BCL2-interacting protein (BIM), is 
repressed by members of miR-17-92 cluster (Ventura et al. 2008). Consistently, deletion 
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of miR-17-92 cluster from hematopoietic cells leads to significant reduction in the 
number of B-cells and increased apoptosis of early B-cell progenitors. The necessity of 
miRNAs for B-lymphocyte development is further supported by the effects of Ago2 
deletion in bone marrow progenitor cells, which impairs differentiation beyond pro-B cell 
stage (O'Carroll et al. 2007). In addition, Ago2-deficient bone marrow cells are unable to 
produce functional red blood cells implying that miRNAs are essential also for 
erythropoiesis. Remarkably, the slicing activity of AGO2 is not vital for the 
abovementioned processes. 
 Another developmental process where miRNAs, and especially the miR-17-92 
cluster, have a fundamental function is lung development. Mice with conditional deletion 
of Dicer in their lungs show defects in lung branching and increased cell death in lung 
epithelium (Harris et al. 2006). Overexpression of miR-17-92 cluster in lung epithelium 
increases the proliferation of the epithelial progenitor cells and inhibits their 
differentiation (Lu et al. 2007). Consistently, the mice lacking miR-17-92 cluster die 
immediately after birth, largely due to underdeveloped lungs (Ventura et al. 2008). It 
remains to be seen whether also other miRNAs, in addition to miR-17-92 cluster, 
contribute to the lung development. 
 In order to find out whether miRNAs regulate morphogenesis or patterning of 
vertebrate limbs, Harfe et al. created a conditional deletion of Dicer in mouse limb 
mesoderm (Harfe et al. 2005). The limbs of the knock-out mice showed impaired 
morphogenesis and were smaller than those of the control mice. The morphogenesis 
defect was accompanied by increased cell death. Interestingly, the differentiation of the 
limb cells was not affected as all normal limb cell types could be found in the Dicer 
knock-out mice. A specific role for miRNAs in limb development has been described by 
Hornstein and collegues (Hornstein et al. 2005). Expression of the signaling gene Shh 
(Sonic hedgehog) is an important determinant of anterior-posterior polarity of fore- and 
hindlimbs in mice. The forelimb-specific induction of Shh is mediated by Hox protein 
HOXB8 (Homeobox B8). Hornstein et al. demonstrated that the inhibition of Shh 
induction in hindlimbs is due to specific expression of miR-196, which in turn can 
regulate HOXB8 levels by mediating cleavage of its mRNA (Yekta et al. 2004; Hornstein 
et al. 2005). 
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 In addition to the aforementioned examples, miRNAs are now known to be 
important for many other developmental processes such as skin morphogenesis, hair 
follicle formation and development of heart and muscle in mice (Zhao et al. 2005; Andl 
et al. 2006; Yi et al. 2008). And without a doubt a plethora of additional functions for 
miRNAs will be discovered in the coming years. miRNAs seem to contribute to 
development by regulating the balance between proliferation and differentiation, by 
suppressing cell death and by serving as switches for lineage selection. Also they are 
needed for maintaining the potential of stem cells and progenitors to differentiate into a 
variety of cell types. In fact, one of the key questions for understanding developmental 
processes is to determine how this pluripotency (of stem cells) or multipotency (of 
progenitors) is maintained and how it is lost in a controlled manner during differentiation. 
2.4 Epigenetics of embryonic stem cells and their differentiation 
ESCs are derived from the inner cell mass of blastocysts and are capable of 
differentiating into any type of cell or tissue of an organism i.e. they are pluripotent 
(Figure 2) (reviewed in (Smith 2001). They can be maintained in culture in their 
undifferentiated state for prolonged periods under appropriate culturing conditions, either 
in the presence of so called feeder cells or in the presence of a cytokine produced by 
these cells called leukemia inhibitor factor (LIF). LIF acts via gp130 receptor to induce 
JAK/STAT (Janus kinase/Signal transducer and transcription activator) signaling cascade 
that enforces the ESCs into continuous self-renewal. Upon removal of LIF the cells will 
continue to proliferate but begin to differentiate. This differentiation can be directed into 
a desired cell type by addition of further factors like retinoic acid (RA). Understanding 
the molecular basis of pluripotency and differentiation is of great interest. Research of 
recent years has started to recognize that ESCs are epigenetically very unique and the 
correct epigenetic regulation could be underlying the “stemness” of ESCs.  
2.4.1 Transcriptional core circuitry of ESCs 
In addition to the external signaling initiated by LIF, intrinsic regulation of self-renewal 
also takes place. Several transcription factors have been discovered to contribute or to be 
essential for pluripotency and self-renewal of ESCs. The best characterized of these 
factors is OCT-4. Deletion of Oct-4 prohibits the development of pluripotent stem cells in  
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Figure 2. ESCs are pluripotent cells isolated from blastocyst stage embryo.  
After 3.5 days of mouse development or 5 days of human development, the fertilized oocyte or zygote has 
developed into a blastocyst. The cells in the inner cell mass (ICM) of the blastocyst are considered 
pluripotent as they have the potential to give rise to all three primary germ layers: ectoderm, mesoderm and 
endoderm.  These in turn develop into the tissues and organs of the body. ESCs are isolated from the ICM 
and can be cultured indefinitely in vitro or differentiated into variety of cell types by using correct culturing 
condition. Modified from (Guasch and Fuchs 2005). 
 
mouse blastocyst and KD of OCT-4 in mouse or human ESCs leads to their 
differentiation (Nichols et al. 1998; Hay et al. 2004). The exact level of OCT-4 
expression is critical since already a mild overexpression of OCT-4 can induce 
differentiation towards endoderm and mesoderm (Niwa et al. 2000). Similarly, depletion 
of another transcription factor, NANOG (“Tir Na Nog” or “land of the ever young” in 
Celtic mythology), induces ESC differentiation (Chambers et al. 2003; Mitsui et al. 2003). 
The strength of the intrinsic self-renewal pathway is reflected by the fact that 
overexpression of NANOG is sufficient to maintain ESC self-renewal in the absence of 
LIF induced external signals. Due to their specific expression in pluripotent cells, 
transcription factors like OCT-4 and NANOG are often used as markers for pluripotency 
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of ESCs. OCT-4 and NANOG can both repress and activate their target genes which they 
regulate through binding to the DNA at the target gene promoters. The decision between 
activation and repression depends on the interacting transcription factors at the promoter. 
One of the interacting partners of OCT-4 is SOX-2 (SRY box-2) that heterodimerizes 
with OCT-4 to regulate common target genes (Yuan et al. 1995).  
 In order to understand the means by which OCT-4, NANOG and SOX-2 can 
confer pluripotency and to identify their target genes, Boyer et al. performed chromatin 
immunoprecipitation of these factors coupled to microarray analysis (ChIP-chip) of 
thousands of promoters in human ESCs (Boyer et al. 2005). Each factor was found to be 
associated with hundreds of promoters of both active and inactive genes. Interestingly, 
over 90 % of promoters occupied by OCT-4 and SOX-2 were also occupied by NANOG. 
Many active genes among the targets were previously associated with pluripotent state 
while the inactive targets included many genes driving developmental processes. OCT-4, 
NANOG and SOX2 were suggested to form a core transcriptional network that can drive 
self-renewal of ESCs and inhibit their differentiation. Also, the three transcription factors 
were all shown to regulate their own expression, forming an autoregulatory circuit that 
can enforce the pluripotent status as well as to allow its rapid silencing. 
 Although critical for stemness of ESCs, OCT-4, NANOG and SOX-2 are not the 
only important regulators and many other transcription factors have been implicated. For 
example, Krüppel-like factors KLF-2, KLF-4 and KLF-5 were recently shown to be 
essential for maintenance of pluripotent status (Jiang et al. 2008). Depletion of all three 
factors induces differentiation and misregulation of Nanog expression. In addition, many 
targets of KLFs are also targeted by NANOG. The reason that KLFs were not previously 
found to be critical for ESC maintenance is mainly due to the fact they are redundant and 
a loss of a single factor is not sufficient to induce a phenotype. 
 The most promising application of the knowledge concerning the transcriptional 
circuitry governing ESC pluripotency is the reprogramming of differentiated cells back to 
the pluripotent status. The first successful reprogramming by using simple expression of 
critical transcription factors was performed by Takahashi and Yamanaka who 
reprogrammd mouse fibroblasts to pluripotent cells by ectopically expressing Klf-4, Oct-
4, Sox-2, and c-Myc (Takahashi and Yamanaka 2006). Also other combinations of 
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transgenes (such as OCT-4, SOX-2, NANOG and LIN28) have been able to reprogram 
human somatic cells into pluripotent cells (Yu et al. 2007). This further underlines the 
importance of these few regulators for ESC self-renewal. 
 The proper silencing of the self-renewal promoting transcriptional network and its 
components such as Oct-4 and Nanog is one of the key steps in successful differentiation. 
It is initiated by activation of transcriptional repressors, such as GCNF (Germ cell nuclear 
factor), that target Oct-4, Nanog, and other genes (Gu et al. 2005). This leads to complete 
silencing of the targeted genes by formation of condensed chromatin structure as well as 
methylation of the promoter DNA. In the chapters 2.4.2 and 2.4.3 I will shortly discuss 
the details of these processes in ESCs before discussing the roles of miRNAs in ESCs in 
chapter 2.4.4.  
2.4.2 Histone modifications in ESCs 
Nuclear eukaryotic DNA is packaged and wrapped around protein structures called 
nucleosomes that are formed by an equimolar octamer of four histone proteins: histones 
H2A, H2B, H3 and H4. The level of packaging of DNA into this chromatin structure is 
known to be affected by post-translational covalent modifications of these histones. 
Addition and removal of histone modifications are catalyzed by a number of enzymes 
specific for a given modification and position. By modulating the packaging of DNA, the 
histone modifications can affect the accessibility of DNA for replication, transcription 
and DNA repair. In addition to altering the accessibility of DNA through changes in the 
interaction between DNA and the nucleosome, histone modifications can serve as binding 
sites for many regulatory proteins, such as transcriptional activators and repressors. 
Different combinations of histone modifications have been suggested to form a so called 
histone code, which can be interpreted by different histone-interacting proteins, leading 
to a correct output, e.g. decreased transcription (Jenuwein and Allis 2001). For example, 
trimethylation of histone H3 at lysine 9 of its N-terminal tail (H3K9me3) by histone 
methyltransferase (HMT) SUV39H1 (Suppressor of variegation 3-9 homolog 1) can 
serve as a binding site for HP1 (Heterochromatin protein-1). HP1 can recruit further 
SUV39H1 proteins to induce the same modification in the surrounding nucleosomes, 
allowing additional HP1 proteins to bind. These HP1 proteins can then dimerize in order 
to form silenced and condensed heterochromatin. Many different histone modifications 
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have been identified, including methylation, acetylation, phosphorylation, and 
ubiquitination (Turner 2002; Kouzarides 2007). And each modification can take place at 
many different positions of each histone. Most modifications take place at the N-terminal 
tails of H3 and H4 but also H2AB has several sites for covalent modifications. Generally, 
acetylation of a histone is associated with accessible and open euchromatin that is 
transcriptionally active while methylation of many lysine residues is linked to both 
transcriptional activity as well as to inaccessible and condensed heterochromatin that is 
transcriptionally silent (also depending on whether mono-, di-, or trimethylation is taking 
place). As notable modifications related to transcriptional activity, di-, and trimethylation 
of H3K4 and H3K79, and of H3K36 are known to occur at the transcription start sites 
(TSS) and at the body of highly transcribed genes, respectively (Shilatifard 2008; Steger 
et al. 2008). Similarly, methylation of arginine residues has been implicated with 
transcriptional activity (Bauer et al. 2002).  
 Chromatin in ESCs is different from that in somatic and differentiated cells. In 
ESCs heterochromatin is localized only in few large domains and is less condensed than 
in differentiated cells (Kobayakawa et al. 2007). Differentiation leads to an increase in 
smaller, highly condensed foci that vary from one cell type to another. This increase in 
heterochromatin condensation can also be observed by ChIP analysis of specific 
repressive histone modifications. RA-induced differentiation of mouse ESCs is 
accompanied by a notable change in the modifications of histones at various repetitive 
regions (Martens et al. 2005). While the undifferentiated cells do not carry any 
methylation of H3K9, H3K27 or H4K20 at their transposons, satellite repeats, or 
ribosomal DNA, methylation of all these residues accumulates soon after the beginning 
of differentiation (with exception of methylation of H3K9 at satellite repeats where it is 
constantly present). Although ESCs are lacking most repressive histone modifications, 
they are very abundant in the markers of open chromatin structure such as acetylation of 
H4 and H3K9 as well as methylation of H3K4 (Azuara et al. 2006). Also, the number of 
late-replicating genes is lower in ESCs than in lineage-committed cells. This is consistent 
with the open chromatin structure of ESCs since late-replication timing is usually 
associated with condensed, more difficully accessible chromatin (Schubeler et al. 2002). 
It has been suggested that the ESC genome is in a permissive default state from where it 
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can differentiate into any given cell type through selective silencing of different parts of 
the genome (see for example (Niwa 2007)). The evidence for accessible chromatin 
structure of ESCs has been further substantiated by Efroni et al. (Efroni et al. 2008). They 
compared ESCs and neuronal precursor cells (NPCs) using several approaches and could 
confirm the more relaxed chromatin organization and higher levels of transcription 
associated histone modifications in ESCs. Intruigingly, the open chromatin structure was 
also accompanied by significantly higher global transcription levels, including 
transcription of genomic regions not usually expressed.  The transcriptional hyperactivity 
was also coupled with higher expression of general transcription factors. 
 Is the lack of repressive histone modifications essential for pluripotency and self-
renewal of ESC? Recent reports suggest this indeed could be the case. Loh and collegues 
demonstrated that OCT-4 controls the expression of two histone demethylases, JMJD1A 
and JMJD2C (Jumonji-containing proteins), and allows their high expression on mouse 
ESCs (Loh et al. 2007). JMJD1A and JMJD2C catalyze the removal of di- and 
trimethylation of H3K9 at promoters of many ESC specific genes, respectively. Thus, 
these enzymes are contributing to the active chromatin structure of ESCs. Importantly, 
KD of JMJD1A and JMJD2C induces differentiation and loss of ESC pluripotency 
through misregulation of expression of transcription factors such as NANOG. 
 Methylation of H3K4 is found at the promoters of almost all active genes (Kim et 
al. 2005) Interestingly, many lineage specific genes and developmental transcription 
factors are not expressed in ESCs at any significant levels despite having high levels of 
H3K4 methylation at their promoter regions. Their expression is repressed by the 
presence of another histone modification, methylation of H3K27 (Azuara et al. 2006; 
Bernstein et al. 2006). These promoters are considered to have a so called bivalent state 
and are silent in ESCs but have the potential to become active in response to correct 
development cues. The methylation of H3K27 is catalyzed by a multiprotein complex 
called Polycomb group repressive complex 2 (PRC2) (Cao et al. 2002; Muller et al. 2002; 
Kirmizis et al. 2004). In D. melanogaster PRC2 identifies its target genes through 
binding to a Polycomb response element (PRE) at the DNA adjacent to the target gene 
but how PRC2 selects its targets in mammals it is still not fully understood. The 
trimethylated H3K27 (H3K27me3) in turn serves as a binding site for another complex 
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named Polycomb group repressive complex 1 (PRC1) that induces repression of the 
target gene through compaction of chromatin that blocks the access for chromatin 
remodeling complexes (Shao et al. 2000; Francis et al. 2004).   
 Upon differentiation of ESCs many lineage-specific genes loose their H3K27 
methylation, gain H3K4 methylation, increase their RNA Pol II occupancy and become 
transcriptionally active (Boyer et al. 2006). Simultaneously, most pluripotency genes 
such as Oct-4 or Nanog are epigenetically targeted for silencing that is accompanied by 
loss of H3K4 methylation and loss of RNA Pol II occupancy as well as increase in 
methylation of histone H3 at positions H3K9 and H3K27 (Mikkelsen et al. 2007; Pan et 
al. 2007; Mohn et al. 2008). One of the better studied examples is silencing of Oct-4 
during differentiation of ESCs. In undifferentiated ESCs Oct-4 promoter, like much of 
the ESC genome, is marked for high transcriptional activity by histone modifications like 
acetylation of H3 and H4 as well as methylation of H3K4 (Hattori et al. 2004; Feldman et 
al. 2006). Within few days of differentiation these modification are completely lost at the 
promoter and are replaced by high levels of methylation of H3K9 and H3K27 (Feldman 
et al. 2006; Pan et al. 2007; Mohn et al. 2008). Following methylation of H3K9 by two 
days of RA-induced differentiation, HP1 is recruited to the promoter to facilitate 
condensation of the chromatin. While at many other loci like centromeric satellite regions 
H3K9 methylation is catalyzed by SUV39H1, at Oct-4 promoter H3K9 methylation is 
catalyzed by another HMT called G9a. Although the more condensed chromatin structure 
created by these local changes in histone modifications can largely repress Oct-4 
expression they are not sufficient to maintain it. Subsequent methylation of DNA at the 
Oct-4 promoter by de novo DNA methyltransferases is needed for irreversible silencing 
of the gene. 
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2.4.3 DNA methylation in ESCs 
Around 5 % of mammalian cytosines are methylated at CpG-dinucleotides. DNA 
methylation is usually considered to be associated with silent chromatin structure and is 
thought to mediate repression either via blocking of transcription factor binding or 
recruitment of proteins carrying methylated DNA binding (MDB) domains (Watt and 
Molloy 1988; Nan et al. 1997; Hendrich and Bird 1998).  
DNA methylation is established by enzymes called DNA methyltransferases 
(DNMTs). Five DNMTs have been identified in mammals. These are DNMT1, DNMT2, 
DNMT3A, DNMT3B and DNMT3L. Lately it has been shown that DNMT2 is in fact 
methylating RNA, not DNA, in vivo (Jurkowski et al. 2008). The remaining four DNMTs 
can be divided into two functional classes. DNMT1 localizes at the DNA replication foci 
and is necessary for copying the methylation patterns during DNA replication from the 
old DNA strand into the new DNA strand (Leonhardt et al. 1992). Thus, DNMT1 is 
maintaining the DNA methylation through cell divisions. Dnmt1 knock-out mice are 
embryonic lethal but the ESCs are viable and, although reduced in DNA methylation, still 
exhibit some DNA methylation (Li et al. 1992). This is because the DNMT3 enzymes 
also possess some maintenance activity and co-operate with DNMT1 to achieve an 
efficient maintanance of DNA methylation (Liang et al. 2002; Chen et al. 2003). On the 
contrary, DNMT1 is unable to induce new DNA methylation de novo. Instead, de novo 
DNA methylation of previously unmethylated CpGs is established by DNMT3 enzymes 
(Okano et al. 1999). Function of DNMT3A and DNMT3B is necessary for normal 
development as well as for differentiation of ESCs (Okano et al. 1999; Li et al. 2007). 
Unlike 3A and 3B, DNMT3L does not have a catalytic domain and is dispensible for 
normal development with the exception of germline development. Instead DNMT3L is 
known to enhance the activity of 3A and 3B and interacts with them to form a functional 
complex in ESCs (Chedin et al. 2002; Li et al. 2007; Ooi et al. 2007). DNMT3L can 
recognize nucleosomes with unmethylated H3K4 and recruit the other DNMT3 enzymes 
to exercise their catalytic activity. Both DNMT3A and DNMT3B are mutually 
stimulative and needed for robust DNA methylation of target gene promoters (Li et al. 
2007). 
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Consistently with its function, Dnmt1 is expressed in all proliferating cells, 
especially in rapidly dividing cells of embryos and in ESCs. Similarly, Dnmt3b (more 
specifically the splicing variants 3b1 and 3b6) and Dnmt3L have highest expression 
levels in undifferentiated ESCs and during the early phases of differentiation. Dnmt3a 
has two major transcriptional variants: Dnmt3a1 is expressed ubiquitously at low levels 
while Dnmt3a2 has similar expression pattern to Dnmt3L with specific expression at high 
levels in ESCs and germ cells (Chen et al. 2002; Su et al. 2002). Upon differentiation of 
ESCs Dnmt3a2/3b/3L are initially upregulated, which is later followed by strong 
downregulation of all three enzymes. At least Dnmt1 and Dnmt3b are also fluctuating 
during cell cycle with their expression peaking during the S-phase (Robertson et al. 2000). 
 Most DNA methylation in primary cells is taking place outside of regulatory 
DNA regions at intergenic DNA and repetitive sequences (Weber et al. 2005). At these 
regions, DNA methylation is needed, for example, for repression of retrotransposon 
expression and maintenance of genomic integrity (Walsh et al. 1998; Karpf and Matsui 
2005). Still, DNA methylation can also take place at regulatory DNA elements like 
promoters. Level of promoter methylation and its functional impact seems to depend on 
the CpG density of the promoter (Weber et al. 2007). Most mammalian genes have dense 
CpG islands in their promoters that appear to avoid DNA methylation. The few CpG 
islands that are methylated are usually transcriptionally inactive. In contrast, the 
promoters with only a few CpG-dinucleotides are often methylated but this methylation 
does not correlate with expression. Importantly, some promoters contain an intermediate 
number of CpGs. Usually these promoters carry methylated DNA and this methylation is 
mostly associated with low levels of expression. Especially germ-line specific genes 
appear to be silenced via DNA methylation.  
 In ESCs, only a small number of promoters is methylated in the undifferentiated 
state (Mohn et al. 2008). But upon differentiation into neuronal precursors more than 300 
promoters gain de novo DNA methylation which is accompanied by transcriptional 
silencing of the respective genes. The promoters gaining DNA methylation are highly 
enriched for genes like Oct-4 and Nanog that are required for pluripotency. As mentioned 
before, DNA methylation seems to be required rather for maintenance of transcriptional 
silencing. For example, silencing of Oct-4 upon differentiation can be reversed in 
33 
Dnmt3a/3b double knock-out ESCs by returning the cells to pluripotent culturing 
conditions (Feldman et al. 2006). Further experiments have shown that silencing of Oct-4 
in ESCs lacking DNMT3 enzymes is incomplete and can become reversed even when the 
cells are kept in the differentiation inducing conditions (Li et al. 2007). Another target 
gene, Nanog, is known to behave in the same manner.  Similarly, silencing and 
heterochromatinization of an integrated reporter transgene can take place independently 
of CpG-dinucleotides but maintenance of this silencing requires the presence of 
methylated CpGs (Feng et al. 2006). These observations suggest that DNA methylation 
serves as an epigenetic memory that prevents accidental reactivation of targeted genes 
later in development where it could be detrimental for the organism.  
2.4.4 miRNAs in ESCs 
As mentioned already in previous chapters, miRNAs are important for normal function of 
mouse ESCs. Depletion of all miRNAs from ESCs by knock-out of Dicer or Dgcr8 leads 
to several different defects. The knock-out cells are viable and continue to self-renew but 
their growth rate is significantly slower that that of wild-type or heterozygous control 
cells (Kanellopoulou et al. 2005; Murchison et al. 2005; Wang et al. 2007). The cells 
exhibit features of pluripotent ESCs such as colony formation and expression of 
pluripotency markers like Oct-4 and Nanog. But the cells fail to differentiate in vivo and 
in vitro showing that, in fact, they are not pluripotent. The initiation of differentiation 
occurs normally in miRNA depleted ESCs but many pluripotency markers do not become 
fully silenced while different lineage-specific genes fail to become activated or are 
delayed in their expression. In addition, Dicer-deficient ESCs show increased expression 
of centromeric transcripts, suggesting that Dicer would be necessary for silencing of 
these repetitive sequences. The phenotypes of Dicer knock-out and Dgcr8 knock-out 
ESCs are very similar arguing that loss of miRNAs is the major cause for these defects. 
 Many miRNAs have been found to be expressed in ESCs and some of them 
appear to be specific for ESCs and embryonic development. Houbaviy et al. described 
expression of miRNAs of the miR-290 cluster in mouse ESCs (Houbaviy et al. 2003). 
The miR-290 cluster consists of six homologous miRNA hairpins, produced from a 
single primary transcript of 2.2 kb in length, and which is expressed specifically in ESCs 
and preimplantation embryos. For most of the miR-290 cluster miRNAs the mature 
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miRNA comes from the descending strand (-3p) of the hairpin except of miR-290 where 
the ascending strand (-5p) is dominant. The mature miR-290 miRNAs become strongly 
downregulated upon ESC differentiation and their expression has not been detected in 
other tested tissues. Curiously, the downregulation of miR-290 cluster miRNAs during 
RA induced differentiation has been shown to depend on GCNF mediated repression of 
Oct-4 and Nanog (Gu et al. 2008).  Recently it has been reported that, in addition to ESCs, 
miR-290 miRNAs are also expressed in primordial germ cells (Hayashi et al. 2008). The 
follow-up experiments by Houbaviy et al. showed that the pri-miR-290 transcript is 
spliced, capped and polyadenylated as any mRNA and is under the regulation by a 
conserved TATA-box in its promoter (Houbaviy et al. 2005). Additionally, they predicted 
in silico the existence of homologous miRNA clusters in other eutherians. In human 
ESCs, the expression of the miR-371 cluster has been confirmed to be  ESC specific 
similarly to the murine miR-290 cluster (Suh et al. 2004). Also another related miRNA 
cluster, the miR-302 cluster, is highly expressed in human ESCs and to a lesser extent in 
mouse ESCs. Still, the miR-302 clusters appear to have slightly less restricted expression 
patterns than miR-290/miR-371 clusters. Since all of these miRNA clusters have specific 
embryonal expression profile, further analysis of their transcriptional regulation would be 
of interest. Curiously, genome-wide ChIP analysis has suggested that the miR-302 cluster 
in mouse might be under the control of transcription factors OCT-4 and NANOG (Loh et 
al. 2006).  
 The very intriguing feature of all of these ESC specifc miRNAs is that they are 
very highly related, especially in their seed sequence, to each other as well as to some 
members of miR-17-92, miR-106a-363 and miR-106b-25 clusters, suggesting functional 
redundancy between these miRNAs (Figure 3). All of the miRNAs share the common 
hexamer AAGUGC within their seed sequence. Recently, deep sequencing aimed to 
identify all miRNAs expressed in mouse ESCs described 126 different mature miRNAs 
expressed at least at the level of 50 molecules per cell (Calabrese et al. 2007). Still, 40 % 
of all mature miRNA molecules in these cells originated from miR-290 and miR-17-92 
clusters, indicating that they might play an important role in maintaining the pluripotency 
of ESCs. Other highly expressed miRNAs included for example miR-15/16 and miR-21. 
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 In contrast to downregulation of ESC specific miRNAs, several miRNAs also 
become upregulated upon differentiation. In later stages of neuronal differentiation, 
brain-specific miR-124 and miR-9 are robustly upregulated and contribute to 
neurogenesis (Krichevsky et al. 2006). Curiously, NANOG was found to bind in the 
proximity of genomic loci encoding both of these miRNAs, suggesting that they could be 
under NANOG-mediated repression in ESCs (Loh et al. 2006). Another miRNA that 
becomes upregulated upon RA-induced differentiation is miR-134 (Tay et al. 2008). 
Overexpression of miR-134 in mouse ESCs was found to be sufficient to induce 
differentiation and miR-134 was suggested to exhibit its activity by directly targeting 
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Figure 3. Many  related miRNAs are highly expressed in mouse ESCs. 
Most of the mature miRNAs from ESC specific miRNA clusters miR-290 and miR-302, miR-467* as well 
as many members of miR-17/106a/106b clusters are highly related. The sequence alignment reveals that all 
of the miRNAs share a common AAGUGC hexamer within their 5’ most nucleotides. On top of this, many 
members of miR-290 and miR-17/106a/106b clusters have a common adenosine in the beginning of their 
seed sequence. In addition, most of the miRNAs have shared GU-dinucleotides in their 3’ half. 
 
transcription factors such as NANOG and LRH1 (Liver receptor homolog 1). 
Interestingly, mature let-7 is not expressed in ESCs but becomes upregulated upon 
differentiation while the precursor of let-7 is constantly expressed also in ESCs (Newman 
et al. 2008; Rybak et al. 2008; Viswanathan et al. 2008). In ESCs the processing of pre-
let-7 into the mature miRNA by Dicer is blocked by LIN28, another marker of 
pluripotency that binds specifically to let-7 pre-miRNA. As ESCs differentiate, LIN28 
becomes downregulated and allows processing and upregulation of mature let-7. The 
downregulation of LIN28 is mediated by another upregulated miRNA, miR-125b, as well 
as by let-7 itself, creating a self-regulatory feedback-loop (Wu and Belasco 2005; Rybak 
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et al. 2008). These interactions between miRNAs and pluripotency regulating factors 
imply that miRNAs might contribute more to the core circuitry of pluripotency than 
previously appreciated. 
2.5 Replication-dependent histone genes 
In metazoans there are two different families of histone genes, replication-independent 
and replication-dependent histone genes. Replication-independent histone genes are 
continuously expressed at constant level to provide histones for example for chromatin 
repair. In mammals replication-independent histone genes are located across the genome 
as single genes. On the contrary, replication-dependent histone genes are located in three 
separate histone gene cluster that are located in the chromosomes 6 (HIST1 cluster) and 1 
(HIST2 and HIST3 clusters) in humans (Marzluff et al. 2002). The largest cluster, HIST1 
contains 55 separate histone genes and there are close to 70 replication-dependent histone 
genes in human genome altogether. Thus, there are 10-20 different genes for each of the 
four core histone proteins as well as for the linker histone H1. Replication-dependent 
histone genes fluctuate in their expression during the cell cycle with a more than 30-fold 
upregulation in histone protein production in the S-phase (Harris et al. 1991). This large 
pool of new histone proteins is needed to cover the newly synthesized DNA after DNA 
replication. In fact, high expression of histones outside the S-phase is very toxic for the 
cell (Osley 1991). The remarkable upregulation of histone expression during the S-phase 
is achieved at two different levels. 
First, transcription of histone genes is coordinately increased two to five-fold as 
the cells enter the S-phase (Heintz et al. 1983). No common transcription factor 
responsible for the regulation of all histone genes has been identified. But Oct-1 and its 
coactivators, for example, are contributing to the upregulation of all H2B genes (LaBella 
et al. 1988; Zheng et al. 2003). Also, phosphorylation of NPAT (Nuclear protein, ataxia-
telangiectasia locus) by cyclin E-cyclin dependent kinase 2 complex can enhance 
transcription of many histones (Ma et al. 2000). On the other hand, the G1-phase specific 
transcriptional repressor RBL2 is binding to promoters of a number of HIST1 cluster 
genes (Litovchick et al. 2007).  
Second and more important, the stability and translation of replication-dependent 
histone mRNAs is robustly increased when DNA synthesis takes place during the S-
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phase. The half-life of an histone mRNA increases from 10 minutes outside the S-phase 
up to one hour in the S-phase (Harris et al. 1991). This specific regulation of stability and 
translation is due to the very unique structure and processing of histone mRNAs. Unlike 
all other metazoan mRNAs, the replication-dependent histone mRNAs do not have poly-
A tails and only few of them have any introns. Instead of polyadenylation, the histone 
mRNAs undergo an alterative 3’ end processing (Figure 4). Their short 3’ UTR contains 
a highly conserved sequence of 26-nt, 16 of which form a perfect stem-loop structure. 
Several nucleotides downstream of the stem-loop structure another conserved sequence 
element called the histone downstream element or HDE is found. The stem-loop of a 
newly synthesized pre-mRNA is bound by a protein called SLBP (stem-loop binding 
protein, sometimes also named HBP for hairpin binding protein). At the same time, small 
nuclear RNA (snRNA) U7 basepairs with its complementary sequence to the HDE and, 
brings its interacting proteins to the site. SLBP helps to stabilize the interaction between 
the pre-mRNA and the U7-protein complex via a bridging protein called ZFP100 (Zinc 
finger protein 100) (Dominski et al. 2002). Once bound to the mRNA, U7 snRNP recruits 
further proteins such as endonuclease CPSF-73 (Cleaveage/polyadenylation specificity 
factor-73) (Dominski et al. 2005). CPSF-73 cleaves the pre-mRNA 5 nucleotides 
(ACCCA) immediately downstream of the stem-loop. Curiously, CPSF-73 is the same 
endonuclease that cleaves all other mRNAs before their polyadenylation. Also other 
components are shared between the 3’ end processing of histone mRNAs and that of 
other mRNAs (Kolev and Steitz 2005; Friend et al. 2007). And, for example, the U2 
snRNP splicing complex has been shown to stimulate the cleavage of histone mRNAs 
(Friend et al. 2007). Once processed, the mature mRNA stays bound by SLBP as it 
becomes exported to the cytoplasm. During translation of the message, SLBP seems to 
function as a replacement for PABP of polyadenylated mRNAs and the presence of the 
stem-loop as well as SLBP are necessary for efficient histone translation (Gallie et al. 
1996; Sanchez and Marzluff 2002).  
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Figure 4. 3’ end processing of a replication-dependent histone mRNA by SLBP and U7 snRNP. 
U7 snRNP basepairs with the HDE of the histone mRNA downstream of the stem-loop structure to 
measure the correct cleavage site. Binding of SLBP to the stem-loop stabilizes U7 binding via an 
interacting bridging protein ZFP100. U7 recruits further proteins to cleave the mRNA after the ACCCA 
sequence. In the absence of U7 or SLBP the downstream polyadenylation signals (AAUAAA) are used. 
 
  The stem-loop of a histone mRNA can also be bound by 3’ hExo (3’ human 
exonuclease), simultaneously with SLBP, forming a ternary complex (Dominski et al. 
2003). The presence of SLBP prevents 3’ hExo from degrading the mRNA during DNA 
replication. But, as the DNA replication is completed at the end of S-phase, SLBP 
becomes phosphorylated and released from the stem-loop. This in turn allows initiation 
of the histone mRNA degradation by 3’ hExo and explains the significant drop in histone 
mRNA half-life at the end of S-phase. The expression of SLBP is regulated in the cell 
cycle with a 10-20 fold upregulation taking place during the S-phase (Whitfield et al. 
2000).  Thus, SLBP is the key player responsible for the increased stability and 
translation of histone mRNAs in the S-phase. 
 The proper processing of histone mRNAs is critical for survivial and normal 
development of an organism. Deletion of SLBP in D. melanogaster is lethal and 
mutations in U7 snRNA disturb proper oogenesis, rendering the flies sterile (Godfrey et 
al. 2006). Consistently, maternal SLBP is required for early embryonic development of 
mouse (Arnold et al. 2008). The disruption of histone mRNA processing leads to 
expression of longer, polyadenylated histone mRNAs. This is due to the use of, often 
multiple, polyadenylation signals located downstream of the normal processing site. 
Reason for the presence of these polyadenylation signals is unclear but it has been 
39 
suggested that they are needed to prevent transcriptional read-through to the following 
genes (Lanzotti et al. 2002). In D. melanogaster, all histone genes have downstream 
polyadenylation signals while in mammals some of the histone genes lack them. Recently, 
two protein complexes, NELF (Nuclear elongation factor) and CBC (Cap-binding 
complex), which are involved in transcription elongation and the coupled mRNA 
processing of many RNA Pol II transcripts, were found to be involved in the selection 
between normal histone mRNA 3’ end processing or their polyadenylation (Narita et al. 
2007). By constructing several different reporter genes, Narita et al. were able to show 
that the location of the histone stem-loop in relation to the poly-A signal does not matter 
for the selection between the two modes of processing. Thus, under normal conditions 
most histone mRNAs would be cleaved after their stem-loop structure even if it would be 
preceded by a polyadenylation signal. Although processing of histone mRNAs after their 
stem-loop is the favored pathway in mammals, there seems to be some leakage to histone 
mRNA polyadenylation even under normal conditions. This is reflected by the existence 
of a number of clones for polyadenylated replication-dependent histone genes in human 
and mouse EST databases. Genome-wide RNAi screen has now identified a number of 
genes needed for proper histone mRNA 3’ end processing in D. melanogaster  (Wagner 
et al. 2007).Although miRNAs have been suggested to regulate a number of basic cellular 
processes, miRNAs and RNAi machinery have not yet been implicated to have a role in 
the regulation of expression and processing of histone mRNAs. 
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MicroRNAs control de novo DNA methylation through
regulation of transcriptional repressors in mouse
embryonic stem cells
Lasse Sinkkonen1, Tabea Hugenschmidt1, Philipp Berninger2, Dimos Gaidatzis2, Fabio Mohn1,
Caroline G Artus-Revel1, Mihaela Zavolan2, Petr Svoboda3 & Witold Filipowicz1
Loss of microRNA (miRNA) pathway components negatively affects differentiation of embryonic stem (ES) cells, but the
underlying molecular mechanisms remain poorly defined. Here we characterize changes in mouse ES cells lacking Dicer (Dicer1).
Transcriptome analysis of Dicer –/– cells indicates that the ES-specific miR-290 cluster has an important regulatory function in
undifferentiated ES cells. Consistently, many of the defects in Dicer-deficient cells can be reversed by transfection with miR-290
family miRNAs. We demonstrate that Oct4 (also known as Pou5f1) silencing in differentiating Dicer –/– ES cells is accompanied
by accumulation of repressive histone marks but not by DNA methylation, which prevents the stable repression of Oct4. The
methylation defect correlates with downregulation of de novo DNA methyltransferases (Dnmts). The downregulation is mediated
by Rbl2 and possibly other transcriptional repressors, potential direct targets of miR-290 cluster miRNAs. The defective DNA
methylation can be rescued by ectopic expression of de novo Dnmts or by transfection of the miR-290 cluster miRNAs, indicating
that de novo DNA methylation in ES cells is controlled by miRNAs.
Short 20–25-nucleotide (nt) RNAs have emerged recently as impor-
tant sequence-specific regulators of gene expression in eukaryotes1–4.
Short RNAs are produced from long double-stranded RNA (dsRNA)
and miRNA precursors, which are processed by the RNase III family
enzymes Drosha and Dicer to yield mature effector molecules, small
interfering RNAs (siRNAs) and miRNAs1–5. miRNAs are the domi-
nant class of short RNAs in mammalian cells, from which several
hundred different miRNAs have been identified and implicated in the
regulation of many cellular processes6,7. Mammalian miRNAs typically
base-pair imperfectly with the 3¢ untranslated region (3¢ UTR) of
target mRNAs and induce their translational repression or degrada-
tion8,9. The eight 5¢ terminal nucleotides form the critical miRNA
region for target mRNA recognition. This region, generally referred to
as the ‘seed’, hybridizes nearly perfectly with the target to nucleate the
miRNA-mRNA interaction10,11. Most computational methods of
miRNA target prediction incorporate this constraint12.
ES cells are pluripotent cells derived from the inner cell mass of
blastocysts. Depending on the culture conditions, ES cells can differ-
entiate into various cell types13. The Oct4, Sox2 and Nanog transcrip-
tion factors form a core circuit responsible for the transcriptional
control of ES cell renewal and pluripotency14,15. Mouse ES cells
contain numerous miRNAs, including a cluster of six miRNAs
(miR-290 through miR-295) that share a 5¢-proximal AAGUGC
motif16,17. The cluster (for brevity referred to as the miR-290 cluster)
is specific to ES cells17. Its expression increases during preimplant-
ation development18 and remains high in undifferentiated ES cells,
but decreases after ES cell differentiation17. Genes and pathways
regulated by the miR-290 cluster are unknown.
The loss of Dicer in mouse ES cells results in miRNA depletion19,20
and causes differentiation defects in vivo and in vitro19. Dicer –/– cells
make no contribution to chimeric mice and fail to generate teratomas
in vivo. In vitro, Dicer –/– cells form embryoid body (EB)–like struc-
tures, but there is little morphological evidence of differentiation.
Expression of Oct4, a characteristic marker of pluripotent ES cells, is
only partially decreased in mutant EBs after day 5 of differentiation,
and expression of endodermal and mesodermal markers is not
detectable19. Similarly, the loss of Dgcr8, a protein required specifically
for miRNA maturation, causes partial downregulation of pluripotency
markers during retinoic acid (RA)–induced differentiation21.
In this work, we investigated the molecular mechanisms underlying
the inability of Dicer –/– ES cells to differentiate. We found that
silencing of the Oct4 pluripotency factor is properly initiated in
differentiating Dicer –/– ES cells, but it is not followed by de novo
DNA methylation of the promoter. Consistent with this, we observed
that levels of de novo DNA methyltransferases are downregulated in
Dicer –/– cells in an miR-290 cluster–dependent manner. Thus, our
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data indicate that the de novo DNA methylation in differentiating ES
cells is regulated by ES-specific miRNAs from the miR-290 cluster.
RESULTS
Transcriptome analysis of Dicer –/– ES cells
To study the roles of miRNAs in gene regulation in ES cells, we
profiled the transcriptomes of Dicer –/– and Dicer+/– ES cells using
Affymetrix microarrays. We found a similar number of transcripts that
were upregulated (2,551; P-valueo 0.001) and downregulated (2,578;
P-value o 0.001) upon the loss of Dicer (Fig. 1a). Analysis of core
pluripotency regulators, as well as different differentiation markers,
indicated that Dicer –/– cells retain characteristics of undifferentiated
ES cells (Supplementary Fig. 1 online).
The binding of miRNAs to the 3¢ UTR of mRNAs commonly results
in degradation of mRNA targets. Numerous studies have reported
significant enrichment of sequences complementary to miRNA seeds
in 3¢ UTRs of mRNAs that are upregulated in miRNA knockdowns, or
downregulated upon overexpression of miRNAs22–24. We searched for
sequence motifs (heptamers) that are enriched in the 3¢ UTRs of
transcripts upregulated in the Dicer –/– cells and that could explain the
mRNA expression changes (Supplementary Methods online). The
three motifs that were most significantly enriched (Fig. 1b) were
all complementary to the seed region of embryonic miRNAs25:
miR-291a-3p, miR-291b-3p, miR-294 and miR-295 in the case of the
first and second motifs (GCACUUU and AGCACUU), and miR-302 in
the case of the third motif (GCACUUA). The seed region of miR-302
differs from that of miR-290 cluster members only in the first
nucleotide (Supplementary Fig. 2a and Supplementary Table 1
online). The enrichment of the GCACUUA motif may imply that
miR-302 has an important role in regulating mRNA expression in
ES cells. Alternatively, it may indicate that miRNAs prefer target sites
with an A residue opposite the 5¢-most nucleotide of the miRNA, as
has been proposed before11. Because the same motif is also most
significantly enriched in the 3¢ UTRs of mRNAs that are downregulated
upon transfection with miR-290 cluster miRNAs (see below), we favor
the second explanation. We also note that the ubiquitously expressed
oncogenic miRNAs of the miR-17/20/93/106 cluster share extensive
similarity at their 5¢ end with the embryonic miRNAs (Supplementary
Table 1) and could also contribute to mRNA regulation in ES cells. As
shown in Figure 1c, the frequency of the top three motifs decreased
gradually from the mRNAs that are most strongly upregulated in
Dicer –/– cells to the mRNAs that are strongly downregulated.
We examined expression of the miR-290 cluster primary transcript
using available microarray data26. Quantification of the primary
transcript indicated that expression of the cluster occurs zygotically
and reaches the highest level in the blastocyst (Supplementary
Fig. 2b). Notably, accumulation of the miR-290 cluster transcript
was downregulated in Dicer –/– ES cells, indicating a possible feedback
control of its expression by the cluster or other miRNAs (Supple-
mentary Fig. 2c). Array analysis of miRNA levels in Dicer+/– and
Dicer –/– ES cells using Exiqon arrays revealed that, as expected17,27,
miR-290 cluster miRNAs are abundantly expressed in ES cells, and
miR-290 cluster and other miRNA levels are reduced in Dicer –/– cells
(Supplementary Fig. 2d and Supplementary Table 2 online).
Identification of primary miR-290 cluster targets
To increase the accuracy of the miRNA target prediction, we compared
the transcriptome profile of Dicer –/– ES cells (transfected with a
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Figure 1 Transcriptome analysis of Dicer –/–
embryonic stem (ES) cells. (a) M (log2(fold change))
versus A (average log2(expression level)) plot for
Dicer –/– versus Dicer +/– ES cells. Each dot represents
a transcript. Significant expression changes (P-value
o 0.001, n ¼ 3) are shown in red. (b) Heptamer
motif analysis of upregulated transcripts indicates
enrichment in motifs complementary to the seed
of miR-290 cluster miRNAs. Motifs whose frequency
in the 3¢ UTRs of upregulated transcripts is
significantly different from the frequency in
the entire set of 3¢ UTRs are in shown in red
(Supplementary Methods). (c) Correlation between
the occurrence of sequence motifs and the change in mRNA expression. Transcripts were divided into five sets on the basis of their change in expression
in Dicer –/– compared with Dicer +/– cells as follows: strong down, more than 2-fold downregulation; down, 1.2-fold to 2-fold downregulation; not changed,
1.2-fold downregulation to 1.2-fold upregulation; up, 1.2-fold to 2-fold upregulation; strong up, more than 2-fold upregulation. (d) M versus A plot for
Dicer –/– ES cells transfected with the miR-290 cluster versus Dicer –/– ES cells transfected with the small interfering RNA against Renilla luciferase
mRNA (siRL), a nonspecific control. Significant expression changes (P-value o 0.001, n ¼ 3) are shown in red. (e) Transcripts that were downregulated with
a P-value o 0.001 in the miR-290 cluster–transfected Dicer –/– cells were extracted and analyzed as in Figure 1b. Many of the significantly enriched motifs
are complementary to positions 2–7 of the miRNAs in the miR-290 cluster. The motifs complementary to the seed of siRL did not show any enrichment,
indicating that there was a minimal off-target effect.
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nonspecific siRNA as a control) with that of Dicer –/– ES cells
transfected with the siRNA-like form of miRNAs of the miR-290
cluster (Fig. 1d). Applying the same heptamer motif analysis used
above, we found a few motifs enriched in transcripts that were
downregulated after miR-290 cluster miRNA transfection. Among
them are motifs complementary to seeds of miR-290 cluster miRNAs,
identical to the top three motifs identified above (Fig. 1e and
Supplementary Table 1). Analysis of both array experiments showed
a good inverse correlation between transcript-level changes in Dicer–/–
cells (compared to Dicer+/– cells) and Dicer–/– cells transfected with
miR-290 cluster miRNAs (compared to control Dicer –/– cells)
(Supplementary Fig. 3a–c online). The correlation holds for
mRNAs that carry the miR-290 cluster seed-matching sequences in
their 3¢ UTR, as well as for those that do not (Supplementary
Fig. 3b,c). The correlation for mRNAs lacking seed-matching
sequences anywhere in the transcript was as good as that shown in
Supplementary Fig. 3c (data not shown). These data suggest that not
only primary miRNA effects, but also many secondary gene-
expression changes controlled by miR-290 cluster miRNAs, are
reversible in Dicer –/– ES cells.
To predict primary miR-290 cluster targets, we used data from both
sets of microarray experiments. We intersected the lists of transcripts
that showed a significant change (P-value o 0.001) in the expected
direction in the Dicer –/– cells compared to Dicer+/– cells (upregula-
tion) and in the miR-290 cluster–transfected Dicer –/– cells compared
to control siRNA-transfected Dicer –/– cells (downregulation). The list
was then filtered to keep only the transcripts whose 3¢ UTRs had at
least one match to the GCACUU hexamer, which is common to all
significantly enriched heptamers. The resulting list of predicted targets
contained 253 mRNAs (Supplementary Table 3 online). However, it
is likely that the number of targets is even larger, as not all expressed
mRNAs are detectable by microarrays and some genes may be
regulated at the protein rather than the transcript level.
Indirect control of de novo methyltransferases by miRNAs
Inspection of microarray data indicated that expression of de novo
DNA methyltransferase genes Dnmt3a, Dnmt3b and Dnmt3l was
significantly downregulated in undifferentiated Dicer –/– ES cells
(Fig. 2a). Protein levels of Dnmt3a2, Dnmt3b1 and Dnmt3b6 were
also lower in Dicer –/– cells, whereas the ubiquitously expressed iso-
form of Dnmt3a, Dnmt3a1 (ref. 28), remained unchanged (Fig. 2b).
Notably, expression of de novo DNA methyltransferases could be
rescued, at both mRNA and protein levels, upon transfection of all
miR-290 cluster miRNAs or miR-291a-3p alone (Fig. 2c–e).
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Figure 2 De novo DNA methyltransferases (Dnmts) are downregulated in Dicer –/– embryonic stem (ES) cells and their expression is rescued by miR-290
cluster miRNAs. (a) Expression of DNA methyltransferases in undifferentiated Dicer +/– and Dicer –/– cells as analyzed by Affymetrix microarrays. The probe
sets detecting mRNAs encoding different DNA methyltransferases are indicated. Mean expression (±s.d.; n ¼ 3) in Dicer +/– cells was set to one. Signals
from probe sets detecting Dnmt3a, Dnmt3b and Dnmt3l were significantly downregulated in Dicer –/– cells (two-tailed t-test P-values, from left to right:
0.0001, 0.0006, 0.0093, 0.0022 and 0.0010). (b) Western blot analysis of Dnmt1, Dnmt3a and Dnmt3b levels in ES cells cultured in the presence of
either leukemia inhibitory factor (LIF) or retinoic acid (RA) for 3 d. a-Tubulin was used as a loading control. Quantification of western blots shown in b and d
and in Figure 3f by image densitometry revealed a 3.0-fold to 5.6-fold change in the level of Dnmt3a2 and a 2.0-fold to 4.4-fold change in the levels of
Dnmt3b1/b6 between conditions of low and high expression of the proteins. (c) The miR-290 cluster miRNAs induce accumulation of mRNAs encoding
Dnmt3a, Dnmt3b and Dnmt3l in Dicer –/– cells. Mean values (±s.d.; n ¼ 3) observed for the siRL-transfected cells (a nonspecific control) were set to one.
The P-values, from left to right, were: 0.0102, 0.0008, 0.0021, 0.0010 and 0.0009. (d) Dnmt3a2 and Dnmt3b expression 3 d after transfection with
siRL, miR-290 cluster or miR-291a-3p. Ponceau staining served as a loading control. (e) Upregulation of Dnmt3a2 and Dnmt3b1/6 (quantified by RT-qPCR)
in response to transfection of either all miR-290 cluster miRNAs or miR-291a-3p into Dicer –/– ES cells. Mean expression values (±s.d.; n ¼ 3) were
normalized to glyceraldehyde-3-phosphate dehydrogenase (Gapdh) and are shown relative to corresponding siRL samples, whose expression values were set
to one (dashed line). (f) Dicer loss affects transcription from the Dnmt3b promoter. Firefly luciferase (FL) reporters containing Dnmt3b promoter fragments
were co-transfected to Dicer +/– and Dicer –/– cells together with the pRL-TK control reporter. Mean FL activity values (±s.e.m., n Z 3) in Dicer +/– cells were
set to one. The P-values, from left to right, were: 0.0192, 0.0391, 0.0238 and 0.0230.
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Similar downregulation of all three Dnmt3 genes upon loss of Dicer
and their upregulation in response to transfection of miR-290 cluster
miRNAs indicated that miRNAs may regulate the expression of
Dnmt3 genes indirectly, possibly by controlling the activity of a
common transcriptional repressor. This possibility is supported by
the observations that Dnmt3a2, Dnmt3b and Dnmt3l contain similar
TATA-less GC-rich promoters, are regulated by SP1-SP3 transcription
factors, and are highly expressed in blastocysts and ES cells but are
downregulated during differentiation into somatic lineages28–31. To
corroborate the possibility of transcriptional regulation, we compared
the activity of firefly luciferase (FL) reporters containing Dnmt3b
promoter regions of different lengths. Activity of the reporters was
significantly lower in Dicer –/– than in Dicer+/– ES cells (Fig. 2f),
arguing that the Dnmt3b promoter is markedly repressed in cells
lacking Dicer and suggesting that downregulation of Dnmt3 genes in
Dicer–/– ES cells may occur at the level of transcription.
Among the predicted primary targets of the miR-290 cluster
(Supplementary Table 3), we identified several annotated32 transcrip-
tional repressors that are upregulated during embryonic differentia-
tion after the blastocyst stage31. They include genes for the basic
Kruppel-like factor Klf3, the nuclear receptor Nr2f2, the zinc-finger
proteins Zmynd11 and Zbtb7, and retinoblastoma-like 2 (Rbl2)
(Fig. 3a,b). Several other observations make Rbl2 a plausible candidate
for the miR-290 cluster–regulated transcriptional repressor of de novo
DNA methyltransferases. The Rbl2 3¢ UTR contains conserved poten-
tial binding sites for miR-290 cluster miRNAs (Fig. 3c), and Rbl2
mRNA is downregulated upon transfection of all miR-290 cluster
miRNAs or miR-291a-3p alone into Dicer –/– ES cells (Fig. 3b,d). Rbl2
repressor was recently shown to associate with the DNMT3B promoter
in human glioblastoma cells (ref. 33 and Discussion). In mouse
ES cells, Rbl2 is expressed at low levels, and during neuronal
differentiation its expression correlates inversely with the expression
of the miR-290 cluster and de novo DNA methyltransferases (F.M. and
D. Schu¨beler, Friedrich Miescher Institute, unpublished results). We
used RNA interference to obtain more direct evidence that Rbl2
indeed regulates the expression of de novo DNA methyltransferases.
Transfection of siRNAs against Rbl2 resulted in a marked increase of
Dnmt3a2 and Dnmt3b expression at both mRNA and protein levels
(Fig. 3e,f). Taken together, these data argue in favor of Rbl2 as a target
of the miR-290 cluster that acts as a repressor, downregulating the
expression of de novo DNA methyltransferases.
Defective DNA methylation of Oct4 in Dicer –/– cells
To investigate in more detail the differentiation defects in Dicer –/– cells
and the possible role of the miR-290 cluster, we examined expression
of Oct4, the core pluripotency regulator of ES cells. When differentia-
tion was induced with 100 nM RA in the absence of leukemia
inhibitory factor (LIF), the mRNA and protein levels of Oct4
decreased similarly in Dicer –/– and control cells at day 3 (Fig. 4a).
The expression level of the orphan nuclear receptor gene Gcnf, an early
repressor of Oct4, Nanog and other pluripotency markers34, was
upregulated to the same extent in Dicer+/– and Dicer –/– cells after
1 d of RA treatment (Fig. 4b). We could also detect accumulation of
repressive histone marks at the Oct4 promoter (Fig. 4c,d), indicating
that the initiation of Oct4 silencing was not strongly perturbed.
However, repression of Oct4 at day 6 of differentiation was clearly
stronger in Dicer+/– ES cells (Fig. 4e). When RA was removed at day 6
and the cells were cultured in the presence of LIF for an extra 4 d, the
Oct4 mRNA levels in Dicer –/– cells increased to approximately 40% of
the initial level, whereas Oct4 expression remained repressed in
Dicer+/– cells (Fig. 4e). A similar pattern of expression was observed
for Nanog (Supplementary Fig. 4 online).
Incomplete and reversible silencing of Oct4 in RA-treated Dicer –/–
ES cells is notably similar to findings demonstrating that the stable
silencing of Oct4 is dependent on a correct de novo methylation of
DNA35,36. Therefore, we used bisulfite sequencing to analyze the
methylation status of the Oct4 promoter during the RA-induced
differentiation. In Dicer +/– ES cells, DNA methylation was already
detectable after 3 d of differentiation; it increased further at day 6 and
remained high following the withdrawal of RA. In marked contrast,
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Figure 3 Retinoblastoma-like protein 2 (Rbl2) regulates the expression
of Dnmt3a2 and Dnmt3b. (a) Levels of Rbl2 mRNA are upregulated in
Dicer –/– cells as indicated by analysis of Affymetrix arrays. The probe
sets detecting expression of Rbl2 are indicated. Mean expression values
(±s.d.; n ¼ 3) in Dicer +/– cells were set to one. The P-values from left
to right are 0.0010 and 0.0023. (b) Transfection of miR-290 miRNAs
into Dicer –/– ES cells downregulates the level of Rbl2 mRNA. Cells
were transfected for 24 h with either a mixture of the miR-290 cluster
miRNAs or with siRL (small interfering RNA against Renilla luciferase
mRNA). Mean expression values (±s.d.; n ¼ 3) in siRL-transfected cells were set to one. The P-values from left to right were 0.0135 and 0.1082.
(c) Schematic representation of the localization of predicted binding sites for AAGUGC seed–containing miRNAs in the 3¢ UTR of Rbl2 mRNA. Predicted
binding sites that contain GU base pairs in the seed and those without GU base pairs in the seed are marked with white and black triangles, respectively.
(d) Downregulation of Rbl2 in response to transfection of Dicer –/– ES cells with either all miR-290 cluster miRNAs or miR-291a-3p. For other details see
Figure 2e. (e) Effect of Rbl2 knockdown on Dnmt3a2 and Dnmt3b mRNA levels. Cells were transfected with siRNAs against Rbl2 (siRbl2) or with siRL as a
control. For other details see Figure 2e. (f) Western blot analysis of Dnmt3a2 and Dnmt3b expression 1 d, 2 d or 3 d after siRbl2 transfection. Expression
after transfection of siRL (3 d) is shown as a control. Ponceau staining served as a loading control.
ART IC L E S
4 ADVANCE ONLINE PUBLICATION NATURE STRUCTURAL & MOLECULAR BIOLOGY
the Oct4 promoter failed to undergo DNA methylation in differentiat-
ing Dicer –/– cells (Fig. 4f).
To address the possibility that impaired maintenance of DNA
methylation is responsible for the observed methylation defect, we
analyzed several typically hypermethylated sequences and found no
loss of their methylation in undifferentiated or differentiated Dicer –/–
ES cells (Supplementary Fig. 5 online). Furthermore, expression of
the maintenance DNA methyltransferase Dnmt1 was not affected
either by the loss of Dicer or upon transfection of miR-290 cluster
miRNAs into Dicer–/– ES cells (Fig. 2a–c), suggesting that maintenance
of DNA methylation is not impaired in Dicer–/– ES cells.
Rescue of de novo DNA methylation of Oct4 by miRNAs
We tested whether ectopic expression of Dnmt3a2, Dnmt3b and
Dnmt3l, or transfection with miR-290 cluster miRNAs, is sufficient
to rescue the defective Oct4 promoter methylation. Co-transfection of
Dicer –/– ES cells with constructs expressing all three methyltransferases
from a heterologous promoter restored the de novo DNA methylation
in Dicer –/– cells treated with RA for 3 d (Fig. 5a). Transfection of
Dicer–/– ES cells with miR-290 cluster miRNAs had a similar effect
(Fig. 5a). These results indicate that the observed Oct4 promoter
methylation defect is due to the repressed expression of de novo DNA
methyltransferases in Dicer–/– ES cells.
To address whether the DNA methylation defect is more general, we
analyzed the methylation status of two testis-specific genes, Tsp50 and
Sox30, which are silenced in ES cells and undergo de novo DNA
methylation during differentiation (F.M. and D. Schu¨beler, unpub-
lished results). Dicer +/– but not Dicer –/– ES cells showed limited
DNA methylation at Tsp50 and Sox30 promoters, even in the
undifferentiated state (Supplementary Fig. 6 online). Differentiation
of Dicer +/– but not Dicer –/– cells was accompanied by additional DNA
methylation (Supplementary Fig. 6). Nevertheless, the DNA-
methylation changes at Tsp50 and Sox30 promoters were less pro-
nounced than those observed at the Oct4 locus, and the de novo DNA
methylation of Tsp50 and Sox30 promoters was not uniformly
distributed along analyzed sequences (Supplementary Fig. 6). Ectopic
expression of de novo DNA methyltransferases affected the accumula-
tion of DNA methylation during differentiation, whereas transfection
of miR-290 cluster miRNAs resulted in increased DNA methylation at
the 3¢ portion of the Tsp50 sequence but had no appreciable effect at
the Sox30 promoter (Supplementary Fig. 6; see Discussion). Taken
together, the data suggest that the defect in de novo methylation in
Dicer –/– ES cells may be of more global character.
Dicer –/– ES cells grow substantially more slowly than Dicer +/– ES
cells20, and we found that transfection of miR-290 cluster miRNAs
into Dicer –/– ES cells partially rescues the growth phenotype (Fig. 5b),
possibly by regulating expression of p21, an established repressor
of cell-cycle progression37 (Supplementary Fig. 7a–c online; see
Discussion). To eliminate the possibility that the observed changes
of Oct4 DNA methylation are a consequence of different proliferation
rates rather than a specific miR-290 cluster–mediated regulation, we
tested whether the proliferation rate of ES cells has an effect on the
onset of de novo DNA methylation and the expression levels of the
Dnmt3 enzymes.
To reduce proliferation of Dicer +/– ES cells to a rate similar to that
of Dicer –/– ES cells (Fig. 5b), cells were treated with rapamycin, an
inhibitor of mammalian target of rapamycin (TOR). Rapamycin
reduces the proliferation of mouse ES cells without significantly
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affecting their cell-cycle profile38, making the growth properties of
rapamycin-treated Dicer +/– ES cells comparable to that of Dicer –/–
cells20. In Dicer +/– cells grown in the presence of rapamycin, DNA
methylation readily accumulated at the Oct4 promoter after 3 d of
RA treatment (Fig. 5a). Likewise, decreased proliferation had no
significant effect on the expression of Dnmt3a2 or Dnmt3b1/6 (Sup-
plementary Fig. 7d). Furthermore, restoration of Oct4 promoter
methylation by ectopic expression of de novo DNA methyltransferases
occurred without an increase in the proliferation rate of Dicer –/– ES
cells (Fig. 5a,b). Taken together, these data demonstrate that the Oct4
promoter methylation defect is not caused by the slower proliferation
of Dicer –/– ES cells but is dependent on the miR-290 cluster miRNAs.
DISCUSSION
Our data indicate that miRNAs bearing the AAGUGC seed, largely
represented by the miR-290 cluster, are the functionally dominant
miRNAs in mouse ES cells. In fact, the miR-290 cluster miRNAs were
able to reverse many of the defects due to loss of Dicer when
transfected into ES cells. We also found that de novo DNA methylation
in differentiating ES cells is controlled by the miR-290 cluster and that
this regulation is required for stable repression of Oct4. We propose
that, in undifferentiated ES cells, the miR-290 cluster miRNAs sup-
press a transcriptional repressor that targets genes encoding de novo
DNA methyltransferases. The predicted primary targets of the miR-
290 cluster include several transcriptional repressors, and we identified
Rbl2 as a factor contributing to repression of Dnmt3 genes.
The expression of approximately one-quarter of predicted primary
miR-290 cluster targets in ES cells is high in the oocyte but reduced in
the blastocyst and somatic cells (data not shown). This resembles the
situation in zebrafish, where the zygotic AAGUGC seed–containing
miR-430 miRNAs control the maternal mRNA degradation39. How-
ever, murine maternal mRNAs are largely degraded before zygotic
genome activation26, hence before the miR-290 cluster expression.
Moreover, the transition between maternal and zygotic gene expres-
sion is much slower in mammals than in the zebrafish40. Thus, the
miR-290 cluster and related miRNAs restrict embryonic expression of
genes that are highly expressed in the oocyte rather than having an
extensive role in the rapid elimination of maternal transcripts. How-
ever, miR-290 cluster miRNAs and miR-430 may share some con-
served roles in development, as the mouse homologs of zebrafish lft1
and lft2, important regulators of mesoderm formation and targets of
miR-430 (ref. 41), are found among B250 predicted primary targets
of miR-290 cluster miRNAs (Supplementary Table 3).
The microarray analysis also identified several transcripts that
showed inverse changes in the Dicer knockout and miR-290 cluster
rescue microarray experiments, but contained no matches to the seed
of miR-290 cluster miRNAs. These are probably secondary targets
whose expression is regulated by the primary targets of the miRNAs.
Notably, the microarray analysis indicated that many secondary
effects, probably brought about by the primary targets, are reversible
despite the fact that the Dicer–/– ES cell line was established a relatively
long time ago.
Both primary and secondary targets probably contribute to the
reduced proliferation rate of Dicer –/– ES cells, which can be partially
rescued by transfecting miR-290 cluster miRNAs. Notably, one of the
predicted primary targets of the miR-290 cluster is p21 (also known as
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Dicer –/– embryonic stem (ES) cells can be rescued by expression of de novo
DNA methyltransferases (Dnmts) or by transfection of miR-290 cluster
miRNAs. (a) Analysis of CpG methylation in four different Oct4 regions.
The scheme identifies positions of bisulfite-sequenced regions with respect
to the Oct4 transcription start site. SP1-GCNF depicts characterized
transcription factor binding sites in the Oct4 promoter. PE-1A and PE-1B
show positions of previously characterized 1A and 1B sequences in the
proximal enhancer and DE-2A is the position of 2A sequence in the distal
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references therein). Represented from top to bottom: untransfected Dicer +/–
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EGFP-Dnmt3a2, EGFP-Dnmt3b and EGFP-Dnmt3l; Dicer –/– cells transfected
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with rapamycin. Both Dicer +/– and Dicer –/– ES cells were differentiated for
3 d with retinoic acid (RA) in the absence of leukemia inhibitory factor
(LIF). For other details, see Figure 4f. The data originate from experiments
independent of that shown in Figure 4f. (b) Effects of different treatments
on proliferation of Dicer +/– and Dicer –/– ES cells. Equal numbers of
undifferentiated Dicer –/– and Dicer +/– cells were transfected with miR-290
cluster miRNAs, siRL or a mix of plasmids expressing Dnmt3a2, Dnmt3b
and Dnmt3l. Alternatively, cells were grown in the presence of rapamycin.
Average number of cells is shown relative to the number of cells present at
day 1 after transfection (±s.d.; n ¼ 3).
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Cdkn1a), a cyclin-dependent kinase inhibitor that has been shown to
repress cell-cycle progression42. It is well established that control of p21
expression is achieved through negative transcriptional regulators37.
Our data argue for an additional layer of control of p21 expression by
miRNAs carrying the AAGUGC seed sequence. p21 mRNA has three
GCACUU motifs in its 3¢ UTR (Supplementary Fig. 7a), two of which
are conserved across mammals. p21 mRNA is upregulated more than
three-fold in Dicer –/– ES cells, and this misregulation can be corrected
by transfection of miR-290 cluster miRNAs (Supplementary
Fig. 7b,c). Thus, upregulation of p21 could be one of the mechanisms
causing the slower-growth phenotype. Although in ES cells miRNAs
carrying the AAGUGC seed sequence are primarily represented by
miR-290 cluster miRNAs, other related miRNAs, such as the oncomirs
of the miR-17/19/106 cluster43, could regulate expression of p21 in
other tissues. Notably, the reverse complement of AAAGUGC (posi-
tions 2–8 in miR-17-5p) was one of the motifs that was highly enriched
in 3¢ UTRs of transcripts upregulated in human HEK293 cells depleted
of Dicer or the argonaute protein AGO2 (ref. 24). At the same time,
these cells grew more slowly, and the p21 transcript was upregulated.
As miR-17/19/106 miRNAs are fairly ubiquitously expressed27, they
may provide another way to modulate expression of the p21 tumor
suppressor, with a predictable outcome for cellular growth.
The category of secondary targets includes de novo DNA methyl-
transferases, which are downregulated in Dicer –/– ES cells and upreg-
ulated upon miR-290 cluster miRNA transfection. Our data suggest
that reduced expression of Dnmt3 genes in Dicer –/– ES cells is the
cause of de novo DNA-methylation defects observed during differ-
entiation. Decreased expression of Dnmt3a2 and Dnmt3b, correlating
with defective DNA methylation, has been described in mouse XX
ES cells44, arguing that even incomplete depletion of Dnmt3
enzymes may be limiting for proper de novo DNA methylation.
Dnmt3a, Dnmt3b and possibly Dnmt3l may function as a complex36.
Hence, even partial downregulation of each of them may strongly
affect DNA methylation.
We investigated whether the proliferation rate itself affects Dnmt3
expression and de novo DNA methylation. We found that Dnmt3
expression and de novo DNA methylation are not impaired when the
growth of control Dicer+/– ES cells is reduced by rapamycin. As the
rapamycin-treated wild-type and Dicer –/– ES cells have comparable
cell-cycle profiles and similarly slow proliferation rates20,38, it is
unlikely that the altered growth rate of Dicer –/– ES cells is responsible
for decreased Dnmt3 gene expression and the loss of de novo
DNA methylation during differentiation. Furthermore, ectopic
expression of de novo DNA methyltransferases rescued de novo
DNA methylation without an apparent effect on proliferation of
Dicer –/– cells. Because de novo DNA methylation proceeds normally in
rapamycin-treated Dicer+/– ES cells, which show minimal proliferation
during 3 d of RA-induced differentiation, it is unlikely that clonal
effects in the cell culture would significantly distort the results of
DNA-methylation analysis.
We propose that the transcription of Dnmt3 genes is regulated in ES
cells by a repressor protein whose mRNA is a target of miR-290 cluster
miRNAs (Fig. 6). Loss of the miR-290 cluster miRNAs in Dicer –/–
cells would cause the upregulation of the repressor, followed by the
downregulation of de novo DNA methyltransferases. This type of
Dnmt3 regulation may be restricted to ES cells, as the levels of Dnmt3
mRNAs are not affected in HEK293 cells with knockdown of Dicer or
Argonaute proteins24. A suitable candidate for the repressor that
targets Dnmt3 genes is Rbl2, whose mRNA has all the features of a
primary miR-290 cluster target. Consistent with our model, knock-
down of Rbl2 in Dicer –/– cells had a positive effect on Dnmt3a2 and
Dnmt3b expression. Rbl2 is a tumor suppressor that is capable of
repressing E2f4 target genes as a part of the DREAM repressor
complex33. Notably, the expression profile of human Dnmt3b during
the cell cycle (low in G1 and G0 and upregulated in S phase45) is
similar to that of the E2f4 target genes repressed by Rbl2 (ref. 33).
RBL2 and the DREAM complex were recently shown to associate
physically with the Dnmt3b promoter in human glioblastoma cells33,
suggesting that RBL2 can directly repress transcription of Dnmt3
genes. Certainly, as the miR-290 cluster controls expression of a
number of transcriptional repressors, Rbl2 may not be the only
regulator of de novo DNA methylation in ES cells. Fabbri et al.46
have recently reported that the miR-29 family of miRNAs (miR-29s)
can directly target Dnmt3a and Dnmt3b mRNAs and repress synthesis
of de novo DNA methyltransferases in human lung cancer cells. miR-29
miRNAs are expressed in mouse ES cells and downregulated upon loss
of Dicer, but our data argue against a major role of these miRNAs in
controlling Dnmt3a/b mRNA or protein levels in mouse ES cells.
One of the functions of de novo DNA methylation during ES cell
differentiation is the stable silencing of the pluripotency program. Our
data indicate that, although the initial phase of transcriptional
repression of Oct4 seems to be undisturbed, the de novo DNA
methylation of the Oct4 promoter is severely impaired during differ-
entiation of Dicer/ cells. These results are consistent with the
observation that stable silencing of Oct4 is dependent on correct
de novo methylation of DNA35,36. The defect in de novo DNA
methylation may not be confined to Oct4, as Nanog, another core
pluripotency factor, showed a similar expression profile (Supplemen-
tary Fig. 4). In addition, the promoters of Tsp50 and Sox30, two testis-
specific genes that are silent in ES cells and acquire de novo DNA
methylation during differentiation, also failed to undergo DNA
methylation in Dicer –/– cells. DNA-methylation data from these two
loci are less conclusive, possibly resulting from slower kinetics of
accumulation of methylation at these loci, exacerbated by a transient
nature of the rescue with miR-290 cluster miRNAs. Nevertheless,
accumulation of DNA methylation at these promoters is consistent
with that of Oct4, suggesting a more general defect in de novo DNA
methylation in Dicer –/– ES cells.
The defects in de novo DNA methylation in Dicer –/– ES cells may
contribute decisively to the loss of the ability to differentiate in vitro
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and in vivo. Notably, Dnmt3a–/– Dnmt3b–/– double-mutant ES cells
retain an undifferentiated morphology, and their late passages fail to
form teratomas in nude mice47. The defects in de novo DNA
methylation may also underlie the variable levels of centromeric
DNA methylation reported for different Dicer –/– ES lines19,20, because
the loss of de novo DNA methyltransferases results in gradual DNA
demethylation during prolonged culture47.
In summary, our analysis of gene expression in mouse Dicer –/– ES
cells indicates that many of the observed transcriptome changes that
occur upon loss of Dicer can be attributed to miRNAs, particularly to
those of the miR-290 cluster. We have identified B250 candidate
primary targets of the AAGUGC seed–containing miRNAs, and we
also identified many genes that they regulate indirectly. Most notably,
we demonstrated that de novo DNA methylation is defective in
Dicer –/– ES cells, and that this is due to the indirect control of
expression of the de novo DNA methyltransferases by the miR-290
cluster. The established link between miR-290 cluster miRNAs and
de novo DNA methylation in ES cells indicates that miRNAs may
contribute substantially to the epigenetic control of gene expression.
METHODS
Cell culture. The Dicer heterozygous (+/–; line D4) and Dicer-deficient (–/–;
line 27H10) ES cells (referred to as Dicer +/– and Dicer–/–, respectively) were
kindly provided by G. Hannon, Cold Spring Harbor Laboratory, Cold Spring
Harbor, New York, USA20. They were maintained on gelatin-coated plates with
DMEM supplemented with 15% (w/v) FCS, sodium pyruvate, b-mercapto-
ethanol, nonessential amino acids and LIF. Differentiation of ES cells was
carried out in the absence of LIF and the presence of 100 nM RA. When
indicated, cells were cultured for 4 d in the presence of 25 nM rapamycin
(200 mM stock of rapamycin dissolved in ethanol). Control cells were grown in
the presence of ethanol at equivalent concentration. For differentiation in the
presence of rapamycin, the cells were cultured for 1 d with rapamycin and LIF
followed by 3 d without LIF and with 100 nM RA and 25 nM rapamycin.
Plasmids. The control reporter constructs encoding firefly (FL) or Renilla (RL)
luciferase (pGL3-FF and pRL-TK, respectively) were described earlier24. FL
reporters under the control of Dnmt3b promoter fragments (p3b-1102/+93-FF,
p3b-1981/+93-FF, p3b-4997/+93-FF and p3b-7886/+93-FF) and constructs
encoding the EGFP-tagged de novo DNA methyltransferases (pCag-EGFP-
Dnmt3a2, p-Cag-EGFP-Dnmt3b and p-Cag-EGFP-Dnmt3L) were kindly
provided by K. Ura, Osaka University Graduate School of Medicine,
Osaka, Japan48,49.
Transfection of reporter constructs. At least three independent transfection
experiments in triplicate were done in each case. For luciferase assays, Dicer –/–
cells were transfected in six-well plates with 500 ng of indicated FL reporter
constructs and 50 ng of pTK-RL as a control, using Lipofectamine 2000 reagent
(Invitrogen). All luciferase assays were performed 24 h after transfection.
Other transfections. Other transfections were performed using the Mouse ES
cell Nucleofection Kit (Amaxa Biosystems) and program A23 of Nucleofector I
apparatus (Amaxa Biosystems). Approximately 3  106 Dicer –/– cells were used
per transfection and the cells were plated immediately after electroporation.
Transfections of siRNAs were performed according to the manufacturer’s
instructions, using 300 pmol of siRNA against RL mRNA (siRL) (Eurogentec),
50 pmol of siGENOME smartPOOL siRNAs against Rbl2 (Dharmacon),
50 pmol of each of the mmu-mir-290, mmu-mir-291a-3p, mmu-mir-292-3p,
mmu-mir-293, mmu-mir-294 and mmu-mir-295 miRNA mimics (Dharma-
con), or 300 pmol of mmu-mir-291a-3p, together with 2 mg of pCX-EGFP50,
which served as control for transfection efficiency. For rescue of de novo DNA
methylation by a mixture of pCag-EGFP-Dnmt3a2, pCag-EGFP-Dnmt3b
and pCag-EGFP-Dnmt3L plasmids, the Dicer –/– cells were co-transfected
with 7 mg of each of these plasmids, using the Nucleofector I apparatus. The
EGFP-expressing cells were collected using a MoFlow cell sorter (Dako
Cytomation) after 3 d of culture in the presence of 100 nM RA and the
absence of LIF.
Chromatin immunoprecipitation. Chromatin immunoprecipitations (ChIPs)
were performed as described previously51. Dicer +/– and Dicer –/– ES cells, either
undifferentiated or treated for 3 d with RA, were cross-linked by adding
formaldehyde directly to the medium to a final concentration of 1% (w/v) at
room temperature. The reaction was stopped after 8 min by adding glycine to a
final concentration of 0.15 M. Cell lysates were sonicated to generate
300–1,500-bp DNA fragments. After preclearing the samples with Protein A
Agarose (Upstate), the immunocomplexes were formed using anti-H3K9me2
or anti-H3K27me3 antibodies (Upstate). Immunocomplexes were collected
with 30 ml of Protein A Agarose (Upstate). The purified DNA and a 1:100
dilution of the respective input DNA were used as templates for quantitative
real-time PCR (RT-qPCR), using the ABI Prism 7000 Sequence Detection
System (Applied Biosystems), Platinum SYBR Green qPCR SuperMix (Invitro-
gen) and primers specific for the glyceraldehyde-3-phosphate dehydrogenase
(Gapdh) and Oct4 promoters. Obtained values were first normalized to the
respective input DNA and further to the enrichment at the Gapdh promoter
where these modifications do not accumulate. Sequences of primers are listed
in Supplementary Table 4 online. Annealing of all primers was done at 55 1C.
Bisulfite sequencing. Bisulfite sequencing was performed using the Epitect
Bisulfite sequencing kit (Qiagen) according to the manufacturer’s conditions.
Up to 2 mg of genomic DNA was used as a starting material. PCR amplification
conditions were as described52. All primers are listed in Supplementary Table 4.
Statistical analysis. Analysis of microarray data and motifs, including statistical
methods, is described in detail in the Supplementary Methods. All remaining
statistical analysis used two-tailed t-tests.
Real-time quantitative RT-PCR (RT-qPCR). Total RNA from ES cells was
extracted using the Absolutely RNA Miniprep Kit (Stratagene). A Thermoscript
RT-PCR kit (Invitrogen) was used for the cDNA synthesis reaction with 1 mg
template RNA and 250 pmol of oligo(dT)20 primer, incubated for 1 h at 55 1C.
Subsequently, cDNA was used as a template for RT-qPCR with the ABI Prism
7000 Sequence Detection System and Platinum SYBR Green qPCR SuperMix,
using gene-specific primers. For Dnmt3 enzymes, splice-variant–specific pri-
mers were used. Sequences of primers are provided in Supplementary Table 4.
Annealing of all primers was done at 55 1C. Relative expression levels were
calculated using the formula 2–(DCt), where DCt is Ct(gene of interest)–Ct(GAPDH)
and Ct is the cycle at which the threshold is crossed. For time course
experiments, the expression level at day 0 in Dicer+/– ES cells or in siRL-
transfected Dicer –/– cells was always set as 1 and expression levels at other time
points were normalized to it.
Western blotting. Cells were lysed in lysis buffer (30 mM Tris-HCl, pH 7.5,
containing 150 mM NaCl, 1 mM MgCl2, 0.5% (v/v) Nonidet P-40, 1 mM DTT
and protease inhibitors) and kept on ice for 10 min. Equal amounts of the lysed
proteins were separated on polyacrylamide-SDS gels, blotted on polyvinylidene
fluoride membrane and probed with the following primary antibodies: anti-
Oct4 (Santa Cruz, dilution 1:2,000), anti–a-tubulin (5.2.1 Sigma, 1:10,000),
anti-Dicer [D349 (ref. 53), 1:5,000], anti-Dnmt1 (Abcam, 1:500), anti-Dnmt3a
(Imgenex, 1:250), anti-Dnmt3b (Imgenex, 1:250) and anti–RNA-polymerase II
(Covance, 1:500). This was followed by incubation with secondary horseradish
peroxidase–coupled antibodies. Detection was performed with ECL or ECL+
kits (Amersham).
Luciferase assays. Luciferase assays were performed using the Dual-Luciferase
Reporter Assay kit (Promega) according to the manufacturer’s instructions. FL
activity was normalized to RL activity expressed from pRL-TK. Normalized FL
activity in cells transfected with pGL3-FF was always set as one.
Note: Supplementary information is available on the Nature Structural & Molecular
Biology website.
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Sinkkonen et al. Supplementary Figure 1
MicroRNAs control de novo DNA methylation through regulation of 
transcriptional repressors in mouse embryonic stem cells
Lasse Sinkkonen, Tabea Hugenschmidt, Philipp Berninger, Dimos Gaidatzis, Fabio Mohn, 
Caroline G. Artus-Revel, Mihaela Zavolan, Petr Svoboda, and Witold Filipowicz
Supplementary Figure 1. Characterization of the differentiation status of Dicer+/– and 
Dicer–/– ES cells. 
(a) Light microscopy images of undifferentiated cells (cells grown in the presence of LIF) 
and cells subjected to the differentiation treatment (grown for 3 days in the presence of 
100 nM RA, in the absence of LIF; RA, 3 d). (b) Levels of mRNAs encoding core 
pluripotency and differentiation markers. Microarray analysis was performed with RNA 
isolated from undifferentiated Dicer+/– and Dicer–/– ES cells. Raw data were calculated as 
described in Materials and Methods.  Median raw values (± s.d.) for each gene were 
taken from probe sets with the strongest hybridization signal. Other probe sets for the 
same genes also did not show significant differences in expression levels between 
Dicer+/– and Dicer–/– cells. Displayed differentiation markers were either used in a 
previous analysis of Dicer–/– ES cells [T (brachyury), Hnf4a, Gata1, Bmp4]7 or were 
culled from published articles (Tpbpb, Cdx2, Gata6)8,9. These markers are indicative of 
the presence of cells of trophectodermal (Tpbpb, Cdx2), extraembryonic endodermal 
(Gata6), embryonic mesodermal (brachyury, Bmp4, Gata1, Gata6), and embryonic 
endodermal (Hnf4a, Gata6) lineages. It is not known why Dicer+/– cells show a low 
microarray hybridization signal of brachyury. Possibly, a small fraction of cells 
spontaneously initiates differentiation. However, other mesodermal markers such as 
Gata1 and Gata6 remained absent. Detectable microarray hybridization signal for Bmp4 
has been previously reported for undifferentiated ES cells (GEO database, and10). (c) RT-
qPCR analysis of Oct-4 and Nanog mRNA levels confirms results of microarray analysis. 
Values, normalized to Gapdh expression, represent means (± s.e.m.) of at least 3 
independent experiments. 
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Supplementary Figure 2. Characterization of expression of the miR-290 cluster. 
(a) Structure of the miR-290 locus and sequences of the miR-290 cluster miRNAs. The 
upper scheme depicts structure of the cluster. Shown is a 4 kb fragment from the 
chromosome 7 genomic contig NT_039413.7 (from 217,800 to 221,800) with relative 
positions of individual miRNAs and orientation of the pri-miRNA transcript. The orange 
line represents a region covered by oligonucleotide probes from the Affymetrix probe set 
1444292_at, which detects pri-miRNA of the miR-290 cluster. Below the map is a 
ClustalW alignment of pre-miRNAs, which was downloaded from the miRbase1 and 
edited using Genedoc alignment editor (http://www.psc.edu/biomed/genedoc). Blue lines 
represent mature miRNA sequences from the ascending (5p) strand and red lines from the 
descending (3p) strand of the pre-miRNA hairpin. Pre-miRNAs of the miR-290 cluster 
yield mature miRNAs primarily from descending (3p) hairpin strands. According to 
Landgraf et al.6, the 5p strands also produce mature miRNAs but they represent only 13% 
of miRNAs generated from the cluster. Note that despite being expressed, not all mature 
miRNA sequences depicted here can be found in the current version of the miBase (9.2). 
(b) Quantification of the miR-290 cluster primary transcript, followed using the 
microarray probe 1444292_at, indicates that the cluster is expressed zygotically. The 
region of the primary transcript covered by the 1444292_at probe set is indicated in panel 
a. The analysis was performed using previously published microarray data11. Raw data 
were calculated as described previously12. Median raw values (± s.d.; n = 4) are shown. 
(c) The miR-290 cluster primary transcript is strongly down-regulated in Dicer–/– ES cells 
(two-tailed t-test: p = 0.0053). Expression of the primary trasncript was followed using 
the microarray probe 1444292_at as described in panel a. The mean expression value (± 
s.d.; n = 3) in Dicer+/– cells was set to one. (d) Levels of the mir-290 cluster miRNAs are 
down-regulated in Dicer–/– cells. Total RNA extracted from either Dicer+/– or Dicer–/– 
cells was analyzed on miRCURYTM LNA arrays, following the manufacturer’s protocol 
(www.exiqon.com). Values calculated for Dicer+/– cells were set as one. The figure 
shows expression levels of only 3p miRNAs of miR-290 cluster, which were reliably 
identified as present in the analyzed RNA samples. The 3p miRNAs represent 87% of all 
miRNAs generated from the cluster6. miR-290-3p is not shown since the Exiqon array 
does not contain a probe for its detection. 
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Supplementary Figure 3. Relationship between the expression changes in the Dicer–/– 
vs. Dicer+/– (x-axis) and miR-290s-transfected vs siRL-transfected Dicer–/– ES cells (y-
axis). Each dot corresponds to a single transcript, and the panels represent: (a) all 
transcripts; (b) transcripts with at least one 7-mer match to one of the 1-8 positions of the 
miRNAs in the 290 cluster in their 3′-UTRs; and (c) transcripts with no 7-mer match to 
any of the miRNAs of the 290 cluster in their 3′-UTRs. The correlation coefficients are 
indicated in each panel. 
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Supplementary Figure 4. RT-qPCR analysis of Nanog expression during the RA-
induced differentiation for 0, 1, 3, or 6 days (0 d, 1 d, 3 d, 6 d), and after returning the 
cells to the LIF-containing medium devoid of RA for up to 4 additional days (2 d after, 4 
d after). Values, normalized to GAPDH expression, represent means (± s.e.m.) of at least 
3 independent experiments. Expression in control Dicer+/– cells at 0d time point was set 
as 1.  
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Supplementary Figure 5. Maintenance DNA methylation is not affected in Dicer–/– ES 
cells. Bisulfite analysis shows the same methylation pattern in undifferentiated and 
differentiated Dicer–/– and Dicer+/– ES cells for typical targets of DNA methylation: 
repetitive DNA and a body of a gene13. DNA methylation of tandemly arrayed repeat 
sequences (centromeric satellite), interspersed LTR retrotransposon sequences (IAP and 
MuERV-L), interspersed non-LTR transposon sequences (L1), and a single copy gene 
sequence (CTCF, exon 9) were analyzed. In the case of IAP, also its 5′ LTR sequence, 
which serves as a promoter for the retrotransposon, was analyzed. The exon 9 sequence 
of the CTCF gene is hypermethylated in numerous tissues14. The ES cell DNA samples 
used to obtain the data were the same as those described in Fig. 6. Blastocyst DNA 
samples served as a control providing the DNA methylation status prior to establishment 
of ES cells. The blastocyst DNA was obtained from a pool of 30 blastocysts from uteri of 
C57BL/6 female mice. An equivalent of three blastocysts was used for each PCR 
reaction. Black dots represent methylated and white dots non-methylated CpGs. Sites for 
which the methylation status was not certain are in grey. Average percentages of the 
methylated CpG sites for ES cell samples range from 89 to 97 % for satellite repeat, 62 to 
70 % for L1, 84 to 92 % for IAP LTR, 90 to 97 % for IAP 5’LTR, 62 to 67 % for 
MuERV, and 75 to 92 % for Ctcf. 
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Supplementary Figure 6. Analysis of de novo DNA methylation of promoters of testis-
specific genes Tsp50 and Sox30, which are transcriptionally silent in undifferentiated ES 
cells and acquire DNA methylation during differentiation in the presence of RA. The 
promoter regions, upstream of the Tsp50 and Sox30 transcription start sites, were 
analyzed in Dicer+/– ES cells, Dicer–/– ES cells, Dicer–/– ES cells co-transfected with 
plasmids expressing EGFP-DNMT3a2, EGFP-DNMT3b, and EGFP-DNMT3L, Dicer–/– 
ES cells transfected with miR-290 cluster miRNA mimics, and Dicer–/– ES cells 
transfected with siRL. Cells were cultured in presence of LIF and without RA (LIF) or 
differentiated for 3 days with RA in the absence of LIF (RA, 3 d). Each row of dots 
represents CpGs in one sequenced clone. Black dots represent methylated and white dots 
non-methylated CpGs. Sites for which the methylation status was not certain are in grey. 
Average percentages of the methylated CpG sites are indicated. 
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Supplementary Figure 7. (a,b,c) p21 is up-regulated in Dicer–/– ES cells and down-
regulated in response to transfection of miR-290s. (a) Schematic representation of 
localization of predicted binding sites for AAGUGC-seed containing miRNAs in 3′-UTR 
of p21 mRNA are marked with black triangles. (b) The level of p21 mRNA is up-
regulated in Dicer–/– cells. RNA isolated from Dicer+/– and Dicer–/– cells was analyzed by 
Affymetrix microarrays. The probe sets detecting expression of p21 mRNA are indicated. 
Mean expression value (± s.d.; n = 3) in Dicer+/– cells was set to 1. The two-tailed t-test 
p-values were 0.0021 and 0.0120. (c) Transfection of miR-290s to Dicer–/– ES cells 
down-regulates the level of p21 mRNA. Cells were transfected with either a mixture of 
the miR-290 cluster miRNAs or siRL used as a control. RNA was isolated 24 h after 
transfection. Mean expression value (± s.d; n = 3) in siRL transfected cells was set to 1. 
The two-tailed t-test p-values were 0.0012 and 0.0070. (d) Expression of Dnmt3a2 and 
Dnmt3b is independent of the growth rate of the Dicer+/– ES cells. Dicer+/– ES cells were 
cultured with or without 25 nM rapamycin and differentiated for three days with RA in 
the absence of LIF (RA, 3 d). mRNA levels of Dnmt3a2, Dnmt3b and Oct-4 were 
analyzed by RT-qPCR. Expression (± s.d.; n = 3) was normalized to that of Gapdh and is 
shown relative to corresponding samples cultured in the presence of LIF without 
rapamycin, whose expression values were set to 1. 
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Supplementary Table 1. Motifs most significantly enriched in 3′-UTRs of mRNAs up-
regulated in Dicer–/– ES cells or down-regulated in Dicer–/– ES cells transfected with 
miRNAs of the miR-290 cluster. 
Enrichments of the 7-mers were analyzed as described in Materials and Methods. Shown 
are the motifs most significantly (posterior probability > 0.99) enriched in 3′-UTRs of 
mRNAs up-regulated in Dicer–/– ES cells or down-regulated in Dicer–/– ES cells 
transfected with miRNAs of the miR-290 family. For each motif, the sequence of the 
motif, posterior probability of the enrichment, occurrence of the motif among up- or 
down-regulated 3′-UTRs, and the enrichment of the motif are shown. For motifs that are 
complementary to sequences within miRNAs, the names and sequences of the matching 
miRNAs are also shown. Sequences complementary to the enriched motif are in capitals. 
A number of top scoring 7-mer motifs enriched in 3′-UTRs of mRNAs down-regulated 
upon transfection of miR-290 cluster miRNAs contain seven or six U residues. The 
significance of these motifs and their enrichment is unknown. 
 
Supplementary Table 1 - Significantly enriched motifs (posterior probability > 0.99)
Motifs enriched in transcripts upregulated in Dicer -/- cells 
Motif Posterior probability Occurrence Enrichment Position miRNA                     Sequence of miRNA
GCACUUU 0.9999999999 489 1.615
(2-8) mmu-miR-17-5p                        cAAAGUGCuuacagugcagguagu
(1-7) mmu-miR-291a-3p                         AAAGUGCuuccacuuugugugcc
(2-8) mmu-miR-93                        cAAAGUGCuguucgugcagguag
(2-8) mmu-miR-20b                        cAAAGUGCucauagugcaggua
(1-7) mmu-miR-291b-3p                         AAAGUGCauccauuuuguuuguc
(2-8) mmu-miR-106b                        uAAAGUGCugacagugcagau
(2-8) mmu-miR-106a                        cAAAGUGCuaacagugcaggua
(2-8) mmu-miR-20a                        uAAAGUGCuuauagugcagguag
(1-7) mmu-miR-294-3p                         AAAGUGCuucccuuuugugugu
(1-7) mmu-miR-295-3p                         AAAGUGCuacuacuuuugagucu
AGCACUU 0.9999999994 545 1.495
(3-9) mmu-miR-17-5p                       caAAGUGCUuacagugcagguagu
(1-7) mmu-miR-302b                         AAGUGCUuccauguuuuaguag
(2-8) mmu-miR-291a-3p                        aAAGUGCUuccacuuugugugcc
(3-9) mmu-miR-93                       caAAGUGCUguucgugcagguag
(3-9) mmu-miR-20b                       caAAGUGCUcauagugcaggua
(1-7) mmu-miR-302d                         AAGUGCUuccauguuugagugu
(2-8) mmu-miR-302c                        cAAGUGCUuccauguuucagugg
(3-9) mmu-miR-106b                       uaAAGUGCUgacagugcagau
(3-9) mmu-miR-106a                       caAAGUGCUaacagugcaggua
(3-9) mmu-miR-20a                       uaAAGUGCUuauagugcagguag
(2-8) mmu-miR-294-3p                        aAAGUGCUucccuuuugugugu
(2-8) mmu-miR-295-3p                        aAAGUGCUacuacuuuugagucu
(2-8) mmu-miR-302                        uAAGUGCUuccauguuuugguga
GCACUUA 0.9999281990 255 1.614
(2-8) mmu-miR-467*                        gUAAGUGCcugcauguauaug
(1-7) mmu-miR-302                         UAAGUGCuuccauguuuugguga
UGCACUU 0.9988487421 415 1.402
(2-8) mmu-miR-291b-3p                        aAAGUGCAuccauuuuguuuguc
AAGCACU 0.9967070829 406 1.392
(4-10) mmu-miR-17-5p                      caaAGUGCUUacagugcagguagu
(2-8) mmu-miR-302b                        aAGUGCUUccauguuuuaguag
(3-9) mmu-miR-291a-3p                       aaAGUGCUUccacuuugugugcc
(11-17) mmu-miR-471               uacguaguauAGUGCUUuucaca
(2-8) mmu-miR-302d                        aAGUGCUUccauguuugagugu
(3-9) mmu-miR-302c                       caAGUGCUUccauguuucagugg
(4-10) mmu-miR-20a                      uaaAGUGCUUauagugcagguag
(3-9) mmu-miR-294-3p                       aaAGUGCUUcccuuuugugugu
(3-9) mmu-miR-302                       uaAGUGCUUccauguuuugguga
Motifs enriched in transcripts downregulated in Dicer -/- cells transfected with miR-290 cluster
Motif Posterior probability Occurrence Enrichment Position miRNA                     Sequence of miRNA
UUUUUUU 0.9999999542 2299 1.175
GCACUUA 0.9999976429 126 2.047
(2-8) mmu-miR-467*                        gUAAGUGCcugcauguauaug
(1-7) mmu-miR-302                         UAAGUGCuuccauguuuugguga
UUUGUUU 0.9999952321 931 1.265
(1-7) mmu-miR-495                         AAACAAAcauggugcacuucuu
UUUUGUU 0.999912871 776 1.272
AGCACUU 0.999696131 224 1.576
(3-9) mmu-miR-17-5p                       caAAGUGCUuacagugcagguagu
(1-7) mmu-miR-302b                         AAGUGCUuccauguuuuaguag
(2-8) mmu-miR-291a-3p                        aAAGUGCUuccacuuugugugcc
(3-9) mmu-miR-93                       caAAGUGCUguucgugcagguag
(3-9) mmu-miR-20b                       caAAGUGCUcauagugcaggua
(1-7) mmu-miR-302d                         AAGUGCUuccauguuugagugu
(2-8) mmu-miR-302c                        cAAGUGCUuccauguuucagugg
(3-9) mmu-miR-106b                       uaAAGUGCUgacagugcagau
(3-9) mmu-miR-106a                       caAAGUGCUaacagugcaggua
(3-9) mmu-miR-20a                       uaAAGUGCUuauagugcagguag
(2-8) mmu-miR-294-3p                        aAAGUGCUucccuuuugugugu
(2-8) mmu-miR-295-3p                        aAAGUGCUacuacuuuugagucu
(2-8) mmu-miR-302                        uAAGUGCUuccauguuuugguga
GCACUUU 0.9996301511 193 1.635
(2-8) mmu-miR-17-5p                        cAAAGUGCuuacagugcagguagu
(1-7) mmu-miR-291a-3p                         AAAGUGCuuccacuuugugugcc
(2-8) mmu-miR-93                        cAAAGUGCuguucgugcagguag
(2-8) mmu-miR-20b                        cAAAGUGCucauagugcaggua
(1-7) mmu-miR-291b-3p                         AAAGUGCauccauuuuguuuguc
(2-8) mmu-miR-106b                        uAAAGUGCugacagugcagau
(2-8) mmu-miR-106a                        cAAAGUGCuaacagugcaggua
(2-8) mmu-miR-20a                        uAAAGUGCuuauagugcagguag
(1-7) mmu-miR-294-3p                         AAAGUGCuucccuuuugugugu
(1-7) mmu-miR-295-3p                         AAAGUGCuacuacuuuugagucu
UUGUUUU 0.9989237718 802 1.245
UAUUUUU 0.9983591123 691 1.264
Supplementary Table 2. Profiling of miRNA levels in Dicer+/– and Dicer–/– ES cells 
using miRCURYTM Exqon microarrays. 
Microarray analysis was performed as described in Supplementary Materials and 
Methods. 190 miRNAs gave significant hybridization signals with both analyzed Dicer+/– 
RNA samples and thus were considered for further analysis. The miRNA expression 
levels in Dicer–/– ES cells were compared to the expression levels in Dicer+/– ES cells. 
The numbers of miRNAs down- or up-regulated, or not changing, with cut-offs of 1.2-
fold, 1.5-fold and 2.0-fold are shown in the table. The miRNAs that were down-regulated 
more than 1.5-fold or 2.0-fold were considered as expressed in ES cells in a Dicer-
dependent manner. These miRNAs are listed and their expression levels normalized to 
the expression levels in a control reference sample (a mixture of total RNA from 11 
different tissues) are indicated to identify miRNAs expressed preferentially in ES cells. 
 
Supplementary Table 2 - miRNA expression profiling in Dicer +/- and Dicer -/- ES cells
Changes in miRNA levels in Dicer -/- cells Number of miRNAs % of all detected miRNAs (n=190)
CUT-OFF 1.2-FOLD
downregulated 1.2-fold 115 60,3
upregulated 1.2-fold 23 12,2
not changed above 1.2-fold 52 27,5
CUT-OFF 1.5-FOLD
downregulated 1.5-fold 69 36,0
upregulated 1.5-fold 8 4,2
not changed above 1.5-fold 113 59,8
CUT-OFF 2.0-FOLD
downregulated 2.0-fold 29 14,8
upregulated 2.0-fold 3 1,6
not changed above 2.0-fold 158 83,6
miRNAs DOWNREGULATED >2.0-fold
Expressed > 1.5-fold higher Expressed between 1.5- to 0.5-fold Expressed < 0.5-fold 
relative to control reference mixture relative to control reference mixture relative to control reference mixture
mmu-let-7d* mmu-miR-136 mmu-miR-101a 
mmu-miR-291a-3p mmu-miR-18 mmu-miR-103 
mmu-miR-292-3p mmu-miR-337 mmu-miR-106a 
mmu-miR-293 (miR-293-3p) mmu-miR-376a mmu-miR-130a
mmu-mir294 (miR-294-3p) mmu-miR-467* mmu-miR-140* 
mmu-miR-295 (miR-295-3p) mmu-miR-541 mmu-miR-146b 
mmu-miR-16
mmu-miR-17-5p 
mmu-miR-191 
mmu-miR-193
mmu-miR-200a 
mmu-miR-20b 
mmu-miR-21
mmu-miR-22
mmu-miR-23a 
mmu-miR-335 
mmu-miR-98 
miRNAs DOWNREGULATED >1.5-fold
Expressed > 1.5-fold higher Expressed between 1.5- to 0.5-fold Expressed < 0.5-fold 
relative to control reference mixture relative to control reference mixture relative to control reference mixture
mmu-let-7d* mmu-miR-136 mmu-let-7i 
mmu-miR-291a-3p mmu-miR-18 mmu-miR-101a 
mmu-miR-292-3p mmu-miR-337 mmu-miR-101b 
mmu-miR-293 (miR-293-3p) mmu-miR-341 mmu-miR-103 
mmu-mir294 (miR-294-3p) mmu-miR-376a mmu-miR-106a
mmu-miR-295 (miR-295-3p) mmu-miR-379 mmu-miR-107 
mmu-miR-697 mmu-miR-467* mmu-miR-10b 
mmu-miR-541 mmu-miR-122a 
mmu-miR-127
mmu-miR-128a 
mmu-miR-130a
mmu-miR-133a*
mmu-miR-140 
mmu-miR-140* 
mmu-miR-142-5p
mmu-miR-143
mmu-miR-146 
mmu-miR-146b 
mmu-miR-148a 
mmu-miR-148b 
mmu-miR-15a
mmu-miR-15b
mmu-miR-16
mmu-miR-17-5p 
mmu-miR-191 
mmu-miR-193 
mmu-miR-195 
mmu-miR-19b
mmu-miR-200a 
mmu-miR-200b 
mmu-miR-20b
mmu-miR-21
mmu-miR-22
mmu-miR-222 
mmu-miR-223 
mmu-miR-23a 
mmu-miR-23b
mmu-miR-24 
mmu-miR-26a 
mmu-miR-27a
mmu-miR-27b 
mmu-miR-29a
mmu-miR-29c 
mmu-miR-30a-5p 
mmu-miR-30b 
mmu-miR-30c 
mmu-miR-30e 
mmu-miR-335 
mmu-miR-338 
mmu-miR-376b 
mmu-miR-449 
mmu-miR-451 
mmu-miR-9* 
mmu-miR-98 
Supplementary Table 3 - Predicted primary targets of the miR-290 cluster miRNAs
RefSeq Gene symbol Description Number of GCACUU motifs
NM_025326 0610011I04Rik Mus musculus RIKEN cDNA 0610011I04 gene 1
XM_001003634 1110060D06Rik PREDICTED: Mus musculus RIKEN cDNA 1110060D06 gene, transcript variant 2 1
XM_978179 1810013L24Rik PREDICTED: Mus musculus RIKEN cDNA 1810013L24 gene, transcript variant 1 2
NM_026437 1810055E12Rik Mus musculus RIKEN cDNA 1810055E12 gene 2
NM_175381 2700081O15Rik Mus musculus RIKEN cDNA 2700081O15 gene 4
NM_172877 4732496O08Rik Mus musculus RIKEN cDNA 4732496O08 gene 1
NM_029037 4930444A02Rik Mus musculus RIKEN cDNA 4930444A02 gene 2
NM_175172 4930506M07Rik Mus musculus RIKEN cDNA 4930506M07 gene 1
NM_173764 4932414K18Rik Mus musculus RIKEN cDNA 4932414K18 gene 2
NM_175263 5730593N15Rik Mus musculus RIKEN cDNA 5730593N15 gene 1
NM_146091 5730596K20Rik Mus musculus RIKEN cDNA 5730596K20 gene 1
NM_025697 6330409N04Rik Mus musculus RIKEN cDNA 6330409N04 gene 1
XM_991839 9030420J04Rik PREDICTED: Mus musculus RIKEN cDNA 9030420J04 gene 1
NM_153117 9530068E07Rik Mus musculus RIKEN cDNA 9530068E07 gene 4
NM_001007577 A630018P17Rik Mus musculus RIKEN cDNA A630018P17 gene 1
NM_177118 A830073O21Rik Mus musculus RIKEN cDNA A830073O21 gene 2
NM_015729 Acox1 Mus musculus acyl-Coenzyme A oxidase 1, palmitoyl 1
NM_007394 Acvr1 Mus musculus activin A receptor, type 1 1
NM_007404 Adam9 Mus musculus a disintegrin and metallopeptidase domain 9 (meltrin gamma) 2
NM_007408 Adfp Mus musculus adipose differentiation related protein 1
NM_001005605 Aebp2 Mus musculus AE binding protein 2 2
NM_001033476 AI450948 Mus musculus expressed sequence AI450948 1
NM_177907 AI593442 Mus musculus expressed sequence AI593442 1
NM_145489 AI661453 Mus musculus expressed sequence AI661453 1
NM_011785 Akt3 Mus musculus thymoma viral proto-oncogene 3 1
NM_028270 Aldh1b1 Mus musculus aldehyde dehydrogenase 1 family, member B1 1
NM_019998 Alg2 Mus musculus asparagine-linked glycosylation 2 homolog (yeast, alpha-1,3-mannosyltransfe 1
NM_009667 Ampd3 Mus musculus AMP deaminase 3 1
NM_134071 Ankrd32 Mus musculus ankyrin repeat domain 32 1
XM_001000870 Ap1g1 PREDICTED: Mus musculus adaptor protein complex AP-1, gamma 1 subunit 1
NM_007457 Ap1s1 Mus musculus adaptor protein complex AP-1, sigma 1 1
NM_009686 Apbb2 Mus musculus amyloid beta (A4) precursor protein-binding, family B, member 2 1
NM_027144 Arhgef12 Mus musculus Rho guanine nucleotide exchange factor (GEF) 12 2
NM_001039515 Arl4a Mus musculus ADP-ribosylation factor-like 4A 1
NM_007488 Arnt2 Mus musculus aryl hydrocarbon receptor nuclear translocator 2 1
NM_030711 Arts1 Mus musculus type 1 tumor necrosis factor receptor shedding aminopeptidase regulator 1
NM_025541 Asf1a Mus musculus ASF1 anti-silencing function 1 homolog A (S. cerevisiae) 2
NM_138679 Ash1l Mus musculus ash1 (absent, small, or homeotic)-like (Drosophila) 3
NM_007496 Atbf1 Mus musculus AT motif binding factor 1 2
NM_177632 BC022623 Mus musculus cDNA sequence BC022623 1
NM_153407 BC035295 Mus musculus cDNA sequence BC035295 1
XM_984947 BC053401 PREDICTED: Mus musculus cDNA sequence BC053401, transcript variant 2 1
NM_012060 Bcap31 Mus musculus B-cell receptor-associated protein 31 1
NM_080708 Bmp2k Mus musculus BMP2 inducible kinase 1
NM_027430 Brp44 Mus musculus brain protein 44 1
NM_009790 Calm1 Mus musculus calmodulin 1 1
NM_177343 Camk1d Mus musculus calcium/calmodulin-dependent protein kinase ID 4
XM_001000085 Camta1 PREDICTED: Mus musculus calmodulin binding transcription activator 1 1
XM_985577 Cand1 PREDICTED: Mus musculus cullin associated and neddylation disassociated 1 2
NM_007610 Casp2 Mus musculus caspase 2 4
NM_009817 Cast Mus musculus calpastatin 1
NM_028763 Cbx6 Mus musculus chromobox homolog 6 1
NM_198164 Cdc2l6 Mus musculus cell division cycle 2-like 6 (CDK8-like) 2
NM_007669 Cdkn1a Mus musculus cyclin-dependent kinase inhibitor 1A (P21) 3
NM_028760 Cep55 Mus musculus centrosomal protein 55 2
NM_019950 Chst5 Mus musculus carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5 1
NM_013885 Clic4 Mus musculus chloride intracellular channel 4 (mitochondrial) 2
XM_921620 Cnot6 PREDICTED: Mus musculus CCR4-NOT transcription complex, subunit 6, transcript variant 3 4
NM_178854 Cnot6l Mus musculus CCR4-NOT transcription complex, subunit 6-like 2
NM_013495 Cpt1a Mus musculus carnitine palmitoyltransferase 1a, liver 1
NM_009963 Cry2 Mus musculus cryptochrome 2 (photolyase-like) 2
NM_026444 Cs Mus musculus citrate synthase 1
NM_173185 Csnk1g1 Mus musculus casein kinase 1, gamma 1 4
NM_177662 Ctso Mus musculus cathepsin O 2
NM_177640 D030056L22Rik Mus musculus RIKEN cDNA D030056L22 gene 2
XM_984040 D630040G17Rik PREDICTED: Mus musculus RIKEN cDNA D630040G17 gene 3
NM_011873 Dazap2 Mus musculus DAZ associated protein 2 3
NM_026302 Dctn4 Mus musculus dynactin 4 4
XM_001005781 Ddef2 PREDICTED: Mus musculus development and differentiation enhancing factor 2 1
NM_001039106 Ddhd1 Mus musculus DDHD domain containing 1 3
NM_007916 Ddx19a Mus musculus DEAD (Asp-Glu-Ala-Asp) box polypeptide 19a 1
XM_898691 Dip2a PREDICTED: Mus musculus DIP2 disco-interacting protein 2 homolog A (Drosophila), transc 1
XM_619261 Dock5 PREDICTED: Mus musculus dedicator of cytokinesis 5, transcript variant 1 1
NM_053090 Drctnnb1a Mus musculus down-regulated by Ctnnb1, a 1
NM_001013371 Dtx3l Mus musculus deltex 3-like (Drosophila) 3
NM_001013380 Dync1li2 Mus musculus dynein, cytoplasmic 1 light intermediate chain 2 2
NM_173386 E330016A19Rik Mus musculus RIKEN cDNA E330016A19 gene 3
NM_001001932 Eea1 Mus musculus early endosome antigen 1 1
NM_007915 Ei24 Mus musculus etoposide induced 2.4 mRNA 1
NM_207685 Elavl2 Mus musculus ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B) 2
NM_007936 Epha4 Mus musculus Eph receptor A4 2
NM_007961 Etv6 Mus musculus ets variant gene 6 (TEL oncogene) 2
NM_153118 Fnbp1l Mus musculus formin binding protein 1-like 1
NM_173182 Fndc3b Mus musculus fibronectin type III domain containing 3B 1
NM_028194 Fryl Mus musculus furry homolog-like (Drosophila) 1
XM_980423 Furin PREDICTED: Mus musculus furin (paired basic amino acid cleaving enzyme), transcript varia 1
NM_008056 Fzd6 Mus musculus frizzled homolog 6 (Drosophila) 1
NM_019749 Gabarap Mus musculus gamma-aminobutyric acid receptor associated protein 1
NM_013814 Galnt1 Mus musculus UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltran 1
NM_013529 Gfpt2 Mus musculus glutamine fructose-6-phosphate transaminase 2 1
NM_133236 Glcci1 Mus musculus glucocorticoid induced transcript 1 1
NM_025374 Glo1 Mus musculus glyoxalase 1 1
NM_021610 Gpa33 Mus musculus glycoprotein A33 (transmembrane) 1
NM_173747 Gpkow Mus musculus G patch domain and KOW motifs 3
NM_019986 Habp4 Mus musculus hyaluronic acid binding protein 4 2
NM_026812 Hddc3 Mus musculus HD domain containing 3 1
NM_010437 Hivep2 Mus musculus human immunodeficiency virus type I enhancer binding protein 2 2
NM_008253 Hmgb3 Mus musculus high mobility group box 3 1
NM_008258 Hn1 Mus musculus hematological and neurological expressed sequence 1 2
NM_010470 Hp1bp3 Mus musculus heterochromatin protein 1, binding protein 3 2
XM_985333 Hs6st1 PREDICTED: Mus musculus heparan sulfate 6-O-sulfotransferase 1 2
NM_175185 Hsdl1 Mus musculus hydroxysteroid dehydrogenase like 1 2
NM_008331 Ifit1 Mus musculus interferon-induced protein with tetratricopeptide repeats 1 1
NM_019440 Iigp2 Mus musculus interferon inducible GTPase 2 1
NM_008371 Il7 Mus musculus interleukin 7 2
NM_172161 Irak2 Mus musculus interleukin-1 receptor-associated kinase 2 1
NM_008390 Irf1 Mus musculus interferon regulatory factor 1 1
XM_001002526 Irf2bp2 PREDICTED: Mus musculus interferon regulatory factor 2 binding protein 2 3
NM_008394 Isgf3g Mus musculus interferon dependent positive acting transcription factor 3 gamma 2
NM_008402 Itgav Mus musculus integrin alpha V 1
NM_010580 Itgb5 Mus musculus integrin beta 5 1
NM_008410 Itm2b Mus musculus integral membrane protein 2B 1
NM_021310 Jmy Mus musculus junction-mediating and regulatory protein 1
XM_978811 Kctd1 PREDICTED: Mus musculus potassium channel tetramerisation domain containing 1, transcr 1
NM_207682 Kif1b Mus musculus kinesin family member 1B 2
XM_994052 Klf3 PREDICTED: Mus musculus Kruppel-like factor 3 (basic) 2
NM_021284 Kras Mus musculus v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog 1
NM_145743 Lace1 Mus musculus lactation elevated 1 2
NM_010685 Lamp2 Mus musculus lysosomal membrane glycoprotein 2 3
NM_172153 Lcorl Mus musculus ligand dependent nuclear receptor corepressor-like 2
NM_010094 Lefty1 Mus musculus left right determination factor 1 1
NM_177099 Lefty2 Mus musculus Left-right determination factor 2 1
NM_001029878 Lonrf2 Mus musculus LON peptidase N-terminal domain and ring finger 2 2
NM_172950 Lpin1 Mus musculus lipin 1 1
NM_080420 Lpo Mus musculus lactoperoxidase 1
NM_172784 Lrp11 Mus musculus low density lipoprotein receptor-related protein 11 1
NM_173038 Lrrc35 Mus musculus leucine rich repeat containing 35 3
XM_984916 Lycat PREDICTED: Mus musculus lysocardiolipin acyltransferase, transcript variant 3 1
NM_172865 Manea Mus musculus mannosidase, endo-alpha 1
NM_027920 March8 Mus musculus membrane-associated ring finger (C3HC4) 8 3
NM_010773 Mbd2 Mus musculus methyl-CpG binding domain protein 2 1
NM_020007 Mbnl1 Mus musculus muscleblind-like 1 (Drosophila) 2
NM_175341 Mbnl2 Mus musculus muscleblind-like 2 1
NM_175088 Mdfic Mus musculus MyoD family inhibitor domain containing 1
XM_976104 Mef2a PREDICTED: Mus musculus myocyte enhancer factor 2A, transcript variant 3 2
XM_001002380 Mfn2 PREDICTED: Mus musculus mitofusin 2, transcript variant 4 1
XM_912670 Mgat5 PREDICTED: Mus musculus mannoside acetylglucosaminyltransferase 5, transcript variant 2 3
NM_008606 Mmp11 Mus musculus matrix metallopeptidase 11 1
NM_011985 Mmp23 Mus musculus matrix metallopeptidase 23 1
NM_008636 Mtf1 Mus musculus metal response element binding transcription factor 1 2
NM_001005864 Mtus1 Mus musculus mitochondrial tumor suppressor 1 1
NM_139063 Muted Mus musculus muted 2
NM_008659 Myo1c Mus musculus myosin IC 1
NM_019542 Nagk Mus musculus N-acetylglucosamine kinase 1
XM_973478 Nck2 PREDICTED: Mus musculus non-catalytic region of tyrosine kinase adaptor protein 2, transc 1
NM_172495 Ncoa7 Mus musculus nuclear receptor coactivator 7 1
NM_008684 Neo1 Mus musculus neogenin 2
NM_008687 Nfib Mus musculus nuclear factor I/B 1
NM_023526 Nkiras1 Mus musculus NFKB inhibitor interacting Ras-like protein 1 2
NM_009697 Nr2f2 Mus musculus nuclear receptor subfamily 2, group F, member 2 2
NM_172416 Ostm1 Mus musculus osteopetrosis associated transmembrane protein 1 1
NM_008775 Pafah1b2 Mus musculus platelet-activating factor acetylhydrolase, isoform 1b, alpha2 subunit 1
NM_011864 Papss2 Mus musculus 3'-phosphoadenosine 5'-phosphosulfate synthase 2 1
NM_028829 Paqr8 Mus musculus progestin and adipoQ receptor family member VIII 1
XM_992943 Pbx3 PREDICTED: Mus musculus pre B-cell leukemia transcription factor 3, transcript variant 6 1
XM_982935 Pcgf4 PREDICTED: Mus musculus polycomb group ring finger 4, transcript variant 4 1
NM_008786 Pcmt1 Mus musculus protein-L-isoaspartate (D-aspartate) O-methyltransferase 1 1
XM_912421 Pde3b PREDICTED: Mus musculus phosphodiesterase 3B, cGMP-inhibited 1
XM_920266 Pdzd2 PREDICTED: Mus musculus PDZ domain containing 2, transcript variant 9 1
NM_019410 Pfn2 Mus musculus profilin 2 4
NM_171824 Pgbd5 Mus musculus piggyBac transposable element derived 5 2
XM_895539 Phip PREDICTED: Mus musculus pleckstrin homology domain interacting protein, transcript varian 3
NM_201406 Pigs Mus musculus phosphatidylinositol glycan anchor biosynthesis, class S 1
NM_181585 Pik3r3 Mus musculus phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 3 (p55) 1
NM_001025309 Pja2 Mus musculus praja 2, RING-H2 motif containing 1
NM_018807 Plagl2 Mus musculus pleiomorphic adenoma gene-like 2 3
NM_031256 Plekha3 Mus musculus pleckstrin homology domain-containing, family A (phosphoinositide binding sp 1
NM_183034 Plekhm1 Mus musculus pleckstrin homology domain containing, family M (with RUN domain) member 2
NM_023564 Plscr3 Mus musculus phospholipid scramblase 3 1
NM_010127 Pou6f1 Mus musculus POU domain, class 6, transcription factor 1 2
NM_024209 Ppp6c Mus musculus protein phosphatase 6, catalytic subunit 1
NM_178738 Prss35 Mus musculus protease, serine, 35 2
NM_008971 Ptk9 Mus musculus protein tyrosine kinase 9 1
NM_011877 Ptpn21 Mus musculus protein tyrosine phosphatase, non-receptor type 21 2
NM_027514 Pvr Mus musculus poliovirus receptor 2
NM_024436 Rab22a Mus musculus RAB22A, member RAS oncogene family 3
NM_026405 Rab32 Mus musculus RAB32, member RAS oncogene family 1
NM_144875 Rab7l1 Mus musculus RAB7, member RAS oncogene family-like 1 1
NM_001038621 Rabgap1l Mus musculus RAB GTPase activating protein 1-like 1
XM_983626 Rapgef2 PREDICTED: Mus musculus Rap guanine nucleotide exchange factor (GEF) 2 1
NM_009826 Rb1cc1 Mus musculus RB1-inducible coiled-coil 1 2
NM_011250 Rbl2 Mus musculus retinoblastoma-like 2 3
NM_029777 Rhbdd1 Mus musculus rhomboid domain containing 1 1
NM_007484 Rhoc Mus musculus ras homolog gene family, member C 1
NM_145491 Rhoq Mus musculus ras homolog gene family, member Q 1
NM_023894 Rhox9 Mus musculus reproductive homeobox 9 1
NM_009068 Ripk1 Mus musculus receptor (TNFRSF)-interacting serine-threonine kinase 1 1
NM_023270 Rnf128 Mus musculus ring finger protein 128 1
NM_011277 Rnf2 Mus musculus ring finger protein 2 1
XM_903197 Rora PREDICTED: Mus musculus RAR-related orphan receptor alpha, transcript variant 4 4
NM_009075 Rpia Mus musculus ribose 5-phosphate isomerase A 1
NM_199476 Rrm2b Mus musculus ribonucleotide reductase M2 B (TP53 inducible) 1
NM_030179 Rsnl2 Mus musculus restin-like 2 1
NM_030692 Sacm1l Mus musculus SAC1 (suppressor of actin mutations 1, homolog)-like (S. cerevisiae) 1
NM_011452 Serpinb9b Mus musculus serine (or cysteine) peptidase inhibitor, clade B, member 9b 2
NM_031179 Sf3b1 Mus musculus splicing factor 3b, subunit 1 2
XM_988661 Sh3glb1 PREDICTED: Mus musculus SH3-domain GRB2-like B1 (endophilin) 1
NM_177364 Sh3pxd2b Mus musculus SH3 and PX domains 2B 3
NM_172966 Sh3rf2 Mus musculus SH3 domain containing ring finger 2 1
NM_134038 Slc16a6 Mus musculus solute carrier family 16 (monocarboxylic acid transporters), member 6 1
NM_025807 Slc16a9 Mus musculus solute carrier family 16 (monocarboxylic acid transporters), member 9 1
NM_172773 Slc17a5 Mus musculus solute carrier family 17 (anion/sugar transporter), member 5 2
NM_018861 Slc1a4 Mus musculus solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 1
NM_021435 Slc35b4 Mus musculus solute carrier family 35, member B4 2
NM_133741 Snrk Mus musculus SNF related kinase 1
NM_029068 Snx16 Mus musculus sorting nexin 16 1
NM_028937 Sohlh2 Mus musculus spermatogenesis and oogenesis specific basic helix-loop-helix 2 1
NM_009274 Srpk2 Mus musculus serine/arginine-rich protein specific kinase 2 3
NM_138744 Ssx2ip Mus musculus synovial sarcoma, X breakpoint 2 interacting protein 1
NM_011374 St8sia1 Mus musculus ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 1
NM_024239 Stambp Mus musculus Stam binding protein 1
NM_133810 Stk17b Mus musculus serine/threonine kinase 17b (apoptosis-inducing) 2
NM_134115 Stk38 Mus musculus serine/threonine kinase 38 1
NM_026343 Stx17 Mus musculus syntaxin 17 1
NM_025932 Syap1 Mus musculus synapse associated protein 1 2
XM_903544 Syde1 PREDICTED: Mus musculus synapse defective 1, Rho GTPase, homolog 1 (C. elegans) 1
XM_981719 Synj1 PREDICTED: Mus musculus synaptojanin 1 1
NM_145968 Tagap Mus musculus T-cell activation Rho GTPase-activating protein 1
NM_198294 Tanc1 Mus musculus tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 2
NM_023755 Tcfcp2l1 Mus musculus transcription factor CP2-like 1 2
NM_146142 Tdrd7 Mus musculus tudor domain containing 7 1
NM_009371 Tgfbr2 Mus musculus transforming growth factor, beta receptor II 3
NM_009373 Tgm2 Mus musculus transglutaminase 2, C polypeptide 1
NM_133352 Tm9sf3 Mus musculus transmembrane 9 superfamily member 3 1
XM_892747 Tmcc1 PREDICTED: Mus musculus transmembrane and coiled coil domains 1, transcript variant 2 2
NM_134020 Tmed4 Mus musculus transmembrane emp24 protein transport domain containing 4 1
NM_144792 Tmem23 Mus musculus transmembrane protein 23 1
NM_009395 Tnfaip1 Mus musculus tumor necrosis factor, alpha-induced protein 1 (endothelial) 2
XM_982893 Tnrc6a PREDICTED: Mus musculus trinucleotide repeat containing 6a 1
NM_009277 Trim21 Mus musculus tripartite motif protein 21 2
NM_178872 Trim36 Mus musculus tripartite motif-containing 36 1
XM_987804 Trps1 PREDICTED: Mus musculus trichorhinophalangeal syndrome I (human) 1
NM_133681 Tspan1 Mus musculus tetraspanin 1 2
NM_026954 Tusc1 Mus musculus tumor suppressor candidate 1 1
NM_028339 Txndc1 Mus musculus thioredoxin domain containing 1 2
NM_153162 Txnrd3 Mus musculus thioredoxin reductase 3 1
NM_019586 Ube2j1 Mus musculus ubiquitin-conjugating enzyme E2, J1 1
NM_172300 Ube2z Mus musculus ubiquitin-conjugating enzyme E2Z (putative) 1
NM_011670 Uchl1 Mus musculus ubiquitin carboxy-terminal hydrolase L1 2
NM_009466 Ugdh Mus musculus UDP-glucose dehydrogenase 1
NM_177561 Usp46 Mus musculus ubiquitin specific peptidase 46 2
XM_977760 Wdr26 PREDICTED: Mus musculus WD repeat domain 26, transcript variant 7 1
NM_011701 Vim Mus musculus vimentin 1
NM_172643 Zbtb41 Mus musculus zinc finger and BTB domain containing 41 homolog 4
NM_010731 Zbtb7a Mus musculus zinc finger and BTB domain containing 7a 4
NM_028864 Zc3hav1 Mus musculus zinc finger CCCH type, antiviral 1 1
NM_011749 Zfp148 Mus musculus zinc finger protein 148 2
NM_175494 Zfp367 Mus musculus zinc finger protein 367 4
NM_009557 Zfp46 Mus musculus zinc finger protein 46 2
NM_133218 Zfp704 Mus musculus zinc finger protein 704 5
NM_133906 Zkscan1 Mus musculus zinc finger with KRAB and SCAN domains 1 5
NM_144516 Zmynd11 Mus musculus zinc finger, MYND domain containing 11 1
XM_893176 Znrf3 PREDICTED: Mus musculus zinc and ring finger 3, transcript variant 2 2
Supplementary Table 4. Primers used in the study. 
 
Primer pair Primer sequences (5´-3´) Reference 
Primers for chromatin immunoprecipitation 
forward TCCCCTCCCCCTATCAGTTC  
GAPDH 
reverse TTGGACCCGCCTCATTTTT  
forward TGGGCTGAAATACTGGGTTC  
Oct-4 
reverse TTGAATGTTCGTGTGCCAAT  
Primers for real-time quantitative RT-PCR 
forward CCATCACCATCTTCCAGG  
GAPDH 
reverse CCTGCTTCACCACCTTCTTG  
forward GGCGTTCGCTTTGGAAAGGTGTTC  
Oct-4 
reverse CTCGAACCACATCCTTCTCT  
forward TGATTCAGAAGGGCTCAGCAC  
Nanog 
reverse GGGATAGCTGCAATGGATGC  
forward TGAATTGGCAGAGCTTGATCC  
GCNF 
reverse CGATCATCTGGGACGGAAAC  
forward AGGGGCTGCACCTGGCCTT 1 
Dnmt3a2 
reverse TCCCCCACACCAGCTCTCC 1 
forward TGGGATCGAGGGCCTCAAAC 1 
Dnmt3b1/b6 
reverse TTCCACAGGACAAACAGCGG 1 
forward CCCGGAGCCAGGTGTACA  
Rbl2 reverse CCTCATCACTGGGCTGGAAT  
Primers for bisulfite sequencing 
Oct-3/4 [-2069] forward GGGAGGAATTGGGTGTGGGGAGGTT 2 
Oct-3/4 [-1677] reverse AAAAATCCCCTCCTTCTACCACAT 2 
Oct-3/4 [-1505] forward TGATGAAGATTATTATTAAGAGAT 2 
Oct-3/4 [-992] reverse CCCCAATCCCCTCACACAAAACTT 2 
Oct-3/4 [-212] forward AGGATTTTGAAGGTTGAAAATGAAGG 2 
Oct-3/4 [-8] reverse TCCCTCCCCAATCCCACCCTC 2 
Oct-3/4 [+1173] forward GTAATTAGTTTTAAGAATAAGGTG 2 
Oct-3/4 [+1340] reverse AAATAAACTATTAATACCTTCCTA 2 
CTCF.bis.9.fwd forward GTTAATTTTTAAGGATGATAGTTTTGTGATT  
CTCF.bis.9.rev reverse AAAACCATAACAAAAACCTAAACCTTAC  
IAP.bis.fwd forward TTGATAGTTGTGTTTTAAGTGGTAAATAAA 3 
IAP.bis.rev reverse AAAACACCACAAACCAAAATCTTCTAC 3 
IAP 5’.bis.fwd forward ATGGGTTGTAGTTAATTAGGGAGTGATA  
IAP 5’.bis.rev reverse CATACAATTAAATCCTTCTTAACAATCTAC  
LINE1.bis.fwd forward TAGGAAATTAGTTTGAATAGGTGAGAGGT  
LINE1.bis.rev reverse TCAAACACTATATTACTTTAACAATTCCCA  
satellite.bis.fwd forward ATACACACTTTAAAACATAAAATATAA 5 
satellite.bis.rev reverse TTYGTTATATTTTAGGTTTTTTAGA 5 
MuERV.bis.fwd forward GTTATTATGTGATTTGAATTA 3 
MuERV.bis.rev reverse ACATACAAAACCATCAATAAAC 3 
Sox30.bis.fwd forward AGGTGTTTTTATATTTGAGAATGATTAGAA 4 
Sox30.bis.rev reverse ATTAAAACCCTTCCAAAACCTTAACTA 4 
Tsp50.bis.fwd forward TAAAAATTGTTATTGAAGTTAAGTTTGG 4 
Tsp50.bis.rev reverse CTAAACCCTTTCTCTAAATCCCTATAC 4 
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Sinkkonen et al. SUPPLEMENTARY MATERIALS AND METHODS 
 
mRNA microarray analysis 
Undifferentiated Dicer+/– and Dicer–/– cells were grown in the presence of LIF as 
described in the main text. Prior to harvesting, Dicer+/– and Dicer–/– cells were grown in 
triplicates for more than one week. For the rescue with the miR-290s mimics, three 
independently cultured Dicer–/– cell samples were transfected separately with either miR-
290 cluster miRNA mimics or siRL, as described in Materials and Methods (main text), 
and harvested 24 h later. We note that at the time of study the miR-290 annotation in 
miRBase1 was for the miR-290-5p and not miR-290-3p. The miR-290-5p mimic was 
therefore included in the transfection together with miR-291a-3p through miR-295-3p 
miRNAs, which represent the main products of their respective hairpins. The 
complement of miR-290-5p seed was not found to be significantly enriched in any seed 
motif analysis, arguing that miR-290-5p does not play a major role in ES cells. 
Total RNA was isolated using Absolutely RNA Miniprep Kit (Stratagene). 5 µg 
of total RNA from each triplicate culture was reverse transcribed with the Affymetrix 
cDNA synthesis kit and cRNA was produced by in vitro transcription (IVT) by T7 RNA 
polymerase, using the Affymetrix IVT kit as per manufacturer’s instructions. 20 µg of 
biotinylated cRNA was fragmented by heating in the presence of Mg2+ (as per 
Affymetrix’s instructions) and 15 µg of fragmented cRNA from each triplicate was 
hybridized to Mouse MOE430 v2.0 GeneChips™. All arrays yielded hybridization 
signals of comparable intensity and quality. BioConductor2 Affymetrix package of the R 
software was used to import the CEL files from the Affymetrix Mouse Genome 430 2.0 
Array. Probe set intensities were then background-corrected, adjusted for non-specific 
binding and quantile normalized with the GCRMA algorithm3. GCRMA-normalized 
microarray data were deposited in the GEO database (GSE7141 and GSE8503). 
 
Data analysis 
To extract a non-redundant set of transcripts for subsequent analyses of 3′-UTR 
sequences, probe sets with _s or _x tags, which map to multiple transcripts from different 
genes, were discarded. Then, the Affymetrix annotation from December 2006 was used 
to obtain the corresponding reference sequence (RefSeq4) for each probe set. When the 
Affymetrix array contained probe sets for alternative RefSeq transcripts for the same 
gene, we only used the RefSeq transcript with the median length 3′-UTR. Through this 
procedure, we obtained an n-to-1 probe set to RefSeq transcript mapping. For transcripts 
that had multiple probe sets, we discarded those that were deficient, as indicated by their 
very low variance across a set of unrelated experiments performed with different cell 
types using the same platform (Affymetrix Mouse Genome 430 2.0). Finally, the log2 
intensities of the probe sets corresponding to a given transcript were averaged to obtain a 
transcript level measurement. We used Limma5 to estimate the fold change and the 
corresponding p-value in the three replicate experiments for each condition. 
To identify those motifs whose frequency in up-regulated (in Dicer–/–) or down-
regulated (in Dicer–/– ES cells transfected with miRNA mimics of the miR-290 family) 
3′-UTRs is significantly different relative to the frequency in the entire set of 3′-UTRs, 
we extracted the set of transcripts up-regulated in the Dicer-/- cells (p-value < 0.001) and 
computed the relative frequency of all 7-mers in the 3′-UTRs of these transcripts 
compared with the entire set of 3′-UTRs represented on the microarray. For each 7-mer, 
we then plotted the log2(number of occurrences in up-regulated 3′-UTRs) on the x-axis, 
and the enrichment in up-regulated 3′-UTRs compared to the entire set of 3′-UTRs on the 
y-axis (Fig. 1b and 1e). We then used a Bayesian model that we previously introduced for 
comparing miRNA frequencies between samples6. Briefly, we estimate the posterior 
probabilities of the model that assumes that the frequency of a given motif is different 
between two sets of transcripts (call this "different" model), and the model that assumes 
that the frequency is the same (call this "same" model), given the observed counts m and 
n of the motif among M and N total motifs in the two samples. We selected as significant 
those motifs that were enriched in the up-regulated or down-regulated set, respectively, 
with a posterior probability of the "different" model > 0.99 
 
miRNA microarray analysis 
Total RNA from two independent cultures of Dicer+/– cells and single culture of Dicer–/– 
cells was extracted using MirVana miRNA Isolation Kit (Ambion). 5 μg of each RNA 
preparation was used for miRNA miRCURYTM microarray analysis as a service by 
Exiqon (Vedbäck, Denmark). As a control, a mixture of 5 μg of total RNA originating 
from 10 mouse tissues (Ambion) supplemented with 500 ng of total RNA from Dicer+/– 
cells was labeled with Hy5 (spectrally equivalent to Cy5) and co-hybridized with either 
the Dicer+/– or the Dicer–/– RNA samples, which were labeled with Hy3 (spectrally 
equivalent to Cy3). The expression level of reliably detected miRNAs was calculated 
relative to the levels in Dicer+/– sample as well as relative to the level in the control 
mixture of total RNAs (reference sample). Most miRNA probes exhibited hybridization 
signal also with Dicer–/– samples, suggesting that the arrays also detect precursors of 
miRNAs or cross-hybridize to unrelated RNAs. The original data are available upon 
request. 
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3.1.3 The silencing of pri-miR-290 locus by de novo DNA methylation during 
neuronal differentiation enables upregulation of neuronal genes 
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3.1.3.1 Aim of the project 
Mature miRNAs of the miR-290 cluster are known to become downregulated upon 
differentiation of ESCs but the mechanism of this downregulation is unknown (Houbaviy 
et al. 2003). Here we aimed to analyze the downregulation of these miRNAs and to 
determine whether transcriptional silencing of the miRNA locus is contributing to this 
downregulation. Since we have previously discovered that miR-290 miRNAs are 
necessary for proper de novo DNA methylation in mouse ESCs (see chapter 3.1.1), we 
were interested to find out whether the silencing of these miRNAs would involve de novo 
DNA methylation, thus creating a potential autoregulatory loop.  
 
3.1.3.2 Results and discussion 
In order to decipher whether the repression of miR-290 miRNAs takes place at the 
transcriptional level, we focused on the pri-miR-290 transcript (Houbaviy et al. 2005). To 
analyze pri-miR-290 in a physiologically relevant system, we took advantage of a 
recently established neuronal differentiation protocol (Bibel et al. 2004; Mohn et al. 
2008). In this protocol the mouse ESCs are differentiated in a course of eight days into 
neuronal precursors (NPs). These precursors are then differentiated additional ten days 
into specific neuronal subtype of radial glial cells (terminal neurons or TNs). First we 
made use of the previously published microarray data (Mohn et al. 2008) to analyze the 
transcriptional changes at these three different developmental stages (ESC, NP and TN). 
Figure 5A shows a schematic representation of the structure of pri-miR-290 locus and the 
location of array probes and PCR primers used to analyze the locus. We analyzed the 
level of pri-miR-290 based on the Affymetrix array probe (1444292_at) recognizing the 
pri-miR-290 as well as the mRNA levels of primary and secondary miR-290 cluster 
targets Rbl2 and Dnmt3s, respectively (Figure 5B). As expected from a primary miR-290 
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cluster target, Rbl2 mRNA level was strongly induced upon differentiation and this 
upregulation could be confirmed also by real-time quantitative reverse transcription-PCR 
(RT-qPCR) (data not shown). At the same time the mRNAs for targets of RBL2 
repression, Dnmt3a2, Dnmt3b and Dnmt3L, were downregulated. It is important to note 
that some probe sets not depicted here, especially for Dnmt3a, showed a different pattern 
of expression. This is most likely due to crosshybridization to alternative transcription or 
splicing variants such as Dnmt3a1, which is known to have different expression pattern 
from Dnmt3a2 (Chen et al. 2002). Interestingly, also pri-miR-290 showed a very strong 
downregulation upon neuronal differentiation (up to 30-fold). Moreover, similar extent of 
repression could be detected by RT-qPCR when the expression of pri-miR-290 was 
normalized to that of glyceraldehyde-3-phosphate dehydrogenase (Gapdh) (Figure 5C). 
This analysis revealed that in ESCs pri-miR-290 is expressed at very high levels at close 
to 50% of the expression of Gapdh. The slight increase observed in pri-miR-290 
expression from NP to TN stage transition is due to a modest decrease in the levels of 
Gapdh and not because of re-expression of pri-miR-290.  
The silencing of pri-miR-290 in neurons was robust and very reminiscent of the 
irreversible silencing of pluripotency genes such as Oct-4 and Nanog. In addition, pri-
miR-290 has similar ESC specific expression pattern as Oct-4 and Nanog. For these 
reasons we hypothesized that silencing of pri-miR-290 might be accompanied by similar 
changes in its chromatin structure as the silencing of these pluripotency genes (see for 
example Mohn et al. 2008). There are only very few pri-miRNAs for which the 
epigenetic regulation at their promoter regions has been described. Thus, we performed 
ChIP analysis using antibodies against RNA Pol II, H3K4me2 and H3K27me3. ChIP was 
perfomed at ESC, NP and TN stages and analyzed by primers detecting the TSS (ChIP 
proximal) or promoter region (ChIP distal) of pri-miR-290. As a control we monitored 
the promoter of the highly expressed Gapdh gene. Consistently with high expression in 
ESCs, RNA Pol II was found highly enriched at the TSS of pri-miR-290 as well as at the 
Gapdh promoter but not in the more distal region of the pri-miR-290 promoter (Figure 
6A). Transcriptional silencing of pri-miR-290 in NPs and TNs was accompanied by 
complete loss of RNA Pol II while it remained present at the active Gapdh locus. 
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Figure 5. Pri-miR-290 is silenced during neuronal differentiation of mouse ESCs. 
(A) Schematic structure of the pri-miR-290 locus depicting the location of the conserved TATA-box, 
mature miRNA hairpins, the classical polyadenylation signal and the probes/primers used in the 
experiments. ChIP, chromatin immunoprecipitation; BS, bisulphite sequencing. (B) Expression of the 
indicated transcripts during neuronal differentiation was analyzed by Affymetrix microarrays and the 
indicated probe sets. Relative expression levels are shown and expression at the ESC stage was set to 1. 
The values represent the mean of two independent microarray experiments. (C) The silencing of pri-miR-
290 was confirmed by RT-qPCR analysis. The expression levels were normalized to the respective 
expression of Gapdh. Values represent the mean of two independent experiments. Error bars show standard 
deviation (SD).  
 
Furthermore, the chromatin modification associated with high transcriptional 
activity, H3K4me2, was well enriched throughout the pri-miR-290 promoter in ESCs and 
was fully removed in the neurons (Figure 6B). H3K27me3, which is associated with 
Polycomb-mediated repression, was not found to be present at Gapdh promoter at any 
stage (Figure 6C). Also, the pri-miR-290 locus was free of this modification in the 
pluripotent ESCs but upon differentiation high levels accumulated at the TSS, suggesting 
that pri-miR-290 might be silenced via activity of PRC2. Interestingly, the enrichment of 
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H3K27me3 was much weaker at the distal promoter region, indicating that the 
modification is present specifically at the TSS. 
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Figure 6. Chromatin changes in transcriptional silencing of pri-miR-290 during differentiation. 
ChIP analysis of Gapdh promoter and distal and proximal promoter regions of pri-miR-290 at ESC, NP and 
TN stages of neuronal differentiation by antibodies against (A) RNA Pol II, (B) H3K4me2 and (C) 
H3K27me3. Relative enrichments after normalization to the respective input DNA are shown. For 
H3K27me3 the enrichment was additionally normalized to the enrichment at an unrelated intergenic 
regions not accumulating H3K27me3. For H3K27me3 the values represent means (+ SD) of two 
independent experiments. For RNA Pol II and H3K4me2, the values come from single experiments. 
 
 Complete silencing and heterochromatinization of many pluripotency genes by 
the Polycomb group proteins is often accompanied by DNA methylation of the locus. 
Since miR-290 miRNAs are contributing to high expression of de novo DNMTs in ESCs, 
it is possible that de novo DNA methylation also contributes to silencing of pri-miR-290, 
creating an autoregulatory circuit. For this reason, we analyzed the DNA methylation in 
ESCs, NPs and TNs at three adjacent regions of the pri-miR-290 locus by bisulphite 
sequencing (Figure 7). Together, the studied regions contain 24 CpGs flanking the TSS 
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of pri-miR-290. As expected, DNA from ESCs contained only low level of CpG-
methylation. But, consistently with the kinetics of de novo DNA methylation of other 
pluripotency genes, pri-miR-290 promoter had become highly methylated in the NPs and 
maintained this methylation also in TNs. Interestingly, the CpG-dinucleotide most 
resistant to methylation (the CpG depicted by the fourth circle from the right in region 
BS2 of Figure 7) is located immediately upstream of the pri-miR-290 TSS, at the position 
-9. None of the sequenced clones from NPs was methylated at this position. And even in 
BS3BS2BS1
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TN
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Figure 7. DNA methylation of pri-miR-290 locus during neuronal differentiation. 
DNA was extracted from the ESC, NP and TN stages of neuronal differentiation and analyzed for CpG 
methylation by bisulphite sequencing. The location of the three examined regions (BS1, BS2 and BS3) is 
depicted in Figure 5A. Each row of dots represents CpGs in one sequenced clone. Black dots represent 
methylated CpGs and white dots represent unmethylated CpGs. Sites for which the methylation status was 
uncertain are in gray. 
 
TNs only one out of the five sequences had methylation at this CpG. The high gain of 
DNA methylation at the pri-miR-290 locus, together with the intermediate CpG density 
of this locus imply that complete silencing of pri-miR-290 and its miRNA products might 
depend on de novo DNA methylation. It will be interesting to examine silencing of the 
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locus in DNMT3A/DNMT3B as well as PRC2 depleted ESCs and to estimate the 
contribution of pri-miR-290 silencing for successful differentiation of ESCs. 
Since expression of miR-290 miRNAs becomes fully silenced in NPs and TNs, 
we asked whether the targets of miR-290 miRNAs (listed in chapter 3.1.3) are enriched 
among transcripts highly expressed in neurons. For this purpose we inspected the 
microarray data for the transcriptional changes between ESCs and NP or TN stage 
neurons. The arrays contained altogether 20,872 probe sets that were reliably detected at 
all three stages. We analyzed what fraction of these probe sets was strongly upregulated 
(> 3-fold), upregulated (> 1.5-fold), did not change (<1.5-fold), was downregulated 
(>1.5-fold) or strongly downregulated (> 3-fold) either between ESCs and NPs or 
between ESCs and TNs (Figure 8A or B, respectively). Then we did the same analysis for 
the 400 reliably detectable probe sets monitoring the expression of miR-290 targets. 
Comparison of distribution of individual fractions in the set of all transcripts and in the 
set of miR-290 target transcripts revealed clear differences between these two groups. 
 
A B
0 %
10 %
20 %
30 %
40 %
50 %
60 %
70 %
80 %
90 %
100 %
All transcripts miR-290 targets
%
 o
f p
ro
be
 s
et
s
Strong up
Up
Not changed
Down
Strong down
0 %
10 %
20 %
30 %
40 %
50 %
60 %
70 %
80 %
90 %
100 %
All transcripts miR-290 targets
%
 o
f p
ro
be
 s
et
s
Strong up
Up
Not changed
Down
Strong down
ESC NP ESC TN
 
Figure 8. The primary targets of miR-290 cluster miRNAs are enriched for neuronal transcripts. 
The reliably detectable probe sets from the microarray analysis of three neuronal differentiation stages 
(ESC, NP and TN) were divided into five different subgroups based on the change in their signal between 
(A) ESCs and NPs or (B) ESCs and TNs. The divide into the subgroups for all transcripts and for miR-290 
target transcripts was compared. Strong up, > 3-fold upregulation; up, > 1.5-fold upregulation; not changed, 
< 1.5-fold change to either direction; down, > 1.5-fold downregulation; and strong down, > 3-fold 
downregulation. 
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While only 7% and 16% of all probe sets are either strongly upregulated or upregulated 
between ESCs and NPs, respectively, as many as 17% and 26% of the probe sets 
detecting miR-290 targets showed similar upregulation (Figure 8A). Also in the 
comparison of ESCs and TNs, the fraction of probe sets with strong upregulation was 
twice as big for miR-290 targets as the one for all probe sets (from 16% to 31%) (Figure 
8B). Curiously, the fractions of mildly upregulated probes sets were similar. In all cases, 
the increased fraction of upregulated probe sets in the miR-290 targets was compensated 
by smaller fractions of mildly downregulated and not-changed probe sets. Thus, 
consistent with miR-290 mediated repression in undifferentiated ESCs, putative miRNA 
targets appear to be enriched in transcripts whose expression increases during neuronal 
differentiation. 
 
3.1.3.3 Conclusions 
Taken together, we have shown that the downregulation of miR-290 miRNAs during 
neuronal differentiation is mediated at the transcriptional level and leads to complete 
silencing of the pri-miR-290 expression. The silencing is characterized by complete loss 
of RNA Pol II and H3K4me2 from the locus and accompanied by strong increase in 
H3K27me3. This leaves open the possibility that pri-miR-290 might be a target of 
Polycomb mediated silencing in neuronal differentiation.  Like many Polycomb target 
genes, pri-miR-290 promoter accumulated DNA methylation during differentiation, 
suggesting that de novo DNA methylation by DNMT3 enzymes might be necessary for 
irreversible silencing of expression of miR-290 miRNAs. All the features of pri-miR-290 
silencing resemble the silencing of many pluripotency genes like Oct-4. This suggests 
that in order for normal development to take place, like expression of Oct-4, the 
expression of miR-290 miRNAs has to be restricted to early embryonic development. 
Indeed, the targets of miR-290 miRNAs are enriched among the transcripts upregulated 
during neuronal differentiation. This further argues that miR-290 miRNAs are important 
for maintaining the pluripotency of ESCs. 
 Since pri-miR-290 locus is a target of DNMT3 enzymes while miR-290 miRNAs 
regulate the expression of DNMT3 enzymes via targeting RBL2, it is concievable that an 
autoregulatory loop exists between these factors (Figure 9). In this regulation, high 
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expression of pri-miR-290 would allow high numbers of mature miR-290 miRNAs in 
ESCs. This in turn would lead to strong downregulation of their primary target RBL2, a 
transcriptional repressor of Dnmt3a2/Dnmt3b, and possibly Dnmt3L, expression, thus 
allowing high expression levels of these enzymes. In this manner, the cells would express 
sufficient numbers of de novo DNMTs to succesfully methylate DNA at their target 
promoters during initiation of differentiation, and allow complete silencing of many 
pluripotency genes, including pri-miR-290. This silencing would then eventually lead to 
upregulation of RBL2 and to RBL2-mediated repression of DNMT3 enzymes, which can 
be observed during neuronal differentiation (Figure 5B). Similar autoregulatory loops 
have already been desribed to exist between miRNAs and transcriptional regulators, for 
example between miR-17-92 cluster and E2F family transcription factors (Sylvestre et al. 
2007). 
 
DNMT3A2
DNMT3BDNMT3L
miR-290 miRNAs
RBL2
NANOG
OCT-4
 
Figure 9. Model for autoregulation between miR-290 miRNAs and DNMT3 enzymes in mouse ESC 
differentiation. 
High expression of miR-290 miRNAs leads to downregulation of RBL2, allowing high expression of 
DNMT3 enzymes. In this way, sufficient number of DNMT3A/3B/3L complexes are available upon 
initiation of differentiation to mediate irreversible silencing of pluripotency genes such as Nanog and Oct-4 
as well as pri-miR-290. Silencing of pri-miR-290 during differentiation leads to increased expression of 
RBL2 and, in turn, causes downregulation of DNMT3s. 
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3.1.3.4 Methods 
 
ESC differentiation 
The differentiation was performed as previously described (Bibel et al. 2004; Mohn et al. 
2008). In short, ESCs were deprived of feeder cells during 3-4 passages and this was 
followed by formation of cellular aggregates by 4 x 106 cells. The aggregates were then 
cultivated in non-adherent dishes for 8 days. At day 4 retinoic acid (5 μM) was added and 
left for the 4 remaining days. Subsequently, the aggregates were dissociated with trypsin 
and plated (2 x 105 cells per cm2) on cationic substrate coated with laminin. After plating 
a medium enriched with supplements was added for 10 days of terminal neuronal 
maturation. 
 
RT-qPCR 
Total RNA was extracted with Trizol (Invitrogen) and purified using RNAeasy columns 
(Qiagen). Thermoscript RT-PCR kit (Invitrogen) was used for the cDNA synthesis 
reaction with 1 μg template RNA and 250 pmol of oligo(dT)20 primer, incubated for 1 h 
at 55 °C. Subsequently, cDNA was used as a template for RT-qPCR with the ABI Prism 
7000 Sequence Detection System and Platinum SYBR Green qPCR SuperMix, using 
primers specific for Gapdh and pri-miR-290. Sequences of primers are provided in Table 
1. Annealing of all primers was done at 55 °C. Relative expression levels were calculated 
using the formula 2–(ΔCt), where ΔCt is Ct(gene of interest)–Ct(Gapdh) and Ct is the 
cycle at which the threshold is crossed. 
 
ChIP 
ChIP was performed mainly as previously described (Weber and Schubeler 2007). The 
ESCs, NPs or TNs were cross-linked in medium containing 1% formaldehyde for 10 min 
at room temperature, scraped off and rinsed with 10 ml of 1xPBS. Pellets were 
resuspended in 15 ml of buffer 1 (10 mM Tris (pH 8.0), 10 mM EDTA, 0.5 mM EGTA, 
0.25% Triton X-100) and twice in 15 ml of buffer 2 (10 mM Tris (pH 8.0), 1 mM EDTA, 
0.5 mM EGTA, 200 mM NaCl). Following the washes the cells were lysed in 1 ml of 
lysis buffer (50 mM HEPES/KOH (pH 7.5), 500 mM NaCl, 1 mM EDTA, 1% Triton X-
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100, 0.1% DOC, 0.1% SDS, protease inhibitors) and sonicated three times for 15 s (using 
a Branson sonicator, amplitude 70%). 70 μg of chromatin was incubated overnight at 4 
°C with 5 μg of the following antibodies: anti-trimethyl-H3K27 (Upstate, #07-449), anti-
dimethyl-H3K4 (Upstate, #07-030), anti-RNA Pol II (Santa Cruz Biotechnology, 
#SC899). The formed immunocomplexes were incubated for 3 h at 4 °C with 30 μl 
protein A-Sepharose beads preblocked with tRNA. Beads were washed twice with 1 ml 
lysis buffer and once with 1 ml DOC buffer (10 mM Tris (pH 8.0), 0.25 M LiCl, 0.5% 
NP-40, 0.5% deoxycholate, 1 mM EDTA), and bound chromatin was eluted in 1% 
SDS/0.1 M NaHCO3. After RNase A treatment, cross-linking was reversed by overnight 
incubation at 65 °C followed by proteinase K digestion. DNA was isolated by 
phenol/chloroform extraction followed by ethanol precipitation and resuspension in 50 μl 
TE. A sample of the input chromatin was treated in the same way to generate total input 
DNA. The purified DNA and the respective input DNA were used as templates for 
quantitative real-time PCR, using the ABI Prism 7000 Sequence Detection System 
(Applied Biosystems), Platinum SYBR Green qPCR SuperMix (Invitrogen) and primers 
specific for the Gapdh and pri-miR-290 promoters. Obtained values were first normalized 
to the respective input DNA and further to the enrichment of an unrelated intergenic 
region in the case of H3K27me3. Sequences of primers are listed in Table 1. Annealing 
of all primers was done at 55 °C. 
 
Bisulfite sequencing 
1 μg of genomic DNA extracted from ESCs, NPs, and TNs was bisulfite converted using 
the Epitect Bisulfite Kit (Qiagen). Three different regions (BS1, BS2, and BS3) of pri-
miR-290 locus were amplified by PCR, the PCR products were gel purified, cloned by 
TOPO-TA cloning (Invitrogen) and sequenced using SP6 reverse sequencing primer. The 
sequences of primers to amplify converted DNA are listed in Table 1. 
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Table 1. Primers used for analysis of pri-miR-290 during neuronal differentiation. 
 
Primer pair Primer sequences (5’ to 3’) 
Primers for RT-qPCR 
forward CCATCACCATCTTCCAGG Gapdh 
reverse CCTGCTTCACCACCTTCTTG 
forward CCACGTGTTCCGGGTTAACT pri-miR-290 
reverse ACCGTCTACTGGGCAGGATG 
Primers for ChIP 
forward TCCCCTCCCCCTATCAGTTC Gapdh promoter 
reverse TTGGACCCGCCTCATTTTT 
forward AGCAGCCCAGTTTGACCATC pri-miR-290 proximal 
reverse CTGGAGCAGAGGCTATCCCA 
forward AGTGAAGGTCACTCTGCCGC pri-miR-290 distal 
reverse AGAGACCAGCATTCCCGATG 
Primers for bisulphite sequencing 
forward AACAAAAGAAAAACAGCCGGGCATGGTG pri-miR-290 BS1 
reverse TCAAATCCTCCCTCTTTTTTACCTT 
forward CCTAGTCACCATAGTAGACCAAGCTGGC pri-miR-290 BS2 
reverse CTGGAGGCAGAGAGGCAGGCAGAAA 
forward CCAGGCTGGCCTTTAACTCTCATTTCTGC pri-miR-290 BS3 
reverse CTCCAACCTGAAGGAAACCTGGATG 
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3.2. Intact RNA silencing machinery is necessary for proper 3’ end 
processing of replication-dependent histone mRNAs. 
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3.2.1 Aim of the project 
Accumulating evidence suggests that miRNAs are involved in regulation of number of 
pathways and processes in mammalian cells. Characterization of these regulatory 
pathways is of great interest. Here we aimed to identify novel processes under miRNA-
mediated regulation by taking advantage of depletion of miRNAs from human HEK293 
cells. miRNAs were depleted by inducible knock-down (KD) of different RNA silencing 
pathway components, namely Dicer and the four human Argonaute proteins. miRNAs are 
known to exhibit much of their regulation via mRNA degradation in HEK293 cells, more 
so than for example in HeLa cells (Schmitter et al. 2006). Thus, HEK293 cells are a good 
model system to identify miRNA targets through analysis of transcriptome changes upon 
depletion of miRNAs. By detailed analysis of the genome-wide transcriptome changes 
after miRNA depletion we were able to identify 3’ end processing of histone mRNAs as a 
process under miRNA-mediated regulation. 
 
3.2.2 Results and discussion 
Previously, stable human HEK293 cell lines suitable for inducible depletion of Dicer or 
any of the four Argonautes were generated in our laboratory (Schmitter et al. 2006). 
Plasmids expressing short hairpin RNAs (shRNAs) were cloned and stably integrated 
into the genome of 293T-REx cell line, which expresses a Tet-repressor. Tet-repressor 
binds to the promoter of the shRNA and represses its expression. Treatment of these cells 
with tetracyclin or its analog doxycyclin leads to relief of repression by Tet-repressor and 
allows expression of the shRNA. The shRNA enters the RNAi pathway and induces KD 
of the targeted gene. RNA isolated from cell lines with depletion of either Dicer or one of 
the Argonaute proteins was used for microarray analysis in order to identify transcripts 
that are regulated by these components of the RNA silencing pathway. The results from 
these experiments suggest that most transcriptomic changes upon loss of Dicer and 
AGO2 are due to depletion of miRNAs (Schmitter et al. 2006).  
 A detailed analysis of the microarray data revealed that many of the human 
replication-dependent histone genes are upregulated upon loss of Dicer in 293T-REx 
cells (Figure 10). There are 61 probe sets on Affymetrix Human U133 2.0 Plus arrays 
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that monitor the levels of 54 different histone genes (Table 2). 17 of these probe sets 
(representing the expression levels of 14 histone genes), showed a more than 1.5-fold 
increase in hybridization signal in both of the tested Dicer-KD cell lines (2-2 and 2b2) 
after 6 days of shRNA induction (Figure 10). For many of the probe sets the increase 
could be observed already 2 days after the Dicer-KD. Likewise, many of the 17 probe 
sets showed an increased signal after 2 days of AGO2 or AGO3 KD when compared to 
the signal in similarly treated control cell lines. The control 293T-REx cell lines express 
either a scrambled hairpin RNA (293T-REx controls 2&3; Figure 10) or have an 
integration of an empty plasmid (293T-REx controls 1&4; Figure 10). In contrast, loss of 
AGO1 or AGO4 seemed to have no effect on the expression of histone genes. 
 The apparent upregulation of histone genes could have several causes. Since 
expression of histone genes is fluctuating during cell cycle, the upregulation could be a 
result of a prolonged S-phase (Harris et al. 1991). Hence, we analyzed the cell cycle 
profile of the cells after 6 days of Dicer-KD. As shown in Figure 11A, after 6 days of 
tetracycline treatment the fraction of the cells in S-phase was around 13% in both 
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Figure 10. Microarray analysis of replication-dependent histone genes after depletion of Dicer or 
Argonaute proteins in 293-T-REx cells. 
The raw expression values of the 17 probe sets monitoring a more than 1.5-fold upregulation of histone 
mRNAs in two different Dicer-KD cell lines after 6 days of tetracycline induction are illustrated as a heat 
map. The numerical values corresponding to the different colours are indicated by the bar on the left. Grey 
color indicates that the microarray probe signal was evaluated as “absent”. The names of the probes sets, 
the respective genes as well as tested cell lines are shown. Dicer-KD cell lines were induced for the 
indicated time points. All other cell lines were induced for 2 days. 
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control and Dicer-KD cells. This result is consistent with the fact that only a 
subpopulation of histone genes is upregulated. In case the upregulation would be due to 
prolonged S-phase all rather than only some of histone genes would be expected to be 
upregulated. Hence, the observed upregulation is likely to be caused by a more specific 
type of misregulation.  
 In order to confirm the microarray results, we performed RT-qPCR analysis of 
RNA extracted from Dicer-KD cells over a time course of 1 to 9 days of induction 
(Figure 11B). We tested five histone genes upregulated on microarrays (one for each 
histone class: H1, H2A, H2B, H3 and H4), using gene specific primer pairs. In addition, 
we tested the expression levels of HIST1H2AB and HIST1H4I, two histone genes not 
affected in the microarray experiments. The levels of upregulated histone mRNAs started 
to increase already a few days after KD induction and continued to accumulate to as high 
as 10-fold increase after 9 days. Interestingly, also HIST1H4I started to show some 
accumulation by 9 days of Dicer-KD, suggesting that most histone mRNAs might be 
affected by the loss of Dicer, although many of them to a lesser extent. Still, 
HIST1H2AB remained unchanged. Importantly, transfection of the Dicer-KD cells after 
7 days of induction with a Dicer construct modified to escape the repression by Dicer-
specific shRNA was sufficient to rescue the effect of the KD on increase in histone 
mRNAs by 9 days. This suggests that the effect is specific for loss of Dicer and is not 
caused simply by expression of the shRNA or its possible off-target effect.  
Similar RT-qPCR analysis of the AGO2-KD cells was able to confirm the 
upregulation of the histone mRNAs also in the absence of AGO2 (Figure 11C). 
Consistent with AGO2 acting downstream of Dicer in the RNA silencing pathway, the 
effect of loss of AGO2 on histone mRNAs was more robust and rapid that in the case of 
Dicer-KD. By 2 days the upregulation could be clearly observed and by 4 days 
expression of HIST1H2BK mRNA had already increased over 10-fold. Curiously, also 
HIST1H2AB became upregulated upon loss of AGO2. 
Tetracyclin inducible KD of both Dicer and AGO2 leads to upregulation of many 
of the replication-dependent histone genes in HEK293 cells. To confirm, that this 
increase in histone mRNAs takes place also in other cell types and upon tetracyclin-  
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Figure 11. Histone mRNAs accumulate after loss of Dicer and AGO2 without an effect on the cell 
cycle. 
(A) Fluoresence-assisted cell sorting (FACS) analysis for percentage of cells in G1- or S-phase of the cell 
cycle after 6 days tetracycline treatment of 293T-REx control cells and Dicer-KD cells. Mean values (+SD) 
from two independent FACS analysis are shown. (B and C) Expression of indicated transcripts in (B) 
Dicer-KD cells or (C) AGO2-KD cells relative to the 293T-REx control cells during a time course of 
tetracycline treatment. For the rescue experiment in panel B the Dicer-KD cells were induced for 7 days, 
transfected by a modified Dicer expression construct and induced for further 2 days. The values were 
normalized to GAPDH and represent mean (+ standard error of mean, SEM) of two to five independent 
experiments.  
 
independent Dicer-KD, we transiently transfected HeLa cells with the shDicer-expressing 
plasmid. Already 1 day after transfection the mRNA and protein levels of Dicer were 
reduced and by three days no Dicer protein could be detected (Figure 12A and B). 
Although at day 1 there was no significant misregulation of histone mRNAs, already by 3 
days the expression of all five histones genes of interest was strongly upregulated (Figure 
12C). In fact, the upregulation was stronger than in the stable Dicer-KD cells, possibly 
due to more efficient KD of Dicer by several copies of shDicer plasmid, enhanced in 
addition by lower starting levels of Dicer in HeLa than in 293T-REx cells (Su et al. 2002 
and our unpublished results). Unexpectedly, upregulation of HIST1H3H was somewhat  
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Figure 12. Histone mRNAs are upregulated upon transient KD of Dicer in HeLa cells. 
(A) The Dicer mRNA level in 1 and 3 days shDicer transfected HeLa cells relative to non-transfected cells. 
(B) Western blot analysis of Dicer levels in HeLa cells before and after transfection of shDicer construct. α-
Tubulin was used as a loading control. (C) Expression of indicated transcripts in 1 and 3 days shDicer 
transfected HeLa cells relative to non-transfected cells. In panels A and C the values were normalized to 
GAPDH and represent mean (+SEM) of three to four independent experiments. 
 
weaker in HeLa than in the stably-transformed Dicer-KD cells when compared to the 
upregulation of other histone mRNAs. Again, HIST1H2AB and HIST1H4I were not 
affected. Taken together, these results further support the idea that the observed 
upregulation of the replication-dependent histone genes is specific for loss of Dicer and 
takes place independently of the used cell type. 
The microarray experiments as well as the abovementioned RT-qPCR 
experiments were performed using cDNA, synthesis of which was primed by oligo-dT. 
Thus, the results reflect the changes of polyadenylated transcripts and not necessarily of 
the levels of histone mRNAs physiologically 3’ processed at the 3’-terminal stem-loop. 
Since replication-dependent histone genes are usually following this mode of the 3’ end 
processing, our results might not apply to the total population of the transcribed histone 
mRNAs. In order to test this, we performed RT-qPCR analysis of some of the histone 
mRNAs using random hexamer priming during the cDNA synthesis. Oligo-dT and 
random hexamer primed RT-qPCR analyses of Dicer-KD cells induced for 6 days 
revealed that the upregulation of HIST1H1C and HIST1H3H is clearly more robust in the 
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oligo-dT primed samples (Figure 13A). This result indicates that, instead of an increase 
in total populations of histone mRNAs, loss of Dicer is causing enhanced 
polyadenylation of the mRNAs, possibly due to affected 3’ end processing at the histone 
stem-loop. A notable exception in Figure 13A is HIST1H2BK, which is robustly 
upregulated in both conditions. This might reflect a normally poor processing of 
HIST1H2BK by U7 and SLBP, leading to a low stability of the S-phase specific 
HIST1H2BK mRNA. And as the polyadenylation would become a more favored 
processing mode, the total level of HIST1H2BK mRNA would increase. This is probable 
since HIST1H2BK is one of the only three human replication-depent histone genes that 
have introns, implying that it might be processed by polyadenylation rather than at the 
histone stem-loop structure.  
To confirm that the shift from production of non-polyadenylated to 
polyadenylated histone mRNAs can indeed be detected as an upregulation in oligo-dT 
primed RT-qPCR experiments, we disrupted the normal histone 3’ end processing in 
HeLa cells by depleting SLBP. This was done by transfecting a pool of siRNAs against 
SLBP into HeLa cells and collecting RNA from these cells 1 and 3 days after the original 
transfection. The siRNA transfection led to a robust downregulation of SLBP mRNA, 
which was accompanied by extremely strong increase in polyadenylated histone 
transcripts (Figure 13B and C). The robustness of the increased polyadenylation upon 
SLBP-KD is likely to be due to complete failure of these cells to process new histone 
mRNAs in a canonical way at the histone stem-loop structure. This may lead to 
inadequate production of histones, what is supported by the observation that all SLBP-
KD cells die already soon after 3 days of KD. Interestingly, also upon loss of SLBP, 
HIST1H3H is affected to a lesser extent than the other tested histone mRNAs in HeLa 
cells. 
 Consistent with our observations, recent results from Narita et al. show that 
disruption of normal histone 3’ end processing by KD of NELF-E or CBP80, and the 
subsequent enhancement of histone mRNA polyadenylation, can be observed 
bymicroarrays as a more intense signal from probe sets monitoring histone mRNAs 
(Narita et al. 2007). Comparison of their microarray data to ours reveals that 11 of 12  
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Figure 13. The KD of Dicer or SLBP leads to increase in polyadenylated histone mRNAs. 
(A) The observed upregulation of histone mRNAs upon loss of Dicer is more robust after oligo-dT priming 
in cDNA synthesis. Expression of indicated transcripts in Dicer-KD cells relative to the 293T-REx control 
cells using either olido-dT or random hexamer primed cDNA after 6 days of tetracycline treatment. (B) The 
SLBP mRNA level in 1 and 3 days siSLBP transfected HeLa cells relative to non-transfected cells. (C) 
Expression of indicated transcripts in 1 and 3 days siSLBP transfected HeLa cells relative to non-
transfected cells. In all panels the values were normalized to GAPDH and represent mean (+SEM) of two 
independent experiments. 
 
histone mRNAs “upregulated” after KD of both NELF-E and CBP80 are also 
“upregulated” upon loss of Dicer (data not shown).  
To find out how general the polyadenylation of replication-dependent histone 
mRNAs is, we studied the publicly available expression data from Genomics Institute of 
Novartis Research Foundation (GNF) (http://symatlas.gnf.org/SymAtlas/) (Su et al. 2002). 
We analyzed which of the 61 GNF probe sets detecting human histone mRNAs show 
reasonably high expression values (raw expression value of more than 100) across a 
panel of 9 tested human cell lines (Table 2). Remarkably, all but one of the probe sets 
reporting increased levels after Dicer-KD also show high basal expression level in these 
cell lines. Most other histone probe sets reported low signals. This suggests that 
transcription of these genes also results in formation of polyadenylated transcripts, in 
addition to the transcripts normally processed at the histone stem-loop. 
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Table 2. Human replication-dependent histones detected by Affymetrix Human U133 Plus 2.0 arrays. 
Gene name Probe set High signal† 
>1,5x  up in 
Dicer-KD  
poly-A 
cloned*  Gene name Probe set 
High 
signal† 
>1,5x  up in 
Dicer-KD  
poly-A 
cloned*  
HIST1H1A 208484_at N N N HIST1H3B 208576_s_at N Y N 
HIST1H1B 214534_at N N N HIST1H3C 208577_at N N N 
HIST1H1C 209398_at Y Y Y HIST1H3D 214472_at Y N Y 
HIST1H1D 214537_at N N N  214522_x_at N N Y 
HIST1H1E 208553_at N N N  214472_at Y N Y 
HIST1H1T 207982_at N N N  214522_x_at N N N 
HIST1H2AB 208569_at N N N HIST1H3E 214616_at N N N 
HIST1H2AC 215071_s_at Y Y Y HIST1H3F 208506_at N N N 
HIST1H2AE 214469_at N N N  208506_at N N N 
HIST1H2AG 207156_at Y Y Y HIST1H3G 208496_x_at Y N Y 
HIST1H2AI 214542_x_at N N N HIST1H3I 214509_at N N N 
 206110_at N N N HIST1H3J 214646_at N N N 
 206110_at N N N HIST1H4A 208046_at N N N 
HIST1H2AJ 208583_x_at N N N HIST1H4B 214516_at N N N 
HIST1H2AK 214644_at N N N HIST1H4C 205967_at Y N Y 
 214644_at N N N HIST1H4D 208076_at N N N 
HIST1H2AL 214554_at N N N HIST1H4E 206951_at N N Y 
HIST1H2AM 214481_at Y N Y HIST1H4F 208026_at N N N 
HIST1H2BB 208547_at N N N HIST1H4G 208551_at N N N 
HIST1H2BC 214455_at N N N HIST1H4H 208180_s_at Y Y Y 
HIST1H2BD 209911_x_at Y Y Y  208181_at N Y Y 
 222067_x_at Y Y Y HIST1H4I 214634_at N N Y 
 222067_x_at Y Y Y HIST1H4J 214463_x_at N N N 
HIST1H2BE 208527_x_at Y Y N  208580_x_at N N N 
HIST1H2BF 208490_x_at Y Y N  214463_x_at N N N 
 208490_x_at Y Y N  208580_x_at N N N 
HIST1H2BG 215779_s_at Y N Y  214463_x_at N N N 
 210387_at Y N Y  208580_x_at N N N 
HIST1H2BH 208546_x_at Y Y N HIST1H4L 214562_at N N N 
HIST1H2BI 208523_x_at Y Y N HIST2H2AA 214290_s_at Y Y N/A 
HIST1H2BJ 214502_at N N Y  218279_s_at N N N/A 
 214502_at N N Y  218280_x_at Y N N/A 
HIST1H2BK 209806_at Y Y Y HIST2H2BE 202708_s_at Y Y Y 
HIST1H2BL 207611_at N N N HIST2H4 207046_at N N N/A 
HIST1H2BM 208515_at N N N HIST3H2A 221582_at Y N Y 
HIST1H2BN 207226_at N N Y HIST3H3 208572_at N N N 
HIST1H2BO 214540_at N N N      
HIST1H3A 208575_at N N N      
 
† = whether the respective probe set shows in average a raw expression signal of above 100 across a panel 
of 9 tested cell lines (HEK293, HEK293T, 293T-REx, HeLa, HepG2, Huh-7, Jurkat, K562 and MCF-7) 
(Su et al. 2002). 
* = whether a longer, polyadenylated variant of the gene has been cloned by the Mammalian Gene 
Collection (MGC) of National Institute of Health (NIH) (Strausberg et al. 2002). 
Y = yes 
N = no 
N/A = not available  
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To further address this possibility, we studied whether any longer and 
polyadenylated transcripts of the human histone genes had been cloned and sequenced by  
the Mammalian Gene Collection (MGC) consortium of the National Institute of Health 
(NIH) (http://mgc.nci.nih.gov/) (Strausberg et al. 2002). As shown in Table 2, for 7 out of 
the 14 upregulated histone mRNAs, a polyadenylated variant has indeed been identified. 
For all detectable histone mRNAs the same numbers are 18 out of 51. Taken together, 
these observations indicate that under normal conditions a subpopulation of replication-
dependent histone genes is giving rise to low levels of polyadenylated transcripts, in 
addition to their normal mature mRNAs, processed at the 3’-terminal stem-loop. 
Disruption of the normal histone mRNA processing, for example by loss of SLBP, leads 
to increased production of mainly longer, polyadenylated transcripts. This is manifested 
in increased mRNA levels in assays relying on oligo-dT priming. 
 To investigate whether the normal processing of histone mRNAs is in fact 
disrupted by the loss of intact RNA silencing pathway, we focused our analysis on one of 
the candidate histones, HIST1H3H. Under normal conditions HIST1H3H is transcribed 
into 473-nt long mature mRNA that is cleaved 5 nts after the stem-loop (Figure 14A). In 
addition, a 1253-nt long polyadenylated transcript arising from the same gene has been 
cloned. To test whether the proportion of the longer HIST1H3H transcripts increases 
upon Dicer-KD, we designed several primer pairs to monitor different regions of the 
gene. The first primer pair (H3H-1) detects all HIST1H3H transcripts due to its location 
in the CDS; the second pair (H3H-2) is flanking the normal processing site and detects 
only the misprocessed, polyadenylated transcripts; the third pair (H3H-3) is located 
several hundred nts downstream of the mature mRNA but still within the longer poly-A+ 
transcript; while the fourth (H3H-4) is located beyond the polyadenylation signals of the 
longer transcript. These primer pairs were used in random hexamer primed RT-qPCR 
experiments to detect the relative expression levels of the different length transcripts 
following 6 or 9 day KD of Dicer (Figure 14B). As measured by the primer pairs H3H-2 
and H3H-3, in 293T-Rex control cells as well as non-induced Dicer-KD cells the longer 
transcripts amount to about 10% of the total HIST1H3H mRNA population (level of 
which is measured by H3H-1). Consistent with being located downstream of either 
mature mRNAs, the H3H-4 primer pair showed a 100-fold lower signal than H3H-1. 
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Still, H3H-4 was amplifying a specific product, likely representing the occasional read-
through products of RNA Pol II. Upon loss of Dicer, after 6 or 9 days of tetracycline 
treatment, the proportion of longer HIST1H3H mRNA had increased to more than 60% 
of total HIST1H3H. Thus, a significant shift in the predominant 3’ end formation 
mechanism had taken place. Interestingly, also amount of transcript detected by H3H-4 
primer pair increased upon loss of Dicer. This is likely due to the increased RNA Pol II 
read-through upon repressed production at the histone stem-loop. 
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Figure 14. Normal 3’ end processing of HIST1H3H disrupted upon loss of Dicer. 
(A) Schematic structure of the HIST1H3H locus depicting the relative location of HIST1H3H CDS, the 
stem-loop structure (SL), the histone downstream element (HDE) and polyadenylation signals (AAUAAA) 
downstream of the mature mRNA. Also location of primer pairs and the RPA probe used are indicated. (B) 
Expression of different length HIST1H3H transcripts relative to the total population of HIST1H3H 
transcripts in 293T-Rex control cells and in Dicer-KD cells at different time points as measured by random 
hexamer primed RT-qPCR. The values were normalized to GAPDH and represent mean (+SEM) of two to 
three independent experiments. (C) RPA analysis of HIST1H3H processing 6 and 9 days after tetracycline 
treatment of 293T-REx control cells and Dicer-KD cells. The used probes and the source of RNA 
hybridized with them are indicated. No intact probe can be detected in the negative control lane where the 
probe was incubated with yeast RNA. 20% of the non-RNase treated free probe was loaded. As a positive 
control, β-actin probe together with mouse total liver RNA was used.  
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 Intriguingly, analysis of inducible TRBP-KD cell lines (TRBP is a co-factor of 
Dicer required for pre-miRNA processing) demonstrated a similar shift towards longer 
HIST1H3H transcripts as observed for Dicer-KD cell lines (data not shown; Haase et al 
2005). Thus, TRBP seems to contribute to the function of Dicer in regulation of histone 
3’ end processing.  
As an alternative approach to verify the increase in longer poly-A+ transcripts we 
used RNase protection assay (RPA). A 384-nt radioactively labeled probe should protect 
a 267-nt long fragment diagnostic of poly-A+ HIST1H3H mRNA (Figure 14A) and 91 nt 
fragment diagnostic of normal histone mRNA. A probe detecting the mouse β-actin 
mRNA was used as a positive control together with mouse liver RNA. When the RPA 
was performed with the HIST1H3H probe and RNA from 6 and 9 day tetracycline 
induced 293T-Rex control cells, only short, 90-nt fragments could be detected (Figure 
14C). This result further argues that most of HIST1H3H mRNA is normally processed at 
the stem-loop structure in these cells. When the same probe was incubated with RNA 
from 6 and 9 day induced Dicer-KD cells, the 90-nt fragments were also detectable. But, 
in addition, longer, ~267-nt fragment was also detectable, demonstrating that a significant 
misregulation of the HIST1H3H processing was taking place upon loss of Dicer. 
Moreover, lower levels of intermediate size RNA fragments were visible in the Dicer-KD 
lanes, likely reflecting hybridization of degraded fragments of the probe to the longer 
HIST1H3H transcript. This data further confirms that KD of Dicer leads to disruption of 
normal histone 3’ end processing and production of longer HIST1H3H transcripts. 
 Finally, to see whether regulation of histone mRNA processing by the RNA 
silencing pathway is conserved to other species, we analyzed expression of histone 
mRNAs in mouse Dicer-/- embryonic stem cells (ESCs). First, we analyzed the 
expression profiles of histone mRNAs in Dicer+/- and Dicer -/- ESCs, based on the 
microarray data described in chapter 3.1. On Affymetrix Mouse MOE430 v2.0 
GeneChips, there are 34 probe sets monitoring expression of only 20 different 
replication-dependent histone mRNAs. Of these, 5 probe sets, representing 3 histone 
mRNAs, showed clear upregulation of more than 1.5-fold (Figure 15A). The upregulation 
of all three mRNAs, Hist1h1c, Hist1h2bc and Hist1h2bp, could be confirmed by RT-
qPCR after oligo-dT primed cDNA synthesis (Figure 15B). Thus, RNA silencing 
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machinery appears to be necessary for histone 3’ end processing in both human and 
mouse cells. 
Still, the number of histone genes affected, as well as extent of upregulation, are 
smaller in mouse ESCs than in the tested human cell lines. There could be several reasons 
for this. First, although conserved, the 3’ end processing of histone mRNAs in mouse and 
human cells might differ in some aspects. Second, the analyzed mouse cells are ESCs that 
are special in many ways e.g. they have an altered cell cycle profile and practically move 
from mitosis directly to a new S-phase, omitting most of the G1-phase (White and Dalton 
2005). Third, while in human cells the depletion of Dicer takes place in a rapid, inducible 
manner, the Dicer-/- ESCs have been cultured for many passages since the removal of 
Dicer and have possibly acquired additional mutations to compensate for their initial 
defects. 
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Figure 15. Histone mRNAs are upregulated in miRNA deficient mouse ESCs. 
(A) The raw expression values of the 5 probe sets monitoring a more than 1.5-fold upregulation of histone 
mRNAs in mouse Dicer-/- ESCs are illustrated as a heat map. The numerical values corresponding to the 
different colours are indicated by the bar on the left. The names of the probes sets, the respective genes as 
well as tested cells are shown. (B and C) Expression of indicated transcripts in (B) Dicer-/- ESCs and (C) 
Dgcr8-/- ESCs relative to the respective heterozygous ESCs as measured by RT-qPCR. The values were 
normalized to Oct-4 and represent mean (+SEM) of three to five independent experiments. Expression 
value in heterozygous cells was set to 1. p-values calculated by two-tailed Student’s t-test are: * < 0.05; ** 
< 0.01. 
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Based on our results, Dicer, AGO2, AGO3, and TRBP appear to contribute to the 
correct balance between different 3’ end processing pathways of histone mRNAs and, at 
least for Dicer, this regulation is conserved from human to mouse. Yet, it is not clear how 
this regulation takes place. One possibility is that these proteins, or other proteins 
functioning in a complex with them, could play a direct role in histone mRNA 
processing. Another, perhaps more likely explanation, is that small RNAs generated by 
Dicer with the help of TRBP are loaded on AGO2 and AGO3, and are capable of 
regulating factors involved in histone 3’ end formation (for example SLBP or U7). So far 
we were unable to identify any genes involved in the histone mRNA processing to be 
misregulated at the mRNA level in Dicer-depleted cells (data not shown). But, we have 
not yet ruled out their possible misregulation at the protein level. 
 To address whether the increased histone mRNA polyadenylation depends on 
miRNAs or some other Dicer products such as endogenous siRNAs, we analyzed the 
expression of polyadenylated histone mRNAs in mouse Dgcr8-/- ESCs (Wang et al. 
2007). DGCR8 is a co-factor Drosha and is needed for processing of pri-miRNAs, and 
thus, for biogenesis of mature miRNAs. The RNA from Dgcr8+/- and Dgcr8-/- ESCs 
(kindly provided by Dr. R. Blelloch) was analyzed by RT-qPCR after the oligo-dT 
primed cDNA synthesis for expression levels of Hist1h1c, Hist1h2bc and Hist1h2bp 
(Figure 15C). As shown in Figure 15C, all three mRNAs were significantly upregulated 
upon loss of DGCR8, indicating that the proper histone 3’ end formation depends on 
expression of mature miRNAs. 
 
3.2.3 Conclusions 
Taken together, these results demonstrate that the presence of the RNA silencing 
machinery is required for normal 3’ end processing of many replication-dependent 
histone genes in mouse and human cells. Most likely, this regulation is mediated by 
conserved miRNAs that are present in all proliferating cells. Possibly, these miRNAs 
regulate one or several components of the 3’ end formation complexes and, in this way, 
contribute to the decision between different 3’ end processing pathways. Identification of 
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these miRNAs and their downstream targets would be of great interest and might reveal 
so far unknown aspects of the molecular decision making that takes place during 
transcription termination. 
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3.2.4 Methods 
Cell culture and transfections of plasmids and siRNAs 
293T-REx and HeLa cell lines were maintained in DMEM supplemented with 10% (w/v) 
FCS (fetal calf serum). In addition, to maintain the expression of Tet-repressor, 293T-
REx cells were cultured in the presence of 5 μg/ml blasticidin. Stable KD cell lines were 
cultured in presence of 200 μg/ml zeocin to maintain shRNA construct. For KD induction 
the cells were treated with 10 μg/ml tetracycline. The Dicer heterozygous (+/–; line D4) 
and Dicer-deficient (–/–; line 27H10) ESCs (kindly provided by G. Hannon, Cold Spring 
Harbor Laboratory, Cold Spring Harbor, New York, USA) were maintained on gelatin-
coated plates in DMEM supplemented with 15% (w/v) FCS, sodium pyruvate, β-
mercaptoethanol, nonessential amino acids and LIF. Transfections of 293T-REx and 
HeLa cells were performed using Lipofectamine 2000 (Invitrogen). shDicer construct 
was generated by Kaifu Tang (Schmitter et al. 2006). Point mutated Dicer expression 
construct able to avoid shDicer was generated by Astrid Haase (Haase et al. 2005). 
SLBP-KD was performed by transcfecting HeLa cells with 10 nM siGENOME 
smartPOOL siRNAs against SLBP (Dharmacon). 
 
FACS analysis 
For 30 min prior to FACS analysis, the control and KD cells were cultured in the 
presence of 10 μg/ml Hoechst33342 dye. Subsequenctly the cells were collected by 
trypsinization to PBS with 3% FCS, filtered (0.22 µm) and analyzed using MoFlow cell 
sorter (Dako Cytomation). 
 
RT-qPCR 
Total RNA from different cell lines was extracted using the Absolutely RNA Miniprep 
Kit (Stratagene). Total RNA from Dgcr8+/- and Dgcr8-/- ESCs was kindly provided by R. 
Blelloch (University of California San Franciso, San Franciso, USA). AThermoscript 
RT-PCR kit (Invitrogen) was used for the cDNA synthesis reaction with 1 μg template 
RNA and 250 pmol of oligo(dT)20 primer or 50 ng of random hexamers, incubated for 1 
h at 55 °C. Subsequently, cDNA was used as a template for RT-qPCR with the ABI 
Prism 7000 Sequence Detection System and Platinum SYBR Green qPCR SuperMix, 
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using gene-specific primers. Sequences of primers are provided in Table 3. Annealing of 
all primers was done at 55 °C. Relative expression levels were calculated using the 
formula 2–(ΔCt), where ΔCt is Ct(gene of interest)–Ct(control gene) and Ct is the cycle 
at which the threshold is crossed.  
 
Western blotting 
Cells were lysed in lysis buffer (30 mM Tris-HCl, pH 7.5, containing 150 mM NaCl, 1 
mM MgCl2, 0.5% (v/v) Nonidet P-40, 1 mM DTT and protease inhibitors) and kept on 
ice for 10 min. Equal amounts of the lysed proteins were separated on polyacrylamide-
SDS gels, blotted on polyvinylidene fluoride membrane and probed with primary 
antibodies against α-Tubulin (5.2.1 Sigma, 1:10,000) and Dicer (D349, 1:5,000). This 
was followed by incubation with secondary horseradish peroxidase–coupled antibodies. 
Detection was performed with ECL kit (Amersham).  
 
RPA 
The sequence for HIST1H3H probe was amplified from genomic DNA of 293T-REx 
cells using specific primers. The primer sequences are provided in Table 3. The amplified 
PCR product was gel purified and cloned into pCRII-TOPO vector downstream of a SP6 
promoter (Invitrogen). The cloned plasmid was used as a template for in vitro 
transcription of the radiolabeled probe together with 10 mCi/ml of [α-32P]UTP. 
Transcription was done using SP6 MAXIscript Kit for 1 h at 37 °C (Ambion). Full length 
radiolabeled probe was gel purified and 40,000 cpm of the probe was used for 
hybridization overnight at 42 °C together with 10 μg of total RNA from 293T-Rex or 
Dicer-KD cells using reagents from and according to RPAIII Kit (Ambion). As a 
negative control yeast RNA was used. In parallel a β-actin probe provided by the kit was 
transcribed and used as a positive control in hybridization to mouse liver RNA (also 
provided). After the hybridization, non-hybridized, single-stranded RNA was digested 
with RNaseA/RNase T1 Mix for 30 min at 37 °C. Remaining RNA was ethanol 
precipitated and run on a 6% denaturating polyacrylamide gel together with 20% of non-
digested free probe. Detection was done using Storm 860 Phosphoimager (Fuji) after 
overnight exposure. 
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Table 3. Primers used in the study. 
Primer pair Primer sequences (5’ to 3’) 
Primers for human genes 
forward CGCTCTCTGCTCCTCCTGTT GAPDH-1 
reverse CCATGGTGTCTGAGCGATGT 
forward TCAAGAAGGTGGTGAAGCAGG GAPDH-2 
reverse TTCCTCTTGTGCTCTTGCTGG 
forward ACTCGGTCTTCTCGTGCAGG HIST1H2AB 
reverse CGCTCGGAGTAGTTGCCTTT 
forward GGTATCACCAAGCCAGCCAT HIST1H4I 
reverse ACACCTTCAACACTCCGCG 
forward GCCGGCTATGATGTGGAGAA HIST1H1C 
reverse GCCTTTCGTTTGCACCAGAG 
forward GTCTTGCCTAACATCCAGGCC HIST2H2AA 
reverse TTGAGTTCACAGGTGCCCCT 
forward CCAAGGCCGTCACCAAGTAC HIST1H2BK 
reverse CCGAAGGCAATTGTGCTTCT 
forward CGCTATCGGCCTGGTACAGT HIST1H3H 
reverse GCGCAAGTCGGTCTTGAAGT 
forward TGTCTGGCCGTGGTAAAGGT HIST1H4H 
reverse GGATGTTATCGCGCAAAACC 
forward AATTGTCCATCATGTCCTCGC Dicer 
reverse CACATGGCTGAGAAGTATACCTGTCT 
forward GACACCTTCGACAACCTGGC SLBP 
reverse GCTCGGAGCTGCTTTCTGC 
Primers for mouse genes 
forward CCATCACCATCTTCCAGG Gapdh 
reverse CCTGCTTCACCACCTTCTTG 
forward GGCGTTCGCTTTGGAAAGGTGTTC Oct-4 
reverse CTCGAACCACATCCTTCTCT 
forward CGGCGCTAGTTCGTATTGGAC Hist1H1c 
reverse GCGCCCAATCAAACGAAGA 
forward CTGTGTTTGGAAATCCGAAGATG Hist1H2bc 
reverse GCGCTTCTTGCCGTCCTT 
forward GTAGAGTTCCTGACCTAACATGCCTG Hist1H2bp 
reverse GCGCTTCTTGCCATCCTTC 
Primers for amplifzing RPA probe 
forward ATCCAGCTCGCACGTCGTAT HIST1H3H 
reverse CGGAAAAATGCCGGACAT T 
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